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Streptococcus uberis is an important cause of intramammary infection in dairy cattle. 
Strains of S. uberis appear to differ in their ability to cause disease based on previous 
epidemiological studies. We explored the pathogenicity of 2 strains of S. uberis, 
where one strain represented a putatively host-adapted type based on its ability to 
cause persistent infection and to spread from cow to cow in a lactating herd. This 
type was part of a clonal complex that is commonly associated with bovine mastitis. 
The other strain, which was isolated from a transient infection in a single animal in 
the same herd and did not belong to any known clonal complex, was selected as 
putatively non-adapted type. Cows (6 per strain) were experimentally challenged in a 
single hind quarter and the adjacent hind quarter was used as mock challenged 
control quarter. Both strains showed an equal ability grow in milk of challenge 
animals in vitro. All cows that were challenged with the putatively host-adapted 
strain developed clinical signs of mastitis, including fever and milk yield depression 
as well as elevated somatic cell count due to influx of polymorphonuclear leucocytes 
and lymphocytes. The cytokine response followed a specific order, with an increase 
in IL-1β, IL-6 and IL-8 levels at the time of first SCC elevation, followed by an 
increase in IL-10, IL-12p40 and TNF-α levels approximately 6 h later. In 4 of 6 
animals, IL-17A was detected in milk between 57 and 168 h post challenge. The 





T lymphocyte ratio, and was observed from 96 h post challenge. This was followed 




 ratio due to continued increase of the CD8
+
 
concentration up to 312 h post challenge. Spontaneous resolution of infection was 
observed in 5 animals and coincided with a measurable IL-17A response in 4 
 
i 
animals, suggesting that IL-17 may be involved in the resolution of intramammary 
infection. To explore the mechanism of action of IL-17A we stimulated bovine PMN 
and bovine blood derived macrophages with recombinant IL-17A in vitro. IL-17A 
enhanced the killing ability of phagocyte toward the challenge strain. With the 
exception of minor elevation of IL-8 levels, no clinical, cytological or immunological 
response was detected in quarters challenged with the non-adapted strain. The 
observed strain specific pathogenicity was consistent across animals, implying that it 
is determined by pathogen factors rather than host factors. We further studied in vitro 
possible mechanisms involved in the differences observed between the two strains 
such as ability to adhere to the mammary epithelial cells, ability to resist to killing by 
phagocytes and ability to form biofilm. The adapted strain FSL Z1-048 showed an 
increased ability to adhere to the epithelial cells and an increase ability to resist to 
killing of monocyte derived macrophages. These mechanisms thus could potentially 
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1. 1 General Introduction 
 
Mastitis is defined as an inflammatory process of the mammary gland. In cattle the 
most common cause is an ascending bacterial infection. Bacterial pathogens causing 
mastitis are divided in two categories: Contagious pathogens and 
environmental/opportunistic pathogens. Contagious pathogens have the infected 
mammary gland as primary reservoir. Infection spreads from cow to cow during the 
milking (Radostis et al., 1994). Environmental pathogens have the herd environment 
as reservoir. Streptococcus agalactiae, Staphylococcus aureus, and Mycoplasma 
bovis are generally classified as contagious pathogens, whilst Escherichia coli and 
Klebsiella pneumoniae are considered environmental pathogens. However, recent 
data suggests that within certain mastitis pathogen species such as E. coli (Dopfer et 
al., 2000), K. pneumoniae (Munoz et al., 2007) and S. aureus (Roberson et al., 1994; 
Smith et al., 2005) both pathogen transmission routes may occur.  
 
Streptococcus uberis is a major mastitis pathogen. It is the most common cause of 
both clinical (32% of the cases) and sub-clinical (13.8% of the cases) mastitis in the 
UK (Bradley et al., 2007). It is often considered an environmental pathogen (Leigh, 
1999), although epidemiological, management and recent molecular data show that 
different strains may have different epidemiology and clinical manifestation 
(Reviewed by Zadoks, 2007). Control programs for contagious mastitis help to 
decrease the prevalence and incidence of S. uberis mastitis (Neave et al., 1969). 
Studies using strain typing methods such as pulsed field gel electrophoresis (PFGE) 
(Phuektes et al., 2001), and multi locus sequence typing (MLST) (Coffey et al., 
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2006) show that many S. uberis strains are present in the herd environment and the 
vast majority of mastitis cases are caused by several different strains. Other studies 
using strain typing showed that most of S. uberis mastitis cases are caused by a few 
strains (Oliver et al., 1998; Zadoks et al., 2003). 
In a longitudinal study an outbreak of S. uberis mastitis in a single herd was 
followed. Results show that most of the infections were caused by a single strain.  
Other strains were also identified by random amplified polymorphic DNA (RAPD) 
typing but they were isolated from single cases only. The predominant strain was 
also isolated from the milking liners suggesting cow to cow transmission during 
milking. The predominant strain was associated with sub-clinical and chronic 
infections in milking cows whereas other strains were associated with transient 
infections in both milking and dry cows. The longer infection caused by the 
predominant strain would provide the opportunity for the bacteria to spread from 
cow to cow (Zadoks et al., 2003). Based on these data and the literature, a host-
adaptation theory has been proposed: S. uberis species presents host-adapted and non 
host-adapted strains. Host-adapted strains are those that cause chronic infections with 
sub clinical manifestation, they affect lactating cows and they can spread from cow 
to cow during milking. Non host-adapted strains are those that are found in the herd 
environment, they cause clinical, transient infections in lactating cows, dry cows and 
pregnant heifers (Zadoks, 2007). 
Despite its importance S. uberis pathogenesis is still poorly understood (Leigh, 
1999). Two hypotheses have been formulated to explain how S. uberis can invade 
and colonize the mammary gland and cause mastitis. The first hypothesis considers 
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S. uberis a "replicating irritant" whereas the second hypothesis considers S. uberis an 
adherent and invasive pathogen. 
Leigh (1999) considers S. uberis a “replicating irritant” which can cause mastitis 
only if its growth rate in milk overcomes the rate of elimination given by milking and 
neutrophils. Ability of two strains to resist neutrophils phagocytosis in vitro was 
correlated to ability to cause clinical mastitis (Leigh et al., 1990). The resistance to 
neutrophil phagocytosis was correlated with the presence of the hyaluronic capsule 
(Leigh and Field, 1994). However, the hyaluronic capsule did not prevent 
phagocytosis by macrophages in vitro (Grant and Finch, 1997). Despite its role, 
presence of the capsule is not necessary to cause clinical mastitis (Field et al., 2003).  
 
Migration of neutrophils in the mammary gland was observed in vivo following 
experimental infections. In those studies the massive migration of neutrophils from 
blood stream into the mammary gland and then into milk was unable to reduce the 
number of S. uberis bacteria in milk. (Pedersen et al., 2003; Rambeaud et al., 2003). 
The second hypothesis considers the ability of S. uberis to adhere to and invade 
mammary epithelial cells a virulence factor that would explain the ability of S. uberis 
to persist in the mammary gland (Tamilselvam et al., 2006). Adherence of S. uberis 
to the mammary epithelial cells in vitro is mediated by a specific protein called 
Streptococcus uberis adhesion molecule (SUAM) (Almeida et al., 2006). The 
adherence is followed by the intracellular invasion of S. uberis into the mammary 
epithelial cells. In vitro, S. uberis is able to survive up to 120 hours in epithelial cells 
without loss of their viability. Different strains of S. uberis have different abilities to 
invade and survive in the mammary epithelial cells. UT336 showed a faster rate of 
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invasion in the first 60 minutes whereas strain UT888 survived better in epithelial 
cells 8 hours post challenge (Tamilselvam et al., 2006). Internalization would explain 
the poor cure rate after antimicrobial treatment of S. uberis mastitis (Zadoks, 2007). 
Internalization of S. uberis in mammary epithelial cells has never been observed in 
vivo. Following an experimental intramammary infection, S. uberis bacteria were 
observed attached to either healthy or damaged secretory cells of mammary gland 
(Thomas et al., 1994).  
 
Based on these two hypotheses different approaches have been used for vaccine 
development. Leigh and colleagues attempted to develop a vaccine using as 
immunogen molecules which mediate essential nutrient acquisition by S. uberis. 
Binding of antibodies to those molecules would block the growth of S. uberis in 
milk. A vaccine using  plasminogen activator (PauA) as immunogen was developed 
(Leigh et al, 1999), but further studies showed that PauA is not essential for growth 
of S. uberis (Ward et al., 2003).The other approach is to induce an immune response 
against the molecules which mediate adhesion and invasion of S. uberis to the 
mammary epithelial cells such as SUAM (Almeida et al., 2006). Attempts were 
made in the past using either intramammary or parenteral route of administration of a 
killed vaccine. In these studies, a protective effect was observed against the infection 
with the same strain (Finch et al., 1994), but not against other strains (Finch et al., 
1997). Results of these trials shown that increased antibodies in milk do not increase 
phagocytosis and killing by neutrophils (Finch et al., 1994). Further studies in vitro 
suggest that specific antibodies may, in cooperation with complement, inhibit S. 
uberis growth in milk (Fang et al., 1998). 
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The innate immune response to an intramammary infection is responsible for the first 
recognition of the pathogen. Recognition via Toll like receptors (TLRs) of pathogen-
associated molecular patterns (PAMPs) present in the bacterial wall of pathogens 
promotes the production of proinflammatory cytokines which trigger the 
inflammatory response (Tizard, 2009). Recent studies show that the innate immune 
response to the intramammary infections is pathogen species specific (reviewed by 
Bannerman, 2009). In response to S. uberis infection of the mammary gland the first 
cytokines detected in milk are pro-inflammatory Tumor Necrosis Factor-α (TNF-α) 
and interleukin-1β (IL-1β) (Bannerman et al., 2004; Rambeaud et al., 2003). These 
cytokines have both local effects such as neutrophil recruitment, and systemic 
effects, such as induction of fever and acute phase protein synthesis by the liver 
(Tizard, 2009). However, in two challenge studies acute phase protein synthesis and 
fever were detected before the increase of these two cytokines in milk (Bannerman et 
al., 2004; Rambeaud et al., 2003). The response may be due to other cytokines with 
similar effects such as interleukin-6 (IL-6). In addition, TNF-α and IL-1β might be 
released by mammary epithelial cells in the interstitial tissue rather than in the 
alveoli. In this case cytokines would be undetectable in milk (Rambeaud et al., 
2003). Interleukin-8 (IL-8) is a chemoattractant produced by several cell type and its 
increase in milk, is coincident with initial increase of somatic cell count. However, 
difference in magnitude and timing of increase of IL-8 were observed in response to 
intramammary infection with different strains of S. uberis (Bannerman et al., 2004; 




Interleukin-12 (IL-12) and Interferon-γ (IFN-γ) activate neutrophils and 
macrophages. IFN-γ is produced by lymphocytes, natural killer cells and monocytes. 
It enhances neutrophil and macrophage phagocytosis (Ellis and Beaman, 2004).  IL-
12 is produced by monocytes, dendritic cells and neutrophils and enhances the 
activity of cytotoxic T-cells and natural killer cells (Langrish et al., 2004). IL-12 and 
IFN-γ promote the Th-1 immune response. S. uberis intramammary infection induces 
the production of both IL-12 and IFN-γ (Bannerman et al., 2004). 
Interleukin-10 is an anti-inflammatory cytokine produced by Th-2-helper 
lymphocytes, B-cells and monocytes. It down-regulates the production of pro-
inflammatory cytokines and promotes the Th2 immune response (Moore et al., 
2001). S. uberis intramammary infection has been shown to induce a delayed 
production of this cytokine compared to what has been observed following the 
infection with gram negative pathogens (Bannerman et al., 2004; Bannerman et al., 
2009). Delayed or absent production of this cytokine might be associated with 
persistent intramammary infections (Bannerman, 2009). 
 
The aim of this study is to test the hypothesis that intramammary infection with 
either putatively host-adapted or putatively non host-adapted S. uberis strains yields 
a different host immune response. In addition, the aim is to test the host response to 
the re-infection with the homologous and the heterologous strain in order to asses if 
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2. 1 Introduction 
 
Streptococcus uberis is a major mastitis pathogen in dairy cattle. It is one of the most 
common causes of both clinical and sub-clinical mastitis in the UK (Milne et al., 
2002; Bradley 2007) and elsewhere (Zadoks, 2007). S. uberis causes mastitis in 
primiparous heifers, dry cows and lactating cows (Hill, 1988; Leigh, 1999). It has 
been considered an environmental pathogen (Leigh, 1999, Zadoks, 2007) however, 
based on epidemiological, management and recent molecular data (Reviewed by 
Zadoks, 2007), a host adaptation theory has been proposed: Host adapted strains are 
more likely to cause chronic, sub-clinical infections in lactating cows and they can 
spread cow to cow during milking. Non host adapted strains are more likely to be 
found in the herd environment and cause clinical, transient infections in lactating 
cows, dry cows and heifers (Zadoks, 2007).  
 
However, possible mechanisms behind host adaptation and pathogenesis of S. uberis 
mastitis are still unclear (Leigh, 1999; Zadoks, 2007). Ability to grow in milk of S. 
uberis was associated with stage of lactation (Rambeaud et al., 2004) or strain type 
(Kliem et al., 2002) however, no association between ability to grow in milk and 
severity of mastitis in vivo was found (Zadoks., 2007). Response to S. uberis 
intramammary infection is characterized by massive influx of neutrophils in the 
mammary gland (Thomas et al., 1994; Pedersen et al., 2003; Rambeaud et al., 2003; 
Bannerman et al., 2004). Different abilities to resist phagocytosis by neutrophils of 
two strains of S. uberis has been observed in vitro. The strain more able to resist 
phagocytosis was more virulent in vivo than the non resistant strain (Hill, 1988). 
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Ability to resist to phagocytosis was attributed to the presence of a hyaluronic 
capsule (Leigh et al., 1990) but this capsule is not essential for the pathogenesis of S. 
uberis mastitis (Field et al., 2003). Despite their massive influx into the mammary 
gland, neutrophils do not appear to be able to reduce the number of S. uberis bacteria 
(Thomas et al., 1994; Rambeaud et al., 2003; Bannaerman et al., 2004). Following 
experimental infection S. uberis bacteria were observed in macrophages but not in 
neutrophils (Thomas et al., 1994). In vitro studies showed the  ability of 
macrophages isolated from dry cow secretions to phagocytise and kill different 
strains of S. uberis (Grant et al., 1997) whereas macrophages isolated from milk 
showed decreased killing activity (Denis et al., 2006). 
 
Challenge studies to characterize innate immune response were conducted on major 
gram positive and gram negative mastitis pathogens (Reviewed by Bannerman, 
2009). These studies, focusing on early cytokine response to the infection, 
demonstrated the specificity of the innate immune response to the major bacterial 
mastitis pathogens species either gram positive and gram negative , particularly 
regarding magnitude, timing and production of cytokines in mammary gland. 
 
Response to S. uberis is characterized by production in the mammary gland of pro-
inflammatory cytokines tumour necrosis factor (TNF-α), interleukin-1β (IL-1β) and 
chemoattractant interleukin-8 (IL-8) (Rambeaud et al., 2003; Bannerman et al., 
2004). Differences in timing and concentration of IL-8 were observed in response to 
strain 0140J (Bannerman et al., 2004) and UT888 (Rambeaud et al., 2003) 
suggesting a strain specificity in the response. In response to the intramammary 
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infection, was also observed the production of anti inflammatory cytokine 
interleukin-10 (IL-10) and T-helper type 1 (Th1) cytokines such as Interferon-γ 
(INF-γ) and interleukin-12 (IL-12) (Bannerman et al., 2004). Lymphocytes are 
involved in the adaptive immune response to the intramammary infection (Riollet et 
al., 2000). In the healthy lactating mammary gland the majority of lymphocytes are 
T-cells and αβ CD8
+
 cells are the predominant subpopulation (Park et al., 1992; 
Taylor et al., 1997; Asai et al., 1998). An increased percentage of CD4
+ 
cells was 
observed in the mammary gland of cows naturally infected with either 
Staphylococcus aureus or Streptococcus spp. (Taylor et al., 1997) suggesting a role 
in response to intramammary infections. A study conducted on cows naturally 
infected with Streptococcus spp. reported parallel increase in CD4, CD8 and γδ cells 
in milk (Soltys and Quinn, 1999).  
 
Recent data suggest the importance of IL-17 response in the context of bovine 
mastitis. Somatic cells obtained from mammary glands with chronic streptococcal or 
enterococcal infections had elevated levels of mRNA encoding IL-17A compared to 
cells from uninfected control quarters (Bruno et al., 2010). IL-17A also modulates 
the response of mammary epithelial cells to staphylococci in vitro (Bourgarn et al., 
2011). These studies suggest that an IL-17 response could exist in the mammary 
gland. In response to IMI however to date, the IL-17A profile of milk during 
development or resolution of intramammary infection (IMI) with S. uberis or other 




The aim of this study is to test the hypothesis that intramammary infection in 
lactating cows with either putatively host-adapted or putatively non host-adapted 
strains of S. uberis yields a different host immune response and investigate some 
aspects of innate and adaptive immune response to the intramammary infection with 
S. uberis and to characterize local cytokine and immune cell profiles during onset 




2. 2 Materials and Methods 
 
2. 2. 1 Challenge Strains 
Challenge strains of S. uberis were selected using epidemiological, clinical and 
molecular data. Strain FSL Z1-048 was selected to represent characteristics of 
putatively host-adapted S. uberis, such as chronicity of infection and contagious 
transmission within a herd, whereas strain FSL Z1-124 was selected to represent 
characteristics of non-adapted S. uberis, such as transient infection and 
environmental origin (Zadoks et al., 2003; Zadoks, 2007). The 2 strains were 
originally isolated from the same herd during the same time period so that 
differences in clinical manifestation and transmission could not be attributed to 
differences in management conditions on the farm of origin. FSL Z1-048 belonged to 
a strain that was isolated from several cases of persistent subclinical mastitis (median 
duration 50 days) in lactating cows during a mastitis outbreak, whereas FSL Z1-124 
belonged to a strain that was isolated from a single case of mastitis of short duration 
(observed duration < 9 days) in a heifer at calving, i.e. without prior exposure to the 
milking machine (Zadoks et al., 2003). The strains are genetically distinct by a large 
number of open reading frames (Lang et al., 2009). Based on multi-locus sequence 
typing, FSL Z1-048 belongs to sequence type (ST) 385 and clonal complex 143, a 
clonal complex that is predominantly associated with subclinical mastitis (Tomita et 
al., 2008). FSL Z1-124 belongs to ST383, which is a singleton, i.e. it is not 





2. 2. 2 Growth of Challenge Strains in Milk  
The ability of both challenge strains to grow in milk was assessed in vitro, using milk 
from the animals enrolled in the challenge study (see below). The bacterial inoculum 
for the in vitro growth experiment was prepared from stock cultures of FSL Z1-048 
and FSL Z1-124 stored at -80°C. Stock cultures were thawed, plated on 5% horse 
blood agar (E&O Laboratories, Bonnybridge, UK) and incubated overnight at 37°C 
to check for viability and purity. Approximately 5 colonies per strain were then 
inoculated into 15 mL of brain heart infusion (BHI) broth (Difco, Cambridge, UK) 
and incubated for 20 h at 37°C. Bacterial concentration of the incubated broth was 
determined by viable count method as detailed at the end of this section while the 
remainder was stored at 4ºC, a temperature that does not permit growth of S. uberis 
(Dogan and Boor, 2004). The next day, stored broth cultures were serially diluted in 
sterile PBS to obtain the target inoculum concentration of 1,000 cfu/mL for each 
strain. The actual inoculum concentration was checked by viable count method.  
 
To assess the growth potential of challenge strains in milk from study animals, milk 
was collected aseptically from both hind quarters of each animal just before milking, 
1 day prior to experimental challenge. Milk samples were kept on ice and transported 
to the laboratory for inoculation of culture plates within 1 hour of sample collection. 
For each cow, equal volumes of milk from both hind quarters were comingled and 10 
l were plated onto horse blood agar (E&O Laboratories) for overnight incubation at 
37°C to check for the absence of contaminants and pathogens associated with IMI. 
For each cow, one 14 mL aliquot of comingled milk was then inoculated with strain 
FSL Z1-048 and 1 aliquot of 14 mL with FSL Z1-124, using approximately 1,000 
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cfu of S. uberis in 1 mL of PBS (see below). Inoculated milk was incubated for 24 h 
at 37°C under shaking (200 rpm). At 0, 3, 6, 12 and 24 h post inoculation, 100 μL of 
milk were taken off and bacterial concentration was determined by viable counting, 
i.e. 1:10 serial dilution series were prepared in sterile PBS and three 10 μL drops per 
dilution were plated onto horse blood agar plates (E&O Laboratories) and incubated 
overnight at 37°C. Colonies were counted when they were in the range of 5 to 50 cfu 
per spot, and the bacterial concentration for each time point (cfu/mL) was calculated 
based on average colony counts for the appropriate dilution. 
 
2. 2. 3 Challenge Study Design 
Twelve non-pregnant, clinically healthy Holstein cows with no history of clinical 
mastitis were used in this experiment. Cows were in mid-lactation (60 to 160 DIM on 
the day of challenge) and parity ranged from 1 to 5. Composite somatic cell count 
(SCC) as measured during 4-weekly milk recording was < 100,000 cells/mL at the 
time of purchase, with the exception of 1 animal that had composite SCC of 152,000 
cells/mL. This animal tested positive for coagulase negative staphylococci in 1 hind 
quarter and the culture negative contralateral quarter was used as challenge quarter. 
On the day before challenge, quarter level SCC was 100,000 cells/mL for 22 of 24 
challenge quarters and between 100,000 and 200,000 cells/mL for the remaining 2 
quarters. Quarter milk samples from all animals were negative for S. uberis prior to 
purchase and between purchase and challenge. Challenge studies were conducted 
using 4 cows at a time, with cows housed in loose housing (group 1) or cubicles 
(groups 2 and 3), with straw bedding in both housing systems. Cows had access to 
water and grass silage ad libitum and concentrate was fed 3 times a day based on 
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milk yield. Cows were milked twice a day at 6 am and 3 pm using a dedicated 
milking unit for each cow. After each milking, all teats were dipped in iodine-based 
teat disinfectant. Each cow was challenged with S. uberis in 1 hind quarter and mock 
challenged with PBS in the other hind quarter as detailed in the next section. In each 
group of 4 animals, strain-quarter combinations (FSL Z1-048/RH, FSL Z1-124/RH, 
FSL Z1-048/LH, FSL Z1-124/LH, where RH = right hind and LH = left hind) were 
allocated to individual cows based on random sampling without replacement. 
Clinical data and samples were collected for 14 days post challenge. All experiments 
were conducted at the Moredun Research Institute (Penicuik, UK) with approval of 
the Institute’s Experiments and Ethical Review Committee in accordance with the 
Animals (Scientific Procedures) Act 1986. 
 
2. 2. 4 Intramammary Challenge  
The bacterial inoculum for challenge experiments was prepared as described for the 
growth curve experiment, with the exception that the target concentration for animal 
challenge was 100 cfu/mL. Challenge doses were kept at 4°C (in the laboratory) or 
on ice (in the milking parlour) until infusion. On the day of challenge, cows were 
milked as per normal procedures, including the use of post milking teat disinfection. 
Subsequently, teat ends were disinfected by scrubbing with cotton wool swabs with 
70% (vol/vol) ethanol. Two mL of inoculum preparation (target dose: 200 
cfu/quarter) were infused into each challenge quarter via a J-12 teat infusion cannula 
(Jorgens Laboratories, Loveland, CO, USA). Control quarters were mock-challenged 
by infusion of 2 mL of sterile PBS. After infusion, teats were dipped in post-milking 
teat disinfectant and cows were returned from the milking parlour to their pen, as per 
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normal procedures. The actual challenge dose for each strain in each challenge round 
was determined by viable count method using spare doses of the inoculum 
preparation.  
 
2. 2. 5 Sample and Data Collection 
Milk samples and clinical data were collected at various time points following 
infusion. For the first 48 h, clinical data and milk samples for SCC determination, 
bacterial culture and cytokine ELISA were collected every 6 h. From 2 to 11 days 
post-challenge, milk samples for SCC and culture were collected twice a day, and 
from 11 to 13 days post-challenge once a day. On days 3 and 4 post-challenge, milk 
samples for cytokine ELISA were collected twice a day and on days 5 through 7 
post-challenge, once a day. Additional milk samples for cytokine ELISA were 
collected on days 10 and 13 post-challenge. Samples for flow cytometric analysis of 
lymphocyte populations were collected on days 1, 2, 4, 6, 8, 10 and 13 post-
challenge. Clinical scores were assigned to each quarter and cow as follows: 0 = no 
clinical signs; 1 = milk alteration only, such as alteration of colour or presence of 
clots; 2 = local signs, such as redness of the udder, pain on palpation, or swelling; 3 = 
systemic signs, e.g. fever, anorexia or lethargy. Quarter milk samples for 
bacteriological analysis were collected using aseptic technique (National Mastitis 
Council, 1999) and stored on ice until refrigeration at 4°C. Separate receptacles were 
used to collect quarter milk samples for SCC measurement, cytokine ELISA and 
flow cytometry. The vast majority of data were recorded and samples were collected 
by Prof. Ruth Zadoks (Moredun Research Institute) and David Reddick (Moredun 
Scientific Ltd, Penicuik, UK)  
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2. 2. 6 Bacteriological Analysis 
For qualitative analysis, 10 μL of milk from each quarter (challenged, mock-
challenged and unchallenged quarters) were plated on horse blood agar (E&O 
Laboratories) and incubated at 37°C for 24 h. Colonies were identified based on 
morphology and standard biochemical tests (Gram staining, catalase test, esculin 
splitting) (National Mastitis Council, 1999). For quantitative analysis, milk samples 
from challenged quarters were serially diluted with 10-fold dilutions from neat to  
10
-8
 in sterile PBS. Triplicate 10 μL aliquots of each dilution were spotted on blood 
agar plates (E&O Laboratories), allowed to air dry and incubated overnight at 37°C. 
Colonies with morphology consistent with S. uberis were counted, if possible in the 
range of 5 to 50 cfu per spot, and the bacterial concentration in milk (cfu/mL) was 
calculated based on average colony counts for appropriate dilutions. Qualitative and 
quantitative bacteriological analysis was performed by Cliff Ramage (Moredun 
Scientific Ltd.). 
 
2. 2. 6 Molecular Typing 
Polymerase chain reaction and pulsed-field gel electrophoresis (PFGE) were used to 
confirm species and strain identity, respectively. Where possible, 3 S. uberis isolates 
from each challenged quarter were analysed, i.e. 1 isolate each from the first and last 
positive sample post challenge and from the time point with peak bacterial shedding. 
A total of 18 isolates were analysed from the 6 cows challenged with strain FSL Z1-
048, with each cow represented by 3 isolates. Five isolates, representing 3 cows, 
were available from animals challenged with strain FSL Z1-124. Species identity of 
isolates was confirmed using PCR primers and parameter settings as described by 
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Phuektes and colleagues (2001b). For PFGE of confirmed S. uberis isolates, 1.5 mL 
of overnight culture in BHI was centrifuged for 10 minutes at 13,400 × g. 
Supernatants were discarded and cell pellets were resuspended in 0.5 mL of TE 
buffer (10 mM tris hydrocloridric acid, 1 mM EDTA, pH 8). Bacterial suspensions 
were mixed with 2% (wt/vol) low melting-point agarose (BioRad Laboratories, 
Hertfordshire, UK) in TE buffer at 56 °C. Plugs were allowed to solidify and 
incubated overnight at 37°C in 2 mL of TE buffer containing 4 mg/mL lysozyme 
(Sigma-Aldrich, Dorset, UK). Supernatants were removed and plugs were incubated 
for 48 h at 56 °C in 2 mL of 0.5 M EDTA containing 2 mg/mL proteinase K (Sigma-
Aldrich) and 1% wt/vol N-laurylsarcosine sodium. Proteinase K solution was 
removed and plugs were washed for 1 h in 36 mL of TE buffer under shaking (100 
rpm). Washing was repeated 6 times. Plugs were pre-incubated in 300 μL of reaction 
buffer containing (1% wt/vol) BSA, 20 mM Tris-acetate, 50 mM potassium acetate, 
10 mM magnesium acetate, and 1 mM dithiothreitol (pH 7.9) for 1 h at 37°C. 
Reaction buffer was removed, 100 μL of enzyme buffer containing 30 units of 
restriction enzyme SmaI (New England Biolabs, Hitchin, UK) were added to each 
plug and plugs were incubated overnight at 25°C. Plugs were then inserted into a gel 
prepared from 1% (wt/vol) PFGE certified agarose (BioRad Laboratories) in 0.5 × 
TBE buffer (45 mM Tris base, 45 mM boric acid, 1 mM EDTA, pH 8.0). Restriction 
fragments were separated by PFGE at 14°C for 24 h, with initial switch time 3 s, 
final switch time 55 s, and linear ramp using a CHEF mapper (BioRad Laboratories). 
Gels were stained with SYBR Gold stain (Invitrogen, Paisley, UK) according 
manufacturer’s instruction, rinsed and photographed under UV light. Molecular 
typing was performed by Mark Lutton (Moredun Research Institute). 
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2. 2. 7 Somatic Cell Counting and Flow Cytometry 
Approximately 25 mL of milk were collected in plastic vials pre-loaded with 
preservative and shipped to National Milk Laboratories (Hillington Park, Glasgow, 
UK) for determination of SCC by Fossomatic milk cell counter (Foss Electronic, 
Hillerød, Denmark). For flow cytometry, approximately 50 mL of milk per quarter 
were collected in plastic Falcon vials (BD Bioscience, Oxford, UK). Milk was kept 
on ice and transported to the laboratory within 30 minutes, where it was diluted with 
an equal volume of cold PBS and centrifuged at 800 × g for 20 min. Using a sterile 
pastette, cell pellets were transferred into 30 mL of PBS and resuspended. Cell 
suspensions were filtered through a 70 μm cell strainer (BD Bioscience) and 
centrifuged at 400 × g for 15 min. Supernatants were discarded and cell pellets 
resuspended in 25 mL of PBS. Washing was repeated once and pellets were 
resuspended in 1 mL of FACS buffer (PBS supplemented with 1% wt/vol BSA). Ten 
μL of cell suspension were stained with an equal volume of trypan blue (Sigma-
Aldrich) and viable cell concentration was determined using a microscope cell 
counting chamber, with cell concentration adjusted to 1x10
6 
cells/mL. Aliquots of 
milk cells were labelled with a panel of monoclonal antibodies (Table 2. 1) to 
identify T-lymphocyte populations and subpopulations, i.e. CD4, CD8 and γδ T cells. 
Fifty microliters of cell suspension were mixed with 50 μL of the appropriate 
blocking buffer (20% vol/vol heat inactivated normal mouse serum in FACS buffer 
for CD4 or CD8 staining; 20% vol/vol heat inactivated normal goat serum in FACS 
buffer for CD3 or γδ staining). Samples were incubated for 30 min at room 
temperature and subsequently centrifuged at 700 × g for 1 min. Supernatants were 
discarded and 100 μL of antibody diluted with the appropriate buffer (10% vol/vol 
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heat inactivated normal mouse serum in FACS buffer for CD4 or CD8 staining; 10% 
vol/vol heat inactivated normal goat serum in FACS buffer for CD3 or γδ staining) 
were added. Samples were incubated for 30 min at 4°C. After staining with anti-CD4 
or anti-CD8 antibody, cells were washed twice with FACS buffer and once with 
PBS. Finally, they were re-suspended in PBS with 1% wt/vol paraformaldehyde for 
10 min. Cells stained with anti-CD3 or anti-γδ antibodies were washed twice with 
FACS buffer; 100 μL of a 1µg/mL dilution of goat anti- mouse IgG conjugated to 
Alexa Fluor 488 (Invitrogen) was added and the cells were incubated at 4°C for 30 
min. After staining, cells were washed and fixed in PBS with paraformaldehyde as 
described for CD4 and CD8 staining. Cells were acquired with a 2 laser Cyan flow 
cytometer (Beckman Coulter, High Wycombe, UK). Cell debris was differentiated 
from cells based on forward and side scatter (Figure 2. 1A) and excluded from 
analysis. Data were collected for a minimum of 10,000 cells for each sample. Data 
were analysed using FlowJo software (Tree Star, Ashland, OR, USA). The 
lymphocyte population was gated based on forward and side scatter and the 
percentage of positive cells for each staining (CD3, CD4, CD8 and γδ) was 
calculated within the lymphocyte gate (Example showed in Figure 2. 1B and C). 
Cytocentrifuge preparations of selected samples were prepared using a Shandon 
Cytospin 4 cytocentrifuge (Thermo Electron Corporation, Milford, MA, USA) and 
stained using a REASTAIN Quick-Diff Kit (Reagena, Toivala, Finland) for 
subsequent differential cell counting. Absolute concentration (i.e. cells/mL) of 
lymphocyte sub-populations was calculated based on SCC and the percentage of 
lymphocytes as determined by flow cytometry, by multiplying the percentage of 




Table 2. 1 Details of mouse monoclonal antibodies used for flow cytometry. 
 
Clone Specificity Isotype Conjugation Cellular expression Source 
CC8 Bovine CD4 IgG2a Alexa Fluor® 647 Helper T cells AbD Serotec
4
 
CC63 Bovine CD8 IgG2a FITC Cytotoxic T cells AbD Serotec
4
 
MM1A Bovine CD3 IgG1 n/a Pan-T cells VMRD Inc.
5
 
GB21A Bovine γδ TCR
1










 p125/p80 IgG1 n/a Isotype control MRI
7
 




TCR = T cell receptor; 
2
 n/a = not applicable; 
3
 BDV = border disease virus (Entrican et al., 1995); 
4
AbD Serotec, Kidlington, UK; 
5 
VMRD Inc., Pullman, WA, USA; 
6
 eBioscience, Hatfield, UK; 
 7 
Kindly provided by Sean Wattegedera, Moredun Research Institute, Penicuik, UK. 
 
Table 2. 2 Details of antibodies used for cytokine ELISAs.  
 
Specificity Antibody Isotype, species Conce. (μg/mL) Source 
IL-1β Coating Polyclonal n/a
2
, rabbit      5 AbD Serotec
3
 
IL-1β Detection Biotinylated polyclonal n/a, rabbit 1 AbD Serotec 
IL-8 Coating 8M6  IgG2a, mouse 5 AbD Serotec 
IL-8 Secondary Polyclonal IgG, rabbit 2 AbD Serotec 
IL-10 Coating CC318  IgG2b, mouse 4 AbD Serotec 
IL-10 Detection Biotinylated CC320  IgG1, mouse 1 AbD Serotec 
IL-12p40 Coating
1
 CC301  IgG2a, mouse 1 AbD Serotec 
IL-12p40 Detection
1
  Biotinylated CC326 IgG2b, mouse 2 AbD Serotec 
TNF-α Coating CC327  IgG2b, mouse 2 AbD Serotec 
TNF-α Detection Biotinylated CC328  IgG2a, mouse 1 AbD Serotec 
1 
IL-12p40 is the subunit that IL-12 has in common with IL-23 (Oppmann et al., 2000);  
2 
n/a = not applicable; 
3





Figure 2. 1 Example of flow cytometry analysis of cells from milk. Cell debris was 
excluded from analysis (A). The lymphocyte population was identified by forward 
and side scatter (B). Within the lymphocyte population sub populations were 
identified by staining with specific antibodies for CD3 (not shown), CD4 (C), CD8 


















2. 2. 8 Cytokine Measurements 
Milk samples for cytokine measurement were collected in sterile 50 mL plastic 
Falcon tubes. Skim milk was prepared by centrifuging 50 mL of milk at 2,800 × g at 
4°C for 20 minutes. The fat layer was discarded and the supernatant was transferred 
to a new 50 mL Falcon tube. Centrifugation was repeated and the supernatant was 
stored at -20°C until analysis. Microtitre plates (Immunolon 2 HB, Thermo Electron 
Corporation, Langenselbold, Germany) were coated overnight at 4°C with 
100 μL/well of the appropriate coating antibody (Table 2. 2) diluted in 0.5 M 
carbonate buffer (0.5 M Na2CO3, 0.5 M NaHCO3, pH 9.6). Wells were washed with 
washing buffer (PBS at pH 7.4 with 0.05% vol/vol Tween 20
 
(Sigma-Aldrich) and 
non-specific binding sites were blocked at room temperature for 1 hour with 300 
μL/well of PBS containing 3% (wt/vol) BSA and 0.05% (vol/vol) Tween 20 (Sigma-
Aldrich). Plates were washed again with washing buffer and incubated for 1 h at 
room temperature with 100 μL/well of skim milk. Each sample was tested in 
duplicate. When necessary, samples were diluted as appropriate with PBS 
supplemented with 0.05% (vol/vol) Tween 20
 
(Sigma-Aldrich) and 1% (wt/vol) BSA 
(reagent diluent). A standard curve of known cytokine concentrations was assayed 
for each plate using appropriate standard diluted in reagent diluent. Recombinant 
bovine standards were used for IL-1β (AbD Serotec, Kidlington, UK), IL-8 
(Kingfisher Biotech, Upper Heyford, UK), and TNF-α (R&D systems, Minneapolis, 
MD, USA). For IL-10 and IL-12p40, recombinant ovine standards were used 
(provided by Sean Wattegedera, Moredun Research Institute, Penicuik, UK). Plates 
were washed with washing buffer and 100 μL/well of appropriate detection antibody 
(Table 2. 2) in reagent diluent were added, followed by incubation for 1 h at room 
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temperature. For IL-1β, IL-10, IL-12p40 and TNF-α plates, 100 μL/well of 
horseradish peroxidase (HRP)-streptavidin diluted 1:500 in reagent diluent (Sigma-
Aldrich) were added, followed by incubation for 45 minutes at room temperature. IL-
8 plates were incubated with 100 μl/well of HRP-conjugated polyclonal goat anti-
rabbit immunoglobulins (Dako, Ely, UK) diluted 1:1,000 in reagent diluent for 1 
hour at room temperature. After incubation with HRP-streptavidin or HRP-
conjugated antibody, plates were washed and incubated for 20 minutes at room 
temperature with 100 μL per well of o-Phenylenediamine dihydrochloride  substrate 
(Sigma-Aldrich). The reaction was stopped with 25 μL per well of 2.5 M H2SO4 and 
optical density was measured at 492 nm using a sunrise absorbance reader (Tecan, 
Theale, UK). Cytokine concentrations in skim milk samples were calculated from the 
standard curve. Concentrations of IFN-γ, IL-6 and IL-17A in milk samples were 
measured with commercial kits (R&D Systems; Pierce biotechnology, Rockford, IL, 
USA and Kingfisher Biotech, respectively) according to the manufacturers’ 
instructions. 
 
2. 2 .9 Statistical Analysis 
All data were entered into a database and checked for outliers and missing values 
using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). Outliers were re-evaluated 
where necessary but no outliners were removed from the data set. Simple descriptive 
and graphical analyses were performed for all parameters. Where necessary, 
transformations were performed to normalize the data, e.g. for SCC and cfu counts. 
To evaluate the impact of strain and time post infusion (PI) on any of the measured 
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parameters, a generalized linear mixed model was fit to the data. The general format 
of the model was: 
 
f(y) = incpt + time + strain + time * strain + Cow + Re 
 
where f(y) is a function of the parameter of interest, i.e. a transformation or identity 
function, as appropriate; incpt is the intercept; time is the time PI; strain is an 
indicator variable indicating either FSL Z1-048 or FSL Z1-124; and time * strain is 
the interaction between time and strain. Cow is a random cow effect, Re is a complex 
error term where R indicates the within quarter correlation of the repeated measures 
and e indicates a random error term, assumed to be normally distributed with mean 0 
and variance σ
2
. The model fit was assessed using the ratio of the deviance to the 
remaining degrees of freedom. Least square means from the models were calculated 
and used for graphing of the data. Significance testing was done to evaluate the 
differences between strains over time using contrasts of the least square means. A 
Bonferroni correction was used in case of comparisons against pre-challenge values 
in infected and control quarters at multiple time points post challenge. Statistical 
significance was declared at P < 0.05. Post-inoculation least square mean values 
were compared to the pre-inoculation (Time 0) values, with the exception of 
lymphocyte concentrations and ratios. The latter were compared between challenge 
quarters and control quarters within time points to allow for significance testing 
despite lack of complete data for individual quarters. Statistical analysis was 
performed by Prof. Ynte. Schukken (Department of Population Medicine and 
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2. 3 Results 
 
2. 3. 1 In-vitro Growth of Challenge Strains in Milk  
The ability of strains FSL Z1-048 (putatively host-adapted) and FSL Z1-124 (non-
adapted) to grow in fresh milk in vitro was tested using milk samples from 8 
individual animals. Results from 1 sample inoculated with strain FSL Z1-048 were 
discarded because of bacterial contamination of the sample. The actual inoculum 
dose ranged between 700 and 1,280 cfu of S. uberis per sample. Both challenge 
strains were able to grow in fresh milk in vitro with significantly higher levels of 
bacterial growth observed with strain FSL Z1-124 compared to strain FSL Z1-048 at 
3, 6 and 12 h post-inoculation (Figure 2. 2A). FSL Z1-124 was first detected at 3 h 
post inoculation, with more than half of the milk samples testing positive, whereas 
strain FSL Z1-048 was first detected in milk at 6 h post inoculation, with only 1 
sample testing positive (Figure 2. 2B). At 24 h post inoculation, all milk samples 
tested positive. The maximal bacterial concentration at 24 h post inoculation did not 












Figure 2. 2 (A) In vitro growth curves of S. uberis strain FSL Z1-048 (full line) and 
FSL Z1-124 (dashed line) in milk from individual cows. Mean bacterial 
concentrations and SEM are shown for culture positive samples. Stars indicate 
significant differences between strains. (B) Proportion of milk samples from 
individual cows inoculated with S. uberis strain FSL Z1-048 (solid bars; n = 7) or 





































































2. 3. 2 Clinical Response 
All 6 cows challenged with S. uberis strain FSL Z1-048 developed clinical mastitis. 
In contrast, none of the 6 cows challenged with strain FSL Z1-124 developed clinical 
signs of mastitis. Clinical signs were first observed 30 to 48 h PI (Table 2. 3). The 
peak in average clinical score (2.2 ± 0.4) occurred between 48 and 57 h PI (Figure 2. 
3A). Increased rectal temperature was observed in all animals challenged with strain 
FSL Z1-048. The first increase in rectal temperature was detected between 24 and 72 
h PI (Table 2. 3). The average temperature reached a peak of 40.0 ± 1.0°C at 36 h PI 
(Figure 2. 3B) and remained elevated at 48 and 57 h PI (P < 0.05). At 72 h, average 
body temperature was not significantly different from pre-challenge levels, despite 
delayed onset of fever in 1 individual (Tab 2. 3, Figure 2. 3B). The body temperature 
of cows challenged with FSL Z1-124 remained at pre-challenge level throughout the 
study. Milk production decreased in all animals challenged with strain FSL Z1-048. 
Mean production decreased by almost 50% on the second day PI and remained 
significantly depressed on day 3 PI (P < 0.05) (Figure 2. 3C). Milk production started 
to increase again at day 4 PI. No change in milk output was observed in animals 










Table 2. 3 Time (hours post infusion) of first detection (bacteria; clinical signs other 
than fever) or first detected increase (temperature, SCC, cytokine levels) of several 
parameters in 6 cows challenged in one mammary quarter with Streptococcus uberis 
strain FSL Z1-048. Apart from body temperature, all parameters were observed or 
measured at quarter level.  
 
 Cow identification 
 1 2 3 4 5 6 
       
Clinical signs 30 30 36 36 48 36 
Temperature 30 24 24 30 72 36 
SCC 30 30 30 30 42 36 
Bacteria 12 18 12 12 18 18 
IL-1β 30 36 30 30 42 36 
IL-6 30 36 30 30 42 30 
IL-8 30 30 30 30 42 36 
IL-10 36 36 30 36 48 42 
IL-12p40 36 36 36 36 48 42 
TNF-α 36 36 42 36 48 36 
IL-17A 144 ND 72 57 ND 72 








Figure 2. 3 (A) Clinical score in response to intramammary challenge with S. uberis 
strain FSL Z1-048. Mean and SEM for 6 cows. 0 = no clinical signs; 1= 
abnormalities in milk, e.g. clots or discoloration; 2 = abnormalities in udder, e.g. 
swelling or pain; 3 = systemic signs, e.g. fever. None of the cows (n = 6) challenged 
with strain FSL Z1-124 showed clinical signs. (B) Rectal temperature in response to 
intramammary challenge with FSL Z1-048 (full line) or FSL Z1-124 (dashed line). 
Mean and SEM are shown. (C) Daily milk yield in response to intramammary 
challenge with S. uberis strain FSL Z1-048 (full line) or FSL Z1-124 (dashed line). 
Daily milk yield was calculated as the sum of morning and afternoon milking. Mean 
and SEM are shown for 6 cows per strain. Values marked by an asterisk are 
















































































































2. 3. 3 Bacterial Culture and Molecular Typing 
Culture of unused doses of the challenge inoculum showed that quarters had been 
infused with 53 to 712 cfu of strain FSL Z1-048 or 80 to 700 cfu of FSL Z1-124. In 
the last round of the experiment, the dose of FSL Z1-124 was increased 
approximately 100-fold, to 14,800 cfu, to determine whether a high inoculum dose 
would induce a clinical response, however, no difference in response was observed 
between animals challenged with either the low or the high dose of this strain. Viable 
S. uberis was isolated from milk from all mammary quarters (n = 6) infused with 
FSL Z1-048 (Figure 2. 4A). Bacteria were first detected at 12 h PI and all quarters 
were positive at 18 h PI (Figure 2. 3B). By 81 h PI, the number of culture positive 
quarters started to fluctuate. Five of 6 animals had cleared the infection 
spontaneously by the end of the study at 312 h post challenge (Figure 2. 4B), as 
confirmed by culture of milk samples collected on a daily basis for 10 days after the 
end of the study. The maximum average concentration of S. uberis in positive 
quarters was observed at 36 h PI (7.67 ± 0.35 Log10 cfu/mL) (Figure 2. 4A). By 96 h 
PI, bacterial concentration had decreased to 3.49 ± 0.54 Log10 cfu/mL and it 
remained at a similar level in culture positive quarters for the rest of the follow-up 
period (Figure 2. 4A). S. uberis was recovered in milk from 4 quarters challenged 
with strain FSL Z1-124 between 12 and 48 h PI, of which 3 had been challenged 
with the low dose and 1 with the high dose. No more than 2 quarters were positive at 
any one time (Figure 2. 4B). Average concentration in positive quarters reached its 
maximum at 24 h post challenge (2.91 ± 0.55 Log10 cfu/mL) (Figure 2. 4A) and all 




From each quarter challenged with strain FSL Z1-048, 3 isolates were used for PCR 
and PFGE, i.e. 1 isolate representing the first isolation, peak concentration and last 
isolation from each quarter, respectively, for a total of 18 isolates. All isolates were 
confirmed to be S. uberis by PCR. PFGE patterns of all isolates matched that of the 
challenge strain (Figure 2. 5). Only a limited number of isolates from quarters 
challenged with FSL Z1-124 were available for analysis, i.e. 1 isolate from 1 quarter 
and 3 isolates obtained at 3 different time points (12, 18, 24 h PI) from a different 
quarter. PCR using species-specific primers yielded a band of 470 bp rather than the 
expected 330 bp. Sequence analysis of the PCR amplicon revealed a 160 bp insertion 
in the 16S-23S rRNA intergenic spacer region. The insertion fragment which showed 
99% sequence homology with the 16S-23S intergenic spacer region of Streptococcus 
porcinus (ATCC35647). Otherwise, the 16S-23S rRNA intergenic spacer amplicon 
showed 100% sequence homogeneity with that of S. uberis reference strains O140J, 
ATCC70047 and ATCC19436. Sequencing of a 740 bp fragment of a second 
housekeeping gene, rpoB (Drancourt et al., 2004), confirmed the species identity of 
FSL Z1-124 as S. uberis. PFGE patterns of isolates from quarters challenged with 
FSL Z1-124 were indistinguishable from the PFGE pattern of the challenge strain 










Figure 2. 4 (A) Bacteria counts in milk of quarters excreting S. uberis strain FSL Z1-
048 (full line) or FSL Z1-124 (dashed line). Mean and SEM are shown. (B) 
Proportion of quarters challenged with S. uberis strain FSL Z1-048 (full bars) or FSL 
Z1-124 (hashed bars) from which S. uberis was recovered. Six quarters (1 per cow) 



















































































































Figure 2. 5 Examples of pulsed field gel electrophoresis patterns of S. uberis isolates 
from quarters challenged with strain FSL Z1-048 (lanes 6 and 8) or FSL Z1-124 
(lanes 3 and 5). The respective challenge strains were included for comparison (lane 
4 and lane 7). Lanes 1 and 2 show a DNA ladder (concatemers of λ DNA) and a 
marker strain (Streptococcus agalactiae STIR-CD-25), respectively.  
 
2. 3. 4 Somatic Cell Count and Flow Cytometry 
All quarters challenged with strain FSL Z1-048 showed an increase in SCC. In 
individual quarters, elevation of SCC was first observed 30 to 42 h PI (Table 2. 3). 
Mean SCC reached its peak (7.40 ± 0.07 Log10 cells/mL) at 42 h PI and remained 
elevated throughout the study (Figure 2. 6). PBS-infused control quarters from 
animals challenged with FSL Z1-048 showed a significant increase in SCC compared 
to pre-challenge levels at several time points post-challenge, e.g. during peak milk 
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yield depression and towards the end of the study (Figure 2. 6). SCC elevation was 
observed in animals challenged with strain FSL Z1-124, in quarters infused with 
bacteria (Figure 2. 6) but not control quarters infused with PBS (data not shown). 
 
A large influx of polymorphonuclear leukocytes (PMNL) in the early stage of the 
infection, confirmed by differential cell counts of cytocentrifuge preparations, 
affected the ability to quantify T-cell populations by flow cytometry, resulting in 
incomplete data on T-cell subsets for some time points (e.g. 96 h PI). In milk from 
quarters infused with strain FSL Z1-048, the mean concentration of CD3
+
 cells was 
significantly elevated from 96 h PI onwards, reaching its highest level at 312 h PI 
(8.18 × 10
5 
± 1.6 × 10
5 





lymphocyte subsets also increased from 96 h PI, with higher concentrations of 
CD4
+
 lymphocytes compared to CD8
+
 lymphocytes present in initial stages of 
infection. The concentration of CD4
+
 cells stabilised after the initial increase whereas 
the concentration of CD8
+ 
cells increased from 144 to 312 h PI (Figure 2. 7B-C). As 
a result, the mean ratio between the 2 populations changed over time, from 0.69 at 
time 0 to peak at 2.8 at 96 h PI (Figure 2. 8). The ratio remained inverted compared 
to the PBS infused control quarters until 240 h PI (P < 0.05) and returned to normal 
at 312 h PI. The concentration of γδ cells increased from 144 h PI, increasing from 
194 ± 171 cells/mL at time 0 to 4.6 × 10
4 
± 2.7 × 10
4 
cells/mL at 144 h PI and 
remained elevated compared to the control quarters until the end of the study (4.4 × 
10
4  
± 3.1 × 10
4 
 cells/ mL at 312 h) (Figure 2. 7D). Concentrations of CD3
+





 or γδ subsets did not change in milk from cows challenged with strain 





Figure 2. 6 SCC in response to challenge with S. uberis strain FSL Z1-048 (full 
lines) or FSL Z1-124 (dashed line). Main and SEM are shown for challenge quarters 
(circles), and for PBS infused control quarters (triangles) of animals challenged with 
strain FSL Z1-048. PBS infused control quarters of animals challenged with FSL Z1-
124 did not show elevation of SCC compared to pre-challenge levels (data not 
shown). Significant differences (P < 0.05) between pre- and post-challenge levels are 
shown for challenge and PBS-infused control quarters of animals challenged with 








































































 l (C) and γδ (D) 
lymphocytes in milk. Mean and SEM are shown for quarters infused with strain FSL 
Z1-048 (full line) and PBS infused control quarters (dashed line) of the same 
animals. Stars indicate significant differences between challenged quarters and PBS 
infused control quarters. Models for γδ lymphocytes did not converge.  
 




 ratio in milk from cows challenged with S. uberis strain 
FSL Z1-048 (full lines) or FSL Z1-124 (dashed lines). Mean and, where possible, 
SEM are shown for challenged quarters (circles) and PBS infused control quarters 
(triangles). Data were available for 5 or 6 quarters per strain at times 0 and 24, for 1 
or 2 quarters per strain at time 96 and for 3 or 5 quarters per strain for other time 
points. Stars indicate significant differences between challenge quarters and PBS 
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2. 3. 5 Cytokine Response 
All quarters challenged with FSL Z1-048 showed an increase in concentration of IL-
1β, TNF-α, IL-8, IL-6, IL-12p40 and IL10, and 4 of 6 quarters showed an increase in 
concentration of IL-17A (Table 2. 3). IL-1β was first detected in challenged quarters 
at 30 to 42 h PI (Table 2. 3), whereas no increase was found in control quarters 
infused with PBS. Mean IL-1β concentration reached its highest level (327 ± 102 
pg/mL) at 48 h PI (Figure 2. 9A). TNF-α was first detected between 36 and 48 h PI 
and the highest mean concentration (1,219 ± 599 pg/mL) was observed at 36 h PI 
(Figure 2. 9B). IL-8 was first detected at 30 to 42 h PI (Table 2. 3) and the highest 
mean IL-8 concentration (4.2 ± 0.2 Log10 pg/mL) was reached at 48 h PI (Figure 2. 
9C). Five of 6 control quarters in FSL Z1-048 challenged animals showed a 
moderate increase in IL-8 concentration (peak of mean concentration 1.72 ± 0.36 
Log10 pg/mL), which coincided with peak concentrations in challenged quarters 
(Figure 2. 9C). IL-6 was first detected at 30 to 42 h PI (Table 2. 3). The IL-6 curve 
was bimodal, with peaks at 48 and 72 h PI (11.3 ± 2.8 and 11.2 ± 2.9 ng/mL 
respectively) (Figure 2. 9D). Increased IL-12p40 concentration was first detected at 
30 to 48 h PI (Table 2. 3). Mean IL-12p40 concentration peaked at 48 h PI (124 ± 35 
bU/mL) (Figure 2. 9E). Increased IL-10 concentration was first detected at 30 to 42 h 
PI (Table 2. 3) and the peak in mean concentration (35.6 ± 8.2 bU/mL) occurred at 
48 h PI (Figure 2. 9F). Interferon-γ was detected at 1 or 2 isolated time points in milk 
from some challenged quarters whilst in other quarters the concentration was 
elevated for up to 10 consecutive time points. This variability was also observed in 
PBS infused control quarters (Figure 2. 9H). The first increase in IL-17A 
concentration was detected 57 to 144 h PI (Table 2. 3) and mean IL-17A 
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concentration reached its peak (463 ± 345 pg/mL) at 81 h post challenge (Figure 2. 
9G). The elevation in concentration of IL-17A coincided with the decrease in 
concentration of S. uberis bacteria in milk from infected quarters (Figure 2. 10). All 4 
animals which showed an increase in levels of milk IL-17A cleared the infection 
before the end of the study, whereas 1 of 2 animals without a detectable IL-17A 
response did not clear the infection spontaneously. 
 
For quarters challenged with strain FSL Z1-124, cytokines were measured in milk 
samples collected at all time-points for 1 animal, and at time-points up to 81 h PI for 
the remaining 5 animals. No increase in concentration of IL-1β, TNF-α, IL-6, IL-10, 
IL-12p40 or IL-17A was observed in challenged or control quarters of cows 
challenged with strain FSL Z1-124. Low levels of IL-8 were detected in 3 of 6 
quarters challenged with strain FSL Z1-124 (data not shown). Elevations in IL-8 
concentration were observed between 12 and 48 h PI and ranged from 32.2 to 72.6 














Figure 2. 9 Cytokine concentration in milk from cows challenged with S. uberis strain FSL Z1-048. 
Mean and SEM are shown for challenge quarters (full line) and, where post-challenge levels were 
above the detection limit, for PBS infused control quarters (dashed line). (A) Concentration of IL-
1β (detection limit 31.25 pg/mL). (B) Concentration of TNF-α (detection limit 125 pg/mL). (C) 
Concentration of IL-8 (detection limit 0.031 ng/mL) (D) Concentration of IL-6 (detection limit 
78.25 pg/mL). (E) Concentration of IL-12p40 (detection limit 0.366 bU/mL). (F) Concentration of 
IL-10 (detection limit 0.825 bU). (G) Concentration of IL-17A (detection limit 188 pg/mL). (H) 
Concentration of IFN-γ (detection limit 156.125 pg/mL). Stars indicate significant elevation 
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Clear differences in ability to cause mastitis in lactating cows were observed between 
the S. uberis putatively host-adapted strain FSL Z1-048 and the non-adapted strain 
FSL Z1-124. The adapted strain FSL Z1-048 was able to cause clinical mastitis in 
lactating cows in all the 6 animals challenged whereas none of the cows challenged 
with the non-adapted strain FSL Z1-124 developed mastitis even using a challenge 
dose 100 fold higher. These findings support the hypothesis that putatively host 
adapted strains identified by epidemiological and molecular data such as FSL Z1-048 
are more adapted to colonize the mammary gland and thus cause IMI than the non 
adapted strains, explaining the predominance of adapted strains within the herds, 
where non adapted strains cause mastitis sporadically. Thus, differences in incidence 
of strain specific IMI are not simply due to different levels of exposure but 
dependant by characteristics of the strains. Surprisingly in this study IMI caused by 
the putatively host adapted strain caused a clinical mastitis which self cured in 5/6 
animals whereas this strain was previously associated with sub-clinical persistent 
mastitis in field. This outcome was indicated as characteristic of the host adapted 
strains (Zadoks et al., 2003; Zadoks et al., 2007). Differences in the host response 
between natural and experimental IMI could be at least partially explained by 
challenge dose and method of exposure, e.g. deposition of bacteria in the teat cistern 
via a cannula.  
                                                 
1
 Prof. R. Zadoks (Moredun Research Institute) contributed to the writing of this section 
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The challenge with strain FSL Z1-124 did not result in a significant cellular response 
and with the exception of low levels of IL-8 which were detected in 3 of the 4 
challenged quarters from which FSL Z1-124 was recovered. This suggests that 
clearance of this strain after the challenge occurs at early stages after the deposition 
of the bacteria in the mammary gland and it is due to is due to resident cells, 
molecules or mechanisms, rather than to influx of cells into the mammary gland 
Several mechanisms described by literature could explain the differences observed. 
These include ability to grow in milk, epithelial adhesion and invasion, resistance to 
killing by phagocytes. 
 
Ability of S. uberis to grow in milk was investigated in the past as possible virulence 
factor (Leigh, 1999; Kliem et al., 2002; Rambeaud et al., 2004) because a rapid 
growth would enable bacteria to replicate within the mammary gland at a rate 
exceeding that by which they are cleared via milking and by the activity of the 
phagocytes such as macrophages and PMNL (Leigh, 1999). However, no clear 
relation between ability of S. uberis to grow in milk and virulence in vivo was found 
as is the case for E. coli (Kornalijnslijper et al., 2004; Zadoks, 2007). In the present 
study the ability to grow in milk of the two strains used in the challenge study was 
investigated. Both strains were able to grow in milk from the challenge animals, thus 
it is unlikely that different pathogenicity observed between the two strains is due to 
the growth in milk. 
 
The differences observed between the strains may be due to a different ability to 
adhere or to invade the mammary epithelial cells which has been suggested to be 
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important for colonization of the mammary gland by S. uberis (Matthews et al., 
1994). Alternatively or additionally, the strains may have different abilities to resist  
killing by phagocytes present in the mammary gland such as PMNL or macrophages, 
although the role of those cell types in the clearance of S. uberis IMI is not clear 
(Leigh, 1999, Pedersen et al, 2003, Bannermann et al., 2004, Denis et al., 2006). 
 
Challenge with the putatively host-adapted strain, FSL Z1-048, resulted in a 
significant cellular and cytokine response in the mammary gland. The onset of 
clinical, bacteriological, cellular and cytokine events within the mammary gland 
relative to challenge with strain FSL Z1-048 differed between animals but the 
sequence and timing of these events within animals was relatively constant.  
 
The increase in cfu count was detected at 12 to 18 h PI followed by a detectable 
increase in SCC and preceded detectable increases in SCC by 12 to 24 h. The initial 
increase in SCC was largely due to influx of neutrophils in the mammary gland and 
SCC reached its highest level at 36 hours PI, which coincided with peak cfu level. 
After that time point, SCC remained elevated until the end of the experiment whereas 
the concentration of S .uberis in milk from infected quarters decreased approximately 
10
4 
fold. This finding suggests that neutrophils play a role in the initial decrease of 
bacterial concentration. This is in agreement with results from previous S. uberis 
challenge studies describing temporal coincidence of influx of neutrophils and 
decrease in bacteria in milk (Hill, 1988; Pedersen et al., 2003). In other challenge 
studies, in contrast, the influx of neutrophils did not result in a decrease of the 




The initial increase in SCC in this study coincides with the first detectable increase in 
IL-8 in all quarters. In a challenge model using S. uberis strain O140J, SCC increases 
also coincided with increase in IL-8, and both were detected at 30 h post challenge 
(Bannerman et al., 2004a). These observations are consistent with the role of IL-8 in 
neutrophil chemotaxis (Watanabe et al., 2008). In a third challenge study, SCC 
increase preceded the first detected increase in IL-8 by approximately 6 hours 
(Rambeaud et al., 2003). In all 3 challenge studies with S. uberis, the increase in IL-8 
levels was sustained for days. The slow but constant reduction of IL-8 concentration 
after the peak observed in our challenge model may reflect the reduction of bacterial 
concentration within the mammary gland. Nevertheless the reduction of IL-8 levels 
was not associated with a parallel reduction in SCC which remained at their maximal 
levels until the end of the study. The major source of this chemoattractant in the 
mammary gland is thought to be the secretory epithelium and its expression is 
dependent on the concentration of the pathogen (Gunther et al., 2010). 
 
The early inflammatory response was also characterised by increased levels of the 
pro-inflammatory cytokines IL-1β and IL-6, which were first detected at 30 to 42 h 
PI, whereas TNF-α , another pro-inflammatory cytokine was detected 6 h later . IL-
1β, which is both pro-inflammatory and pyrogenic, reached a peak and remained 
significantly elevated until 57 h PI, which coincided with the febrile response 
observed in our study. Elevations of these cytokines were in our study earlier and 
shorter than elevations observed in response to other S. uberis strains (Rambeaud et 
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al., 2003; Bannerman et al., 2004a) suggesting that host immune response may differ 
between bacterial strains as it differs between bacterial species (Bannerman, 2009). 
 
Concentration of IL-6 showed a bimodal peak at 48 and 72 h PI, and remained 
elevated until 96 h PI. IL-6 peaked relatively later and remained elevated longer than 
pro-inflammatory cytokines IL-1β and TNF-α. This may reflect its role of both pro-
inflammatory and anti-inflammatory cytokine which plays a crucial role in the 
transition from innate to adaptive immunity, for example by inducing the production 
of antagonists of IL-1β and TNF-α thus reducing the inflammatory response 
(Weissenbach et al., 2004). Moreover, IL-6 modulates T cell polarisation and 
promotes T cell trafficking into tissues (Jones, 2005). IL-6 was detected in cows with 
clinical mastitis due to streptococci, staphylococci or E. coli (Taylor et al., 1997). 
Up-regulation of IL-6 mRNA has been reported in blood PMNL after intramammary 
challenge with S. uberis (Moyes et al., 2010) thus detection in milk may be due to 
migration of these cells to the mammary gland. Bovine mammary epithelial cells can 
express IL-6 in vitro (Bougran et al., 2011) suggesting that production of this 
cytokine in the mammary gland may also occur locally. In humans and mice, IL-6 
promotes the migration of lymphocytes to the site of inflammation (Weissenbach et 
al., 2004; McLoughlin et al., 2005). In our study IL-6 levels increased before the 
lymphocyte influx, suggesting that IL-6 may have a similar function in cattle.  
 
First increase in levels of  IL-10 and IL-12p40 was detected 6 h after the increase in 
IL-8 (Table 2. 3) and concentration of these cytokines remained elevated respectively  
up to 72 and 81 h PI .The observed increase in IL-12p40 levels may indicate the 
 
48 
presence of IL-12 or IL-23, because our ELISA assay is based on the detection of the 
p40 subunit which is shared by these two cytokines (Oppmann et al., 2000).  
After challenge with S. uberis strain O140J in a separate study, IL-10 and IL-12p40 
levels increased at the same time as IL-8 levels, and remained elevated for up to 168 
h (Bannerman et al., 2004a). The sustained levels of these cytokines observed by 
Bannerman and colleagues may reflect the fact that in their challenge model bacterial 
concentration continued to increase until the end of the study whereas in our study 
concentration of bacteria after a peak observed at 36 h PI decreased by 
approximately 10
4
 fold by 72 to 81 h PI then concentration remained relatively 
stable, until spontaneous resolution which occurred in 5 animals (Figure 2. 4).  
 
First detection of IL-17A occurred at 72 h PI and the rise of the concentration of this 




T lymphocytes, although the 
exact time of onset of lymphocyte influx was not measured (Figure 2. 7, 2. 9). IL-
17A is produced mainly by CD4
+ 
Th17 cells. In vitro, the differentiation of naive T-
cells into CD4
+ 
Th17 requires the presence of IL-6 and TGF-β1. The differentiation 
of naive T cells is further supported by IL-1  and TNF- , (Stockinger and Veldhoen, 
2007) and subsequent maintenance of differentiated Th17 cells is promoted by IL-23 
(Stritesky et al., 2008). In our study elevation of IL-1 and IL-6 levels was followed 
by elevation of IL-12p40/IL-23p40 and TNF-  levels which preceded elevation of 





which increased their levels more rapidly than CD8
+
 cell population, resulting 
in an inversion of the CD4:CD8 ratio (Figure 2. 7). Inversion of the CD4:CD8 ratio 
has been observed in cows with naturally acquired mastitis due to Streptococcus spp. 
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(Taylor et al., 1997; Soltys and Quinn, 1999). Although the concentration of CD4
+
 
cells remained high the ratio normalized after 240 h PI due to sustained influx of 
CD8
+
 cells. These findings together support the hypothesis that differentiation of 
naive T-cells into Th17 cells may occur in response to the IMI with S. uberis. 
Temporal association of increase of IL-17A and influx of CD4
+ 
suggests moreover  
that this cell population may be the source of  IL-17A detected in the milk in our 
challenge study.  
 
Spontaneous resolution of infection occurred in 5 of 6 animals. Resolution was 
preceded by increased levels of IL-17A in 4 of 6 animals, and was temporally 
associated with influx of lymphocyte, moreover reduction of bacterial concentration 
in infected quarters coincided with the rise of this cytokine (Figure 2. 10). IL-17 is 
considered important for control of extracellular bacterial infections (Curtis and 
Way, 2009). In mice, IL-17A mediates acquired immunity to streptococcal 
colonization and infection, by stimulating pneumococcal killing by PMNL (Lu et al., 
2008). Moreover, in vitro, IL-17 up-regulates genes that encode antimicrobial 
proteins in bovine mammary epithelial cells. These compounds may have a role in 
bacterial killing in the mammary gland (Bougarn et al., 2011). Our findings suggest 
that IL-17A may play a role in control and resolution of S. uberis intramammary 
infection. 
 
Resolution of the infection may also be mediated by CD8
+
 lymphocytes. A recent 
study showed that S. uberis specific CD8
+
 memory cells are present in most cows, 
regardless of prior intramammary infection with S. uberis, and these cell population 
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is has a direct killing activity against S. uberis in vitro (Denis et al., 2011). This 
study together with the observation that clearance of infection occur in our study 
after the increase of CD8
+
 support the hypothesis that CD8
+ 
lymphocytes  play a role 
in response to S. uberis IMI. 
 
In conclusion, our study demonstrates that putatively host adapted strain FSL Z1-048 
and non-adapted strain FSL Z1-124, which caused IMI with different 
epidemiological patterns in a field study, elicit distinct clinical and immune 
responses after experimental challenge of lactating dairy cows. Moreover, this study 
suggests that neutrophils, lymphocytes and IL-17A may play important roles in 


















Figure 2. 10 Concentration of S. uberis bacteria (dashed line) and IL-17A (full line) in milk from 
mammary quarters challenged with strain FSL Z1-048. Quarters with detectable IL-17A are shown. 
Elevation of IL-17A coincided with decreased concentration of bacteria after the initial peak. All 
the quarters with detectable IL-17A cleared the infection by the end of the study (312 h PI). Cow 










































































































































































































































































Host Response to Secondary Challenge 
with Streptococcus uberis 
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3. 1 Introduction 
 
In the past decades implementation of control plans and hygienic measures have 
decreased prevalence of mastitis. However, it is still the most costly disease on dairy 
farms. Beside control programs and hygienic prevention, a vaccine against S. uberis 
would help to reduce the number of mastitis cases (Leigh, 1999; Zadoks, 2007; Denis 
et al., 2009). 
 
In the past years different approaches have been taken to develop a vaccine against S. 
uberis. Adhesion and invasion of the epithelial cells is considered a crucial step in 
the colonization of the mammary gland by S. uberis (Prado et al., 2011). S. uberis 
adhesion molecule (SUAM), a protein involved in the adhesion and invasion of 
epithelial cells in vitro was identified (Chen et al., 2011). Serum of cows immunized 
with recombinant SUAM contained SUAM-specific antibodies and reduced the 
adhesion and the internalization of S. uberis to mammary epithelial cells in vitro but 
the efficacy of this vaccine is yet to be tested in vivo (Prado et al., 2011). A similar 
approach was taken  to develop a vaccine using recombinant GapC protein as 
immunogen (Fontaine et al., 2002), a surface associated molecule common to several 
species of Streptococci involved in the adhesion to the host cells, but in vivo efficacy 
has to be further tested (Leigh, 2002). A different approach was used in the 
development of a vaccine targeting the plasminogen activator (PauA), a protein 
involved in the acquisition of nutrients by S. uberis. The aim of this vaccine was to 
impair the ability of the bacteria to acquire nutrients, reducing the growth rate of the 
bacteria in the mammary gland. A reduction of number of bacteria in the mammary 
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gland would reduce the inflammatory response of the host (Leigh, 1999). Subsequent 
studies showed that PauA is not necessary for the growth of S. uberis in milk (Ward 
et al., 2003), moreover strains lacking the gene encoding for PauA have been 
described (Gilchrist et al., 2013) 
 
Although promising, studies conducted using vaccines targeting specific components 
or products of S. uberis did not show evidence of successful protection in vivo or, in 
the case of SUAM, descriptions of such studies are lacking. In other studies, rather 
than using selected targets, the whole organism was used and in these studies some 
evidence of protection was observed in vivo. Subcutaneous vaccination with killed S. 
uberis or intra mammary inoculation with killed S. uberis was shown to protect cows 
from intramammary infection with the same strain (Finch et al., 1994, 1997). None 
of the animals vaccinated by the intramammary route showed clinical disease or 
bacteria in milk after the subsequent challenge, whereas animals vaccinated 
subcutaneously showed a reduced bacterial concentration in milk compared to the 
control animals but developed clinical signs of mastitis. In these studies, protection 
was significant only against the homologous strain (Finch et al, 1994; Finch et al., 
1997) whereas only a small decrease of bacterial concentration in milk was observed 
in quarters challenged with a heterologous strain of S. uberis (Finch et al., 1997). 
Due to the large number of different strains (Zadoks, 2007) the lack of protection 
against heterologous strains observed in these studies represents an important 




Specific milk antibodies against S. uberis were raised after the vaccination with 
killed S. uberis and were different in isotype composition depending on the route of 
administration. With intramammary vaccination, IgG1, IgG2 and IgM responses 
were observed, whereas with subcutaneous vaccination only IgG1 and IgG2 
responses were observed. These antibodies, when tested in vitro, did not show an 
enhanced opsonising and did not increase the ability of neutrophils to kill S. uberis 
(Finch et al., 1994). These data suggest that the humoral immune response may not 
be protective against intramammary infection with S. uberis, although the hypothesis 
that antibodies were protective by preventing or reducing the adhesion of bacteria to 
the mammary gland cells cannot be ruled out (Leigh, 1999). Specific antibodies 
could theoretically bind the bacterial adhesins involved in the process of adhesion 
and invasion of the epithelial cells, impairing the ability of the bacteria to adhere and 
invade the host cells thus reducing the pathogenicity. 
 
In addition to a humoral response, intramammary vaccination with killed S. uberis 
evoked a strong cellular immune response. Lymphocytes isolated from blood and dry 
period mammary gland secretions of vaccinated animals showed a proliferative 
response to S. uberis in vitro (Finch et al., 1994). Recent data suggest a possible 
involvement of lymphocytes in control of S. uberis mastitis. CD8
+
 cells specific to S. 
uberis isolated from blood of dairy cows expressed the memory cell repertoire 
antigen (CD45RO
+
) regardless of exposure history with S. uberis. These cells 
responded to the stimulation with S. uberis in vitro by proliferating. The vast 
majority of the cells were of the Th1 profile producing IFN-γ and were also able to 
directly kill S. uberis in vitro (Denis et al., 2011). Based on these findings authors 
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speculated that an effective vaccine against S.uberis would ideally generate S. uberis 
specific CD8
+
 memory cells in the mammary gland. 
 
Vaccines are based on the induction of an immunological memory, which is the 
ability of the adaptive immune system to respond to each subsequent encounter with 
a given antigen in a faster and more effective manner (Jenaway et al., 2001). Little is 
known about immunological memory following natural exposure of the mammary 
gland with S. uberis. Protective effect of previous infection with S. uberis was 
observed in cows intramammarily challenged with the live bacteria of the 
homologous strain, showing a reduction in the number of susceptible quarters 
between the first and the secondary challenge (Hill, 1988) although the possible 
mechanism behind protection was not investigated.  
 
Recently, epidemiological studies have been conducted. A longitudinal study showed 
an increased rate of S. uberis intramammary infection in quarters that had recovered 
from mastitis caused by the same pathogen in the past (Zadoks et al., 2001). 
Schukken et al. (2009) found that clinical mastitis with Streptococcus spp. did not 
reduce the severity, measured by milk loss, of subsequent clinical cases caused by 
the same pathogen. These epidemiological studies suggest that intramammary 
infection is not protective to a subsequent infection with the same pathogen, and that 
protective immunological memory is not induced. 
 
The aim of the present work is to characterize the host response of lactating cows 
previously challenged with S. uberis to the secondary challenge with a homologous 
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or heterologous strain to test the hypothesis that immunological memory exists 
following intramammary infection with S. uberis. Moreover the host response was 
measured at quarter level to test the hypothesis that, if memory responses are elicited, 
local (quarter level) immunological memory differs from systemic (mammary gland 
level) immunological memory. As for the response to the primary challenge 
described in the Chapter 2, clinical response, cellular subsets and cytokines involved 
in the response were characterized. 
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3. 2 Materials and Methods 
 
3. 2. 1 Study Design 
In total, 12 clinically healthy Holstein cows previously challenged with S. uberis 
strain FSL Z1-048 or FSL Z1-124 were used in this experiment (Table 3. 1). As for 
the primary challenge, the secondary challenge experiments were conducted using 
four cows at time. After the primary challenge (See Chapter 2 for details) one cow 
primary challenged with strain FSL Z1-048 and still infected with the challenge 
strain at the end of the initial follow-up period (14 days) was treated with 4 daily 
administrations of penethamate hydrodide  (Mamyzin 10 g intramouscular  injection, 
Boehringer Ingelheim, Bracknell, UK), an antimicrobial tested before as effective 
against strain FSL Z1-048 (Prof. R. Zadoks, personal communication). Cows were 
allowed to rest for 14 d and bacteriological milk examination was performed prior 
the secondary challenge to ensure that all the mammary quarters were free of 
infection.  
 
At secondary challenge cows were challenged in uninfected quarters. To test the 
hypothesis that immunological memory against intramammary infection with S. 
uberis exists and that it is strain specific, half of the cows received the same strain as 
at the primary challenge (homologous strain) whereas half received the other strain 
(heterologous strain). To test the hypothesis that local (quarter level) immunological 
memory differs to systemic (mammary level) immunological memory, two quarters 
per cow were challenged: the quarter that had been inoculated at primary challenge 
(previously challenged quarter) and the contralateral or the diagonally opposed 
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quarter (naive quarter) were challenged. No mock challenged control quarters were 
used. Allocation of homologous or heterologous secondary challenge was 
randomized. An example of one round of the experiment is shown in Figure 3. 1. In 
two cases, complete randomization was not possible because quarters that were mock 
challenged in the primary challenge experiment acquired a spontaneous infection 
during the resting period. The number of animals and quarters for each challenge is 
summarized in Table 3. 1. 
 
COW
LF RF LF RF LF RF LF RF
LH RH LH RH LH RH LH RH
PRIMARY 
NC NC NC NC NC NC NC NC
CHALLENGE
FSL Z1-124 PBS PBS FSL Z1-124 PBS FSL Z1-048 FSL Z1-048 PBS
SECONDARY 
NC NC NC NC NC NC NC NC
CHALLENGE
FSL Z1-124** FSL Z1-124* FSL Z1-048* FSL Z1-048**  FSL Z1-124* FSL Z1-124** FSL Z1-048** FSL Z1-048*
* Naive quarters
** Previously challenged quarters




Figure 3. 1 Example of experimental design. Large squares represent the udder of 4 
cows used in each of three rounds of infection. Udders are divided in the 4 mammary 
quarters (LF left front, RF right front, LH left hind, RH right hind). In the primary 
challenge experiment half of the cows were challenged with strain FSL Z1-048 and 
half with strain FSL Z1-124. Each cow was infused with the challenge strain in one 
rear quarter whereas the other rear quarter was infused with PBS as control. In the 
secondary challenge experiment half of the cows were re-challenged with the same 
strain (homologous) as the primary challenge (either FSL Z1-048 or FSL Z1-124). 
Half were challenged with the other (heterologous) strain. For each cow one quarter 
received both a primary and secondary bacterial challenge (previously challenged 
quarters). A second quarter received PBS in the primary challenge as control and S. 
uberis bacteria in the secondary challenge (naive quarters). The remaining quarters 









Table 3. 1 Number of animals and mammary quarters used for secondary 
challenge with Streptococcus uberis. Cows were previously challenged with FSL 
Z1-048 or FSL Z1-124 and received a secondary challenge with the homologous 
or heterologous strain. Challenged quarters had been used for the primary 
challenge (previously challenged) or were challenged for the first time on this 
occasion (naive). 
 
Strain Cows Quarters 
Strain FSL Z1-048 n=6  n=12  
     
 as Homologous n=3 n=6   
     
   Previously challenged n=3 
   Naive n=3 
     
 as Heterologous n=3 n=6   
     
   Previously challenged n=3 
   Naive n=3 
     
     
Strain FSL Z1-124 n=6  n=12  
     
 as Homologous n=3 n=6   
     
   Previously challenged n=3 
   Naive n=3 
     
 as Heterologous n=3 n=6   
     
   Previously challenged n=3 




3. 2. 2 Intramammary Challenge  
The bacterial inoculum for challenge experiments was prepared as described for the 
primary challenge (see section 2. 2. 4 for the details). 
 
3. 2. 3 Sample and Data Collection 
Milk samples and data were collected with the same frequency as in the primary 
challenge study (see section 2. 2. 8 for the details). Cows were followed up to 7 days 
or 168 h post infusion (PI). At completion of the follow-up, cows were culled. All 
experiments were conducted at the Moredun Research Institute (Penicuik, UK) with 
approval of the Institute’s Experiments and Ethical Review Committee in accordance 
with the Animals (Scientific Procedures) Act 1986. The vast majority of data were 
recorded and samples were collected by Prof. Ruth Zadoks (Moredun Research 
Institute) and David Reddick (Moredun Scientific Ltd, Penicuik, UK) 
 
3. 2. 4 Bacteriological Analysis and Molecular Typing 
Milk for quantitative and qualitative bacteriology analysis was collected every 6 h 
for the first 2 d post infusion and twice a day from 3 to 7 d PI. Species and strain 
identity of the S. uberis isolates were confirmed by PCR and PFGE respectively (for 
detailed protocols see section 2. 2. 6 and 2. 2. 7). A total of 39 isolates from animals 
challenged with strain FSL Z1-048 and 5 isolates from animals challenged with 
strain FSL Z1-124 were available for strain typing. Qualitative and quantitative 
bacteriological analysis was performed by Cliff. Ramage (Moredun Scientific Ltd.). 




3. 2. 5 Somatic Cell Counting and Flow Cytometry 
Milk samples for SCC determination were collected every 6 h for the first 2 d PI and 
twice a day from 3 to 7 d PI. Milk samples for flow cytometric analysis were 
collected on days 1, 2, 4 and 6 PI. Samples to analyze the T lymphocyte populations 
cells isolated from milk were stained with CD3, CD4, CD8 and γδ antibodies (for 
detailed protocols see section 2. 2. 8). 
 
3. 2. 6 Cytokine Measurements 
Milk samples for cytokine measurements were collected every 6 h for the first 2 d PI, 
twice a day from 3 to 5 d PI and once a day from 6 to 7 d PI. ELISA tests were used 
to determine the concentration of TNF-α, IL-1β, IL-6, IL-8, IL-10, IL-12p40, IL-17A 
and IFN-γ (for detailed protocols see section 2. 2. 9). 
 
3. 2. 7 Statistical Analysis 
Due to the complexity of the study design and the number of the hypotheses being 
tested, the number of observations for each treatment was extremely low (n= 3, Table 
3. 1). As a result, the power of the study was very low even where numerical results 
were clearly different between groups. No statistical significance was attained 
comparing groups with un-paired t-tests. Therefore, no further significance testing 







3. 3 RESULTS 
 
3. 3. 1 Clinical data 
 
3. 3. 1. 1 Clinical Response to Secondary Challenge with Strain FSL Z1-048 
Considering clinical data collected at cow level such as fever, anorexia and lethargy, 
all 6 cows that received S. uberis FSL Z1-048 at secondary challenge developed 
clinical mastitis. At quarter level, differences were observed between cows that 
received it as the homologous challenge (e.g. animals that also received strain FSL 
Z1-048 at primary challenge) and those that received it as the heterologous challenge 
(e.g. animals that were primary challenged with strain FSL Z1-124). In animals 
receiving FSL Z1-048 as homologous challenge, local signs of mastitis at quarter 
level were observed in all 3 naive quarters whereas only one out of 3 previously 
challenged quarters showed visible abnormalities (Table 3. 2). In animals receiving 
FSL Z1-048 as heterologous challenge, clinical signs at quarter level were observed 
in all 6 quarters regardless of whether they were naive (i.e. quarters that were mock 
challenged at primary challenge experiment) or previously challenged (i.e. quarters 
that were challenged at primary challenge experiment) (Table 3. 3). Because of 
severe clinical conditions, two animals which received strain FSL Z1-048 as 
heterologous challenge were treated with antimicrobials and eliminated from the 
study (respectively at 48 and 81 h PI). The results for this challenge group are 
presented for 3 animals until 48 h PI, 2 animals between 57 and 81 h PI and 1 animal 




Clinical signs were first detected in individual cows challenged with FSL Z1-048 as 
homologous strain between 36 and 42 h PI and between 30 and 57 h PI in cows 
challenged with FSL Z1-048 as the heterologous strain. Mean clinical score peaked 
at 72 h PI in cows challenged with FSL Z1-048 as the homologous strain and at 57 h 
PI in cows challenged with FSL Z1-048 as the heterologous strain (Figure 3.2). 
 
Body temperature increased in 3 out of 3 cows challenged with FSL Z1-048 as 
homologous strain as well as in 3 out of 3 cows challenged with FSL Z1-048 as 
heterologous strain. The first increase in body temperature in individual animals was 
detected between 36 and 57 h PI both groups, regardless of strain homology. The 
mean temperature peak was observed 57 h PI in cows receiving FLS Z1-048 as the 
homologous or the heterologous secondary challenge and was 40.1 ± 1.3 and 40.6 ± 
0.6 °C, respectively (Figure 3. 3).  
 
Milk production decreased in all the cows in response to the secondary challenge 
with strain FSL Z1-048. The decrease started the first day following the infusion and 
continued until the third day (Figure 3. 4). Daily milk yield was reduced by 
approximately 50% by the fourth day PI in cows challenged with FSL Z1-048 as 
homologous strain whereas in cows which received it as the heterologous strain milk 







3. 3. 1. 2 Clinical Response to Challenge with Strain FSL Z1-124 
None of the cows challenged with strain FSL Z1-124 either as homologous or 
heterologous strain developed clinical mastitis. Body temperature remained on the 
baseline, and no reduction in daily milk yield was observed (Figure 3. 4). 
 
 
Figure 3. 2 Clinical score in cows after secondary challenge with FSL Z1-048 either 
as heterologous (hashed bars, n=3) or homologous strain (solid bars, n=3). Mean and 
SD are shown. 0 = no clinical signs; 1= abnormalities in milk, e.g. clots or 
discoloration; 2 = abnormalities in udder, e.g. swelling or pain; 3 =systemic signs, 
e.g. fever. Two animals that received FSL Z1-048 as heterologous secondary 
challenge were removed from the study after 48 h and 81 h PI respectively. 
 
Figure 3. 3 Body temperature in cows secondary challenged with FSL Z1-048 either 
as heterologous (squares, n=3) or homologous strain (triangles, n=3). Mean and 
standard deviation are shown. Two animals that received FSL Z1-048 as 






















































Figure 3. 4 Daily milk yield in cows secondary challenged with strain FSL Z1-048 
(solid lines) or FSL Z1-124 dashed lines. Mean and standard deviation are shown for 
the cows which received the homologous strain (triangles) and the heterologous 
strain (squares).Three cows per group are shown except for the group that received 
FSL Z1-048 as heterologous secondary challenge (n=3 up to and including 2 d PI, 
n=2 between 2 and 4 d PI and n=1 until 6 d PI) 
 
3. 3. 2 Bacterial Culture and Molecular Typing 
 
Culture of unused doses of the challenge inoculum showed that quarters had been 
infused with 53 to 160 cfu of strain FSL Z1-048 or 80 to 143 cfu of strain FSL Z1-
124. In the last round of the experiment, the challenge dose of strain FSL Z1-124 was 
increased to 20,660 cfu to determine whether a higher inoculum dose would induce a 
clinical response. Bacteriological analysis on milk from quarters was performed in 




























3. 3. 2. 1 Strain FSL Z1-048 
S. uberis was isolated in milk from all cows that received strain FSL Z1-048 at 
secondary challenge either as homologous or heterologous strain (Figure 3. 5 and 3. 
6). Bacteria were detected in milk of 3 of 3 naive quarters in cows that received this 
strain as homologous secondary challenge. All 3 quarters were positive between 30 
and 168 h PI (Figure 3. 5). S. uberis was isolated in milk from 2 of 3 previously 
challenged quarters that received the strain as homologous secondary challenge. 
Quarter 5RH was tested positive continuously from 18 to 168 h PI whereas quarter 
4RH was positive at 18, 42, 48 and 96 h PI (Figure 3. 5, Table 3. 2). Mean 
concentration in previously challenged quarters which received FSL Z1-048 as 
homologous strain reached its peak (3.38 ± 3.21 Log10 cfu/mL) at 48 h PI. In naive 
quarters the peak (7.31 ± 1 Log10 cfu/mL) was much higher and observed at 42 h PI 
(Figure 3. 7). S. uberis was isolated in milk from all the cows challenged with strain 
FSL Z1-048 as heterologous challenge either in naive (n=3) or previously challenged 
(n=3) quarters. S. uberis was first detected in quarters between 18 and 24 h in 
previously challenged quarters and between 24 and 30 h in naive quarters (Table 2. 
3). Thereafter, the quarters remained positive until the end of the study (n=1) or the 
antimicrobial treatment (n=2, Figure 3.6). Maximal bacterial concentrations in both 
naive and previously challenged quarters were observed between 57 and 72 h PI (8.1 









Figure 3. 5 Number of bacteriologically positive quarters after secondary challenge 
with FSL Z1-048 as homologous strain. Naive (solid bars, n=3) and previously 
challenged quarters (hashed bars, n=3) are shown. 
 
Figure 3. 6 Number of bacteriologically positive quarters after secondary challenge 
with FSL Z1-048 as heterologous strain. Naive (solid bars, n=3) and previously 
challenged quarters (hashed bars n=3) are shown. After 48 h and 81 h PI animals 
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Figure 3. 7 Concentration of S. uberis bacteria in milk after secondary challenge 
with FSL Z1-048 as homologous strain. Mean and standard deviation are shown for 
naive (solid lines, n=3) and previously challenged (dashed lines, n=2 quarters).  
 
Figure 3. 8 Concentration of S. uberis bacteria in milk of cows secondary challenged 
with FSL Z1-048 as heterologous strain. Mean and standard deviation are shown for 
naive (solid lines) and previously challenged (dashed lines) quarters. 3 quarters per 
group are shown up to and including 48 h, 2 from 57 to 81 h PI and 1quarter only 


















































































Figure 3. 9 Number of positive quarters of cows after secondary challenge with FSL 
Z1-124 either as homologous or heterologous strain. 11 quarters were infused with 
strain FSL Z1-124 in total in the secondary challenge. Four quarters and 3 cows 














































Table 3. 2 Time (hours post infusion) of first detection (bacteria) or first detected increase (SCC, 
cytokine levels) and maximal concentration of several parameters in milk from mammary quarters 
of cows after secondary challenge with Streptococcus uberis strain FSL Z1-048 as homologous 
strain. Each animal was challenged in two quarters, one naive and one previously challenged with 
the same strain. 
 
ND not detected, NA not applicable 
 
Table 3. 3 Time (hours post infusion) of first detection (bacteria) or first detected increase (SCC, 
cytokine levels) and maximal concentration of several parameters in milk from mammary quarters 
of cows after secondary challenge with Streptococcus uberis strain FSL Z1-048 as heterologous 
strain. Each animal was secondary challenged in two quarters, one naive and one previously 
challenged with a different strain. 
 Heterologous naive  Heterologous previously challenged 
Animal/Quarter 7RH 8RF* 9RF** 7LH 8LH* 9LH** 
  Time Conc. Time Conc. Time Conc. Time Conc. Time Conc. Time Conc. 
Clinical signs (quarter) 
81 NA 36 NA 57 NA 96 NA 36 NA 57 NA 
Bacteria (Log10 cfu/mL) 
24 7.44 24 8.02 18 8.36 30 8.01 24 8.01 24 8.02 
SCC (Log10 cell/mL) 
57 7.48 42 7.48 42 7.19 57 7.48 48 7.48 42 7.48 
IL-1β (pg/mL) 
81 111.4 48 93.18 57 111.2  72 203.1 42 227.8 81 71.89 
IL-8 (ng/mL) 
120 3.400 48 40 57 15.40  81 40 48 4.113 48 40 
TNF-α (pg/mL) 42 4189 48 1921 36 705.8  57 578.4 42 1705 48 1055 
IL-6 (ng/mL) 96 4.982 48 1.396 81 4.877  81 8.893 48 4.847 81 4.113 
IL-10 (bU/mL) 
120 15.08 48 3.547 81 13.07  81 26.4 48 6.303 81 9.844 
IL-12p40 (bU/mL) 
96 63.49 48 14.28 57 127.2  72 55.92 48 88.28 48 86.38 
IL-17A (pg/mL) 
ND - ND - 81 339.1  ND - 48 393.3 81 223.3 
* treated with antimicrobials at 48 h PI 
** treated with antimicrobials at 81 h PI 
ND not detected, NA not applicable 
 
 Homologous naive  Homologous previously challenged 
Animal/Quarter  2LH 4LH 5LH 2RH 4RH 5RH 
  Time Conc. Time Conc. Time Conc. Time Conc. Time Conc. Time Conc. 
Clinical signs (quarter) 36 NA 42 NA 42 NA ND NA ND NA 72 NA 
Bacteria (Log10 cfu/mL) 18 7.25 24 8.9 24 7.1 ND - 18 3.75 30 7.55 
SCC (Log10 cell/mL) 36 7.48 36 7.48 36 7.48 57 6.7 57 6.94 48 7.48 
IL-1β (pg/mL) 42 135.3 42 189.8 42 153.3  ND - ND - 57 301.1 
IL-8 (ng/mL) 36 10.18 36 40 36 19.55  48 0.369 48 1.271 48 39.39 
TNF-α (pg/mL) 42 3762 42 8000 72 3130  ND  - 57 823.5 48 5039 
IL-6 (ng/mL) 42 15.17 42 18.09 42 3.18  57 0.086 48 0.437 57 3.755 
IL-10 (bU/mL) 42 24.85 42 21 42 19.04  48 1.763 48 1.385 57 16.27 
IL-12p40 (bU/mL) 42 27.61 42 132.7 48 29.38  ND - ND - 57 114.5 
IL-17A (pg/mL) ND - 57 633.2 72 279.9  ND - ND - 57 878.1 
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3. 3. 2. 2 Strain FSL Z1-124 
S. uberis was isolated in milk from only 3 of 6 cows after secondary challenge with 
strain FSL Z1-124 either as homologous or heterologous strain. Bacteria were 
isolated in both the previously challenged and the naive quarter in one individual 
cow which received strain FSL Z1-124 as heterologous challenge (quarters 1RH and 
1LH respectively) and from one quarter in other two cows 1 (RH, naive quarter) and 
12 (LH, previously challenged quarter) which received strain FSL Z1-124 as 
homologous challenge (Figure 3. 9). Concentration of bacteria in milk in individual 
quarters ranged from 2.52 to 3 Log10 cfu/mL. 
 
3. 3. 3 Strain Typing 
From each quarter challenged with strain FSL Z1-048, 3 isolates were used for PCR 
and PFGE, i.e. one isolate representing the first isolation, peak concentration and last 
isolation, respectively, for a total of 36 isolates. All isolates were confirmed to be S. 
uberis by PCR and PFGE patterns of all isolates matched that of the challenge strain. 
Only 7 isolates were available from cows secondary challenged with strain FSL Z1-
124. Five isolates from quarters challenged with FSL Z1-124 were confirmed to 
belong to the challenge strain, i.e. 2 isolates from quarter 10RH obtained at 96 and 
168 h PI and 3 isolates obtained from quarter 12RH at 18, 42 and 48 h PI.  
 
3. 3. 4 Somatic Cell Count 
Somatic cell count was measured in mammary quarters during the resting period 




After secondary challenge, elevation in SCC was observed in all the previously 
challenged quarters which received FSL Z1-048 as homologous strain, however, 
SCC in individual quarters varied considerably amongst the quarters. First elevation 
was detected in individual quarters between 48 and 57 h PI (Table 3. 3) and mean 
concentration reached the maximal level (6.87 ± 0.15 Log10 cell/mL) by 57 h PI 
(Figure 3. 10).  
 
Elevations in SCC were observed in all the naive quarters after secondary challenge 
with FSL Z1-048 as homologous strain. First elevation in individual quarters was 
detected at 36 h PI (Table 3. 2) and maximal mean concentration was observed 42 h 
PI (7.31 ± 0.23 Log10 cell/mL). Elevation in SCC was also observed in all cows 
challenged with strain FSL Z1-048 as heterologous strain. In previously challenged 
quarters, the first elevation was detected in individual quarters between 42 and 57 h 
PI (Table 3. 3). The peak in mean concentration (7.25 Log10 cell/mL) was observed 
81 h PI (Figure 3. 10). First increase was detected in naive quarters between 42 and 
57 h PI (Table 3. 3) and maximal elevation of mean concentration (7.24 ± 0.08 Log10 
cell/mL) was reached by 57 h PI (Figure 3. 10). 
 
No increase in SCC was observed in previously challenged or naive quarters after 
secondary challenge with strain FSL Z1-124, either in cows which received the strain 
as homologous or heterologous challenge (data not shown). SCC was increased at 
time 0 in previously challenged quarters of cows which received FSL Z1-124 as 





Figure 3. 10 SCC in cows after secondary challenge with FSL Z1-048 as 
homologous (triangles) or heterologous (squares) strain. Mean and standard 
deviation for naive (solid lines) and previously challenged (dashed lines) quarters are 
shown. 3 quarters per group are shown for cows that received the homologous strain, 
3 quarters per group are shown up to 48 h, 2 from 57 to 81 h PI and 1quarter only 
















































3. 3. 5 Milk Concentrations of T Cell Subsets as Determined by Flow Cytometry 
 
Concentrations of T-cell subsets were measured in milk from quarters after 
secondary challenge of cows with strain FSL ZI-048 or FSL Z1-124. Cells 
expressing CD3 (pan T cell marker), CD4, CD8 and γδ TCR were assessed. 
 
3. 3. 5. 1 Concentration of T cell Subsets in Cows After Secondary Challenge 
with Strain FSL Z1-048 
Concentration of CD3
+
 cells was elevated in all the quarters after challenge with FSL 
Z1-048 as homologous strain, regardless of whether they were previously challenged 
or naive. Mean concentration in previously challenged quarters increased from 276 ± 
254 × 10
3 
cell/mL at 0 h (pre- infusion) to 1,243 ± 1,245 × 10
3 
cell/mL 96 h PI 
(Figure 3. 11). Mean concentration in naive quarters increased from 1.22 ± 1.27 × 
10
3 
cell/mL at 0 h to 364 ± 19 × 10
3 
cell/mL 96 h PI (Figure 3. 11).  
 
All the T cell subsets (CD4, CD8 and γδ) were increased after the challenge with 
FSL Z1-048 as homologous strain (Figures 3. 12, 3. 14). The increase of CD4
+ 
cells 
preceded the increase of CD8
+
 cells in naive quarters. In fact, CD4:CD8 ratio 
changed in naive quarters from 0.68 ± 0.03 to 1.71 ± 0.32 at 96 h PI. In contrast, the 
CD4:CD8 ratio in previously challenged quarters remained below 1 until the end of 




milk cells was also observed in cows challenged with FSL Z1-048 
as heterologous strain. Mean concentration in previously challenged quarters 
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increased from 2.6 ± 3.0 × 10
3 
cell/mL at time 0 to 74 ± 78 × 10
3 
cell/mL 48 h PI 
(Figure 3. 11). Mean concentration increased in naive quarters from 1.4 ± 1.3 × 10
3 
cell/mL at time 0 to 4.5 ± 3.4 × 10
3 
cell/mL 48 h PI. All the T cell subsets increased 
in concentration by the end of the study. Mean CD4:CD8 ratio was inverted at 144 h 
PI (Figure 3. 14). It increased from 0.72 ± 0.27 at time 0 to 1.73 at 144 h PI in 
previously challenged quarters and from 0.66 ± 0.25 at time 0 to 1.29 at 144 h PI in 




Figure 3. 11 Milk CD3
+
 cell concentration after secondary challenge with FSL Z1-
048 as homologous (triangles) or heterologous (squares) strain. Mean and, where 
possible, standard deviation for naive (solid lines) and previously challenged (dashed 
lines) quarters are shown. Three quarters per group were available from cows that 
received FSL Z1-048 as the homologous strain. Three quarters per group are shown 
up to 48 h, 1 at 96 and 144 h PI and 1quarter only after 81 h PI for cows that received 
FSL Z1-048 as the heterologous strain. No quarters were available at 96 h PI for 
previously challenged quarters that received FSL Z1-048 as heterologous strain. The 
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Figure 3. 12 Milk CD4
+
 cell concentration in cows after secondary challenge with 
FSL Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, 
where possible, standard deviation for naive (solid lines) and previously challenged 
(dashed lines) quarters are shown. 
 
 
Figure 3. 13 Milk CD8
+
 cells in cows after secondary challenge with FSL Z1-048 as 
homologous (triangles) or heterologous (squares) strain. Mean and, where possible, 
standard deviation for naive (solid lines) and previously challenged (dashed lines) 

































































Figure 3. 14 Milk γδ cells in cows after secondary challenge with FSL Z1-048 as 
homologous (triangles) or heterologous (squares) strain. Mean and, where possible, 
standard deviation for naive (solid lines) and previously challenged (dashed lines) 
quarters are shown. 
 
 
Figure 3. 15 Milk CD4:CD8 ratio in cows after secondary challenge with FSL Z1-
048 as homologous (triangles) or heterologous (squares) strain. Mean and, where 
possible, standard deviation for naive (solid lines) and previously challenged (dashed 
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3. 3. 5. 2 Concentration of T Cell Subsets in Cows After Secondary Challenge 
with Strain FSL Z1-124 
No elevation in milk T cell populations was observed in cows after secondary 
challenge with FSL Z1-124 either as homologous or heterologous strain. Mean 
concentrations of T cells remained at the pre-infusion levels both in previously 




 cells in previously 
challenged and naive quarters remained at pre-infusion levels throughout the study 
(data not shown).  
 
3. 3. 6. 5 Milk Cytokines  
 
3. 3. 6. 1 Concentration of Milk Cytokines in Cows after Secondary Challenge 
with strain FSL Z1-048 
The concentrations of several cytokines (IL-1β, IL-8, TNF-α, IL-6, IL-10, IL-12p40, 
IL-17A, and IFN-γ) were measured in milk from cows after secondary challenge 
with S. uberis strains FSL Z1-048 or FSL Z1-124.  First time of detection and 
maximal concentrations of cytokines in milk after secondary challenge with strain 
FSL Z1-048 are summarized in Table 3. 2 for cows receiving the strain as 
homologous secondary challenge and in Table 3. 3 for cows receiving the strain as 
heterologous secondary challenge. 
 
The concentration of IL-1β increased in milk of all naive quarters of cows that 
received FSL Z1-048 as homologous secondary challenge. The first increase in these 
quarters was detected 42 h PI and mean concentration reached a peak of 144.3 ± 41.7 
 
80 
pg/mL (n=3) at 42 h PI. IL-1β was detected only in one previously. challenged 
quarter that  received FSL Z1-048 as homologous secondary challenge. In this 
quarter first detection and peak of concentration (301.1 pg/mL) was at 57 h PI (Table 
3. 2). 
 
IL-1β increased in all naive and previously challenged quarters of cows that received 
FSL Z1-048 as heterologous strain. In previously naive quarters, IL-1β was first 
detected between 42 and 57 h PI and peak mean concentration (118.3 ± 120 pg/mL, 
n=2) was observed at 72 h PI (Figure 3. 16). In previously challenged quarters, IL-1β 
was first detected between 48 and 72 h PI. Mean maximal concentration (102.3 ± 
12.9 pg/mL, n=2) was observed 81 h PI (Figure 3. 16). 
 
Figure 3. 16 Concentration of milk IL-1β in cows after secondary challenge with 
FSL Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, 
where possible, standard deviation for naive (solid lines) and previously challenged 
(dashed lines) quarters are shown. Three quarters for each group are shown for cows 
after secondary challenge with FSL Z1-048 as homologous strain. Three quarters for 
each group are shown for cows after secondary challenge with FSL Z1-048 as 
heterologous strain up to and including 48 h PI, 2 quarters from 57 to 81 h PI and 1 
quarter from 96 h PI to the end of the study (168 h PI). The same number of quarters 
was available for measurement of IL-8, IL-6, TNF-α, IL-10, IL-12p40 and IL-17A 



























IL-8 was first detected at 36 h in all three naive quarters challenged with FSL Z1-048 
as homologous strain, with peak mean concentration at 42 h 20.35 ± 17.12 ng/mL. 
Concentration of milk IL-8 also increased in all quarters after secondary challenge 
with FSL Z1-048 as homologous strain. In these quarters, the first elevation of IL-8 
was detected 48 h PI, with peak mean concentration of IL-8 (13.4 ± 22.5 ng/mL) 
occurring at 72 h PI (Figure 3. 17). The maximal concentration of IL-8 was highly 
variable between individual animals: in quarter 2 RH, the maximum concentration 
was ca. 10 fold lower than the maximal concentration observed in quarter 4RH and 
ca. 100 fold lower than the maximal concentration observed in quarter 5RH.  
 
Concentration of IL-8 was also increased in all cows after secondary challenge with 
FSL Z1-048 as heterologous strain. In previously challenged quarters first elevation 
was observed between 36 and 57 h PI, with maximal mean concentration (16. ± 21 
ng/mL) occurring at 48 h PI (Figure 3. 17). In naive quarters, first elevation was 
observed between 36 and 57 h PI and mean concentration in these quarters (39.92 ± 






Figure 3. 17 Concentration of milk IL-8 in cows after secondary challenge with FSL 
Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, where 
possible, standard deviation for naive (solid lines) and previously challenged (dashed 
lines) quarters are shown. 
 
Concentration of TNF-α was increased in all the naive quarters after secondary 
challenge with FSL Z1-048 as homologous strain. In individual quarters, first 
elevation was detected between 42 and 72 h PI and maximal mean concentration 
(3,344 ± 4,035 pg/mL) was observed 81 h PI (Figure 3. 18). Concentration of TNF-α 
was increased in 2 of the 3 previously challenged quarters which received FSL Z1-
048 as homologous strain. First elevation was detected in individual quarters at 57 h 
PI. Maximal mean concentration (1,954.31 ± 2,703.31 pg/mL) was observed at 81 h 
PI (Figure 3. 18). Maximal concentration observed in quarter 5RH was 5-fold that 
observed in quarter 4RH.  
 
Concentration of TNF-α was elevated in all quarters that received FSL Z1-048 as 
heterologous strain, either in naive or previously challenged quarters. In individual 
naive quarters elevation of TNF-α was first detected between 42 and 48 h PI and 





























In individual previously challenged quarters first elevation was detected between 36 
and 48 h PI and maximal mean concentration (1,704 ± 2,153 pg/mL) was observed at 
48 h PI (Figure 3. 18) 
 
 
Figure 3. 18 Concentration of milk TNF-α in cows after secondary challenge with 
FSL Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, 
where possible, standard deviation for naive (solid lines) and previously challenged 
(dashed lines) quarters are shown. 
 
Concentration of IL-6 was increased in all the quarters after secondary challenge 
with FSL Z1-048 as homologous strain, whether naive or previously challenged. 
Elevation in IL-6 concentration in naive quarters was first detected at 42 h PI and 
maximal mean concentration (11.6 ± 8.8 ng/mL) was detected at 57 h PI (Figure 3. 
19). Elevation in IL-6 concentration was first detected in previously challenged 
quarters between 48 and 57 h PI and maximal mean concentration (1.3 ± 2.1 ng/mL) 
was observed at72 h PI (Figure 3. 19). Concentration in two individual previously 

































Concentration of IL-6 was elevated in all the quarters after secondary challenge with 
FSL Z1-048 as heterologous strain. First elevation was detected in individual naive 
quarters between 42 and 57 h PI and maximal mean concentration (1.9 ± 2.6 ng/mL) 
was detected at 48 h PI. First elevation was detected in individual previously 
challenged quarters between 42 and 72 h PI and  maximal mean concentration (2.5 ± 
2.1 ng/mL) was detected 72 h PI (Figure 3. 19).  
 
 
Figure 3. 19 Concentration of milk IL-6 in cows after secondary challenge with FSL 
Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, where 
possible, standard deviation for naive (solid lines) and previously challenged (dashed 
lines) quarters are shown. 
 
Concentration of IL-10 was elevated in all the quarters after secondary challenge 
with FSL Z1-048 as homologous strain. First elevation in individual naive quarters 
was detected at 42 h PI, and maximal mean concentration (17.5 ± 7.8 bU/mL) was 
detected at 48 h PI (Figure 3. 20). First detection of IL-10 in individual previously 
challenged quarters was between 48 and 57 h PI. Maximal mean concentration (6.4 ± 

































Concentration of IL-10 was increased in all the quarters that received FSL Z1-048 as 
heterologous strain at secondary challenge. First elevation of IL-10 concentration 
was detected between 42 and 57 h PI in naive quarters and maximal mean 
concentration (18.1 ± 11.7 bU/mL) was observed at 81 h PI (Figure 3. 20). First 
elevation of IL-10 was detected in previously challenged quarters between 48 and 72 
h PI and maximal mean concentration (15 bU/mL) was observed at 120 h PI (Figure 
3. 20).  
 
Figure 3. 20 Concentration of milk IL-10 in cows after secondary challenge with 
FSL Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, 
where possible, standard deviation for naive (solid lines) and previously challenged 
(dashed lines) quarters are shown. 
 
Concentration of IL-12p40 was increased in all the naive quarters which received 
FSL Z1-048 as homologous strain. First increase was detected between 42 and 48 h 
PI. Maximal mean concentration (62 ± 60 bU/mL) was observed 48 h PI (Figure 3. 
21). 
Concentration of IL-12p40 was increased in one out of three previously challenged 
quarters that received FSL Z1-048 as homologous strain. IL-12p40 was first detected 




























Concentration of IL-12p40 was increased in all the quarters after secondary 
challenge with FSL Z1-048 as heterologous strain, whether naive or previously 
challenged. First increase in individual naive quarters was detected 42 to 57 h PI  and 
maximal mean concentration (58.2 ± 50.4 bU/mL) was observed at 48 h PI (Figure 3. 
21). First increase in individual previously challenged quarters was detected between 
48 and 72 h PI and maximal mean concentration (64 ± 90 bU/mL) was observed 57 h 
PI (Figure 3. 21).  
 
Figure 3. 21 Concentration of milk IL-12p40 in cows after secondary challenge with 
FSL Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, 
where possible, standard deviation for naive (solid lines) and previously challenged 
(dashed lines) quarters are shown. 
 
Concentration of IL-17A was increased in 2 of 3 naive quarters that received FSL 
Z1-048 as homologous strain. Elevation was first detected in individual naive 
quarters between 57 and 81 h PI and maximal mean concentration was observed at 
72 and 144 h PI (211 ± 366 and 211 ± 187 pg/mL, respectively, Figure 3. 21). IL-
17A was elevated only in one previously- challenged quarter that received FSL Z1-
048 as homologous strain. First elevation in that quarter was observed at 57 h PI and 
































IL-17A was first detected at 48 and 81 h PI in 2 of 3 previously challenged quarters 
that received FSL Z1-048 as homologous strain and reached a maximal mean 
concentration of 131 ± 127 pg/mL . Concentration of IL-17A was elevated in 1 of 3 
previously naive quarters that received FSL Z1-048 as heterologous strain. First 
elevation in quarter 9RH was observed at 72 h PI and maximal concentration (339 
pg/mL) was observed at 81 h PI (Figure 3. 22, Table 3. 2).  
 
Figure 3. 22 Concentration of milk IL-17A in cows after secondary challenge with 
FSL Z1-048 as homologous (triangles) or heterologous (squares) strain. Mean and, 
where possible, standard deviation for naive (solid lines) and previously challenged 
(dashed lines) quarters are shown.  
 
3. 3. 6. 2 Concentration of Milk Cytokines in Cows After Secondary Challenge 
with strain FSL Z1-124 
 
No increase in concentration of any of the cytokine measured was observed in milk 
































3. 3. 7 Comparison between Primary and Secondary Challenge Response 
 
In order to allow a comparison between the host response to primary and secondary 
challenge with strain FSL Z1-048, relevant data from the primary (Chapter 2) and 
secondary challenge experiments were plotted together. The clinical, bacteriological 
and SCC responses to the secondary challenge with S. uberis were very similar to the 
host response following the primary challenge described in Chapter 2. The 
temperature profile (Figure 3. 23) was comparable between primary and secondary 
challenge although the peak of the average temperature was delayed following the 
secondary challenge by approximately 20 h compared to the response to the primary 
challenge. A similar delay was observed for concentration of bacteria in milk (Figure 
3. 24) and SCC (Figure 3. 25). The delayed response was observed both in cows that 
received strain FSL Z1-048 as homologous secondary challenge and in cows that 
received it as a heterologous secondary challenge (Figure 3. 23, 3. 24B, 3. 25B). The 
previously challenged quarters of the cows that received strain FSL Z1-048 as 
homologous showed a peak of the bacterial concentration approximately 10
4
 times 
lower than the peak reached following the primary challenge or the peak reached in 















Figure 3. 23 Temperature in response to secondary challenge with S. uberis FSL Z1-
048. Mean and, where possible, standard deviation are shown for cows that received 
FSL Z1-048 at secondary challenge (two quarters per cow), either as homologous 
strain (black dashed line, n=3) or as heterologous strain (black solid line, n=3), and 
in response to the primary challenge (one quarter per cow, n = 6, red solid line, see 
Section 2. 3. 2 for details). Two cows that received FSL Z1-048 as heterologous 
strain at secondary challenge, were treated with antibiotics at 48 and 81 h PI 



































Figure 3. 24 Concentration of S. uberis bacteria in milk of cows after secondary 
challenge with strain FSL Z1-048 as homologous (A) or heterologous (B) strain. Per 
cow, 2 quarters were challenged, i.e. one quarter that had been challenged whit S. 
uberis before and one quarter that had been mock challenged with PBS at primary 
challenge of the cow. Three cows were challenged for each group. Average and, 
where possible, standard deviations of bacteria concentration are shown for 
previously challenged quarters (dashed lines) and naïve quarters (solid lines). 
Concentration of bacteria in quarters that received the primary challenge (n=6; one 



















































































Figure 3. 25 SCC in milk of cows after secondary challenge with strain FSL Z1-048 
as homologous (A) or heterologous (B). Three cows were challenged for each group. 
Average and standard deviations of SCC are shown for previously challenged 
quarters (dashed lines) and naïve quarters (solid lines). SCC in quarters that received 
the primary challenge (n=6, one quarter per cow) is shown with the red line (see 











































































3. 4 Discussion 
 
Putatively host adapted strain FSL Z1-048 caused mastitis in all (6/6) cows upon 
secondary challenge whereas none of the cows secondarily challenged with non 
adapted strain FSL Z1-124 developed clinical signs of mastitis. Intramammary 
infection in cows secondarily challenged with strain FSL Z1-048 was characterized 
by clinical signs, increased body temperature and reduction in milk production. S. 
uberis bacteria were isolated in 11 of the 12 quarters challenged with strain FSL Z1-
048 whereas only 4 of the 11 quarters secondarily challenged with strain FSL Z1-124 
became bacteriologically positive. The differences between the two strains in ability 
to cause intramammary infection and clinical disease are in accordance with those 
observed following the primary challenge (see Chapter 2). Both SCC and milk CD3
+
 
concentration were increased in all quarters challenged with FSL Z1-048 compared 
with the pre-infusion levels. As observed in the primary challenge, the host response 
was also characterized by production of cytokines IL-1β, TNF-α, IL-6, IL-8 IL-10 
and IL-17A in the mammary gland. 
 
Differences were observed between cows that received strain FSL Z1-048 as a 
homologous secondary challenge and those that received it as a heterologous 
secondary challenge. All the quarters that received the strain as a heterologous 
challenge (6/6) developed clinical mastitis, whereas only 4 out of 6 quarters that 
received FSL Z1-048 as homologous challenge developed clinical mastitis (e.g. no 
signs of inflammation and no alterations of milk were visible. Furthermore, 2 out of 
3 cows challenged with FSL Z1-048 as heterologous strain had to be treated with 
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antibiotics before the end of the study due to severe clinical signs, whereas none of 
the cows challenged with FSL Z1-048 as homologous strain required antibiotic 
intervention. 
 
In the present study the two quarters that did not develop clinical mastitis following 
challenge with FSL Z1-048 were quarters challenged with this same strain in the 
primary challenge. These previously challenged quarters showed an increased SCC 
at the time of challenge (day 0). This may explain the protective effect that was 
observed because high pre-challenge SCC has been described as protective factor for 
IMI during challenge with S. aureus (Schukken et al., 1999). Protective effect 
against S. uberis IMI mediated by high SCC was observed in the past following, 
intramammary infusion of IL-1β (Wedlock et al., 2004, Wedlock et al., 2008), or 
following implantation of an intramammary device which stimulated the influx of 
phagocyte cells (Nickerson et al., 1990) indicating that pre-existing high milk SCC 
can protect against IMI with S. uberis. However, high SCC would be unacceptable as 
mean to control mastitis in dairy farming because the increase in SCC would result in 
a deterioration of the milk quality with economical losses (Jayarao and Wolfgang, 
2003). 
 
The two previously challenged quarters that did not develop clinical mastitis also 
showed a lower or undetectable concentration of milk cytokines compared to that 
observed in naive quarters, suggesting that the inflammatory response in these 
quarters was lower than that observed in naive quarters and that prior infection of the 
quarter had attenuated the inflammatory response. The protective effect of prior 
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infection was limited to the affected quarter (local effect) with no evidence of 
protection in the adjacent quarter (no systemic effect). 
 
Flow cytometry data suggest that the increase in SCC of previously challenged 
quarters secondarily challenged with the homologous strain FSL Z1-048 observed 
after the challenge was due to increase of PMN (Figure 3. 15) as well as CD3
+
 
population (Figure 3. 26). The increase of CD3
+
 cells at 96 h PI was due to the 






In contrast, naive quarters challenged with FSL Z1-048 as homologous strain and all 
the quarters challenged with FSL Z1-048 as heterologous strain showed an increase 
of CD4
+
 cells at 96 h PI which caused an inversion of CD4:CD8 ratio. A similar 
inversion of the CD4:CD8 ratio was observed in response to the primary challenge 
with strain FSL Z1-048 (Chapter 2). Previous studies suggest a possible role of 
lymphocytes in the protection given by a S. uberis vaccine. Vaccine studies 
performed in the past (Hill et al., 1993, Finch et al., 1994) showed some degree of 
protection against S. uberis IMI in animals immunized with killed S. uberis and that 
protection, when achieved, was related with a strong proliferative response of 
lymphocytes, either from peripheral blood or from mammary gland secretions. A 
recent study showed that S. uberis specific CD8
+
 cells are present in mammary gland 
secretions (Denis et al., 2011) of cows previously infected with S. uberis as well as 
cows  with no history of S. uberis infection. These memory cells were able to expand 
when cultured with S. uberis and they were able to kill this bacteria in vitro, 
suggesting a possible role in acquired immunity to S. uberis IMI. In our study the 
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subsets was observed after the secondary challenge with a homologous strain of S. 
uberis indicating an expansion of T-cell population at quarter level, suggesting a 
potential reactivation of a T-cell response although it has not been tested if the 
response is specifically raised against S. uberis antigens. 
 
Host response to the secondary challenge in cows that received FSL Z1-048 as 
heterologous strain was largely similar to that observed in the primary challenge 
regardless of it was the homologous or the heterologous strain. A delayed increase of 
bacterial numbers in milk was observed which was reflected in a delayed host 
response as observed for the temperature and for the SCC. Cows used in the 
experiment were in mid to late lactation at primary and secondary challenge, 
therefore changes in immune competency due to changes in energy balance as 
observed in early lactating cows are unlikely to explain the delayed onset of 
symptoms, as most changes in immune competence occur during early lactation 
(Suriyasathaporn et al., 2000). It could be speculated that delay is due to the immune 
memory response to antigens shared by the two strains and the generation of cross-
reactive antigen-specific immune responses. Several factors limit our ability to draw 
conclusions about cross-protection between strains. First, strain FSL Z1-124 largely 
failed to evoke a response, both at primary and at secondary challenge. If the two 
strains that were used had both evoked a measurable response, comparison of 
homologous and heterologous secondary challenge might have been more 
meaningful. Secondly, the number of cows and quarters per challenge group was 
limited to begin with and in one group (secondary challenge with FSL Z1-048 as 
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heterologous strain), 2 of 3 cows were lost to follow up due to severity of disease 
whereas in another group (secondary challenge with FSL Z1-048 as homologous 
strain), 2 of 3 cows failed to develop infection after challenge. This reduced the 
number of animals or quarters per challenge group to a single individual.  
 
In summary, we described the host response to a secondary intramammary challenge 
with S. uberis. The study provides some indications on the immune memory that can 
be developed locally by the mammary gland following the infection with S. uberis, 
however the small number of the observed individual due to the complex design 
study and the clinical response does not allow a comparison between the groups due 
to the low statistical power. The observations made need to be further studied using a 


















Figure 3. 26 Concentration of SCC (black lines, left Y axes) and CD3
+
 cells 
(red lines, right Y axes) in milk from individuals quarters. Mammary quarters 
were previously challenged with strain FSL Z1-048 and received the same 























































































































































Adhesion and Invasion of Mammary 




4. 1 Introduction 
 
In our in vivo challenge experiment we observed clear differences in the 
pathogenicity between the putatively adapted strain FSL Z1-048 and the non adapted 
strain FSL Z1-124 (Chapter 2 and 3). Although able to grow in milk as demonstrated 
in vitro (Chapter 2), strain FSL Z1-124 was not able to cause mastitis in any of the 
cows challenged. Several mechanisms may contribute to the observed difference in 
the strains’ ability to cause intramammary infection (IMI). Mechanisms that have 
been postulated to play a role in the pathogenesis of IMI include biofilm formation 
and bacterial adhesion and invasion. Adhesion to and internalization into epithelial 
cells is considered a crucial stage for the infection process in bacterial diseases 
because this allows the pathogen to target the appropriate tissue (Finlay and Cossart, 
1997). In the context of mastitis the adherence to the mammary gland epithelia 
would allow the bacteria to colonize the lactating mammary gland despite the flow of  
milk (Leigh, 1999), as during milking non-adherent bacteria are excreted with milk. 
The importance of adhesion and invasion mechanisms has been shown for major 
mastitis pathogens such as Staphylococcus aureus (Lammers et al., 1999, Hebert et 
al., 2000) and Escherichia coli (Dopfer et al., 2000; Dogan et al., 2007), although all 
evidence is based on in vitro studies rather than in vivo studies. Invasion of the cells 
would also prevent the phagocytes eliminating the bacteria and protect it from 





Pathogenesis of intramammary infection due to Streptococcus uberis is poorly 
understood (Leigh, 1999; Zadoks, 2007). It has been hypothesized that adhesion to 
and invasion into mammary epithelial cells play a major role during the invasion of 
the mammary gland by S. uberis but very little evidence of adhesion and invasion of 
the mammary alveolar epithelium were found in vivo . Studies conducted on explant 
tissue obtained from bovine mammary glands showed that S. uberis failed to adhere 
to the live epithelium but showed a limited tropism for epithelial dead cells and a 
marked tropism for exposed connective tissue, as demonstrated by light and 
electronic microscopy (Thomas et al., 1992). However the EF20 strain used in the 
study was able to cause mastitis in a limited number of cows when infused 
intramammarily (Hill, 1988; Leigh et al., 1990). 
 
Despite the fact that invasion of epithelial cells by S. uberis has never been observed 
in vivo or in primary cell culture, extensive work performed in vitro using the 
mammary epithelial cell line MAC-T suggests that invasion is an important 
mechanism in S. uberis mastitis. Several strains of S. uberis are able to adhere and 
invade MAC-T cells in vitro (Matthews et al., 1994). In these studies, bacteria were 
observed in intracellular vacuoles, and in a separate study were found to survive and 
possibly replicate in the epithelial cells up to 120 h after the challenge (Tamilselvam 
et al., 2006). In this second study, differences were found between the strains, with 
strain UT888, which was more able to cause chronic mastitis, surviving 
intracellularly for longer than strain UT366, which caused a more transient mastitis. 
This study suggests that invasion of mammary epithelial cells may be important in 
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the pathogenesis of IMI, by providing an intracellular reservoir in the mammary 
gland tissue which protect the bacteria from the host immune response. 
 
A protein involved in the adhesion process of S. uberis to the epithelial cells has been 
identified (Fang et al., 1999). The protein SUAM (Streptoccus uberis adhesion 
molecule), identified initially as lactoferrin binding protein for its ability to bind 
lactoferrin, was found to mediate the internalization process in the mammary 
epithelial cells in vitro (Almeida et al., 2006). Antibodies against SUAM reduce the 
ability of S. uberis strains to adhere to and invade MAC-T cells in vitro, suggesting a 
crucial role of this molecule in the adhesion and invasion process (Almeida et al., 
2006; Prado et al., 2011). The gene encoding SUAM has been identified by PCR in 
numerous strains of S. uberis suggesting that it is highly conserved (Luther et al., 
2008). The role of the SUAM as an adhesin and the fact that it is highly conserved in 
S. uberis strains raised the interest in its potential use as target for a vaccine (Prado et 
al., 2011). After the experimental immunization with SUAM antigen cows produce 
specific antibodies against the molecule in serum and in colostrum, although the 
ability of the antibodies to reduce the adhesion and the invasion was tested and 
proven only in vitro (Prado et al., 2011). 
 
Like the role of invasion and SUAM, the role of biofilm in intramammary infection 
has been investigated in vitro. Biofilm is a sessile form of bacterial growth. Bacteria 
growing as biofilm are described as “a structured community formed by bacteria 
themselves enclosed in a self produced polymeric matrix and attached to an inert or 
living surface” (Consterton et al., 1999). This would allow bacteria to colonize 
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hostile environments. In the context of   bovine mastitis this would allow the bacteria 
to resist the host defences within the mammary gland and to resist antibiotics 
(Melchior et al., 2006). Differences in the ability to form biofilm have been found 
between different strains of S. aureus with   strains isolated from the mammary gland 
more capable of forming biofilm in vitro than strains isolated from extra-mammary 
sources such as teat skin and milk liners (Fox et al., 2005). This suggests a possible 
role for biofilm formation in bacterial colonisation of the mammary gland. Ability to 
grow as biofilm has also been shown for S. uberis (Varihmo et al., 2010; Crowley et 
al., 2011; Gilchrist, 2011), where biofilm growth has been associated with the up-
regulation of genes involved in adhesion and internalization of S. uberis to the 
mammary epithelial cells and sugar metabolism (Crowley et al., 2011). This suggests 
that biofilm formation may important for colonization of the mammary gland by S. 
uberis, although for several species of coagulase-negative staphylococci (CNS) no 
correlation has been found between the ability to form biofilm and persistence of IMI 
or severity of mastitis (Simojoki et al., 2012). 
 
The aim of this study was to test the ability of the host-adapted and non-host adapted 
S. uberis strains from the challenge study, FSL Z1-048 and FSL Z1-124 respectively, 
to adhere and to invade mammary epithelial cells in vitro. In addition, both strains 
and additional representatives of putatively host-adapted and non-adapted S. uberis 
ecotypes were tested for their ability to form biofilm in vitro. The hypothesis to be 
tested was that host-adapted strains are better able to colonize the mammary gland 
compared to non-host adapted strains as a result of increased epithelial adherence, 




4. 2 Materials and Methods 
 
4. 2. 1 Epithelial Cell Adhesion and Invasion Assay 
 
4. 2. 1. 1 Tissue Culture Conditions 
Immortalized bovine mammary epithelial cell line BME-UV1 cells (Zavizion et al., 
1996) were cultured at 37 °C 5% CO2 in 75 cm
2 
tissue culture flask (Corning). BME-
UV1 complete medium consisted of a mix containing 40% Ham`s F-12 nutrient 
mixture, 30% RPMI-1640 medium and 20% NCTC 135 medium. All the media were 
supplied by Gibco (Paisley ,UK). The medium was supplemented with 10% (wt/vol) 
heat inactivated fetal calf serum, 0.1% (wt/vol) lactose, 0.1% (wt/vol) lactalbumin 
hydrolysate, 1.2 mM glutathione, 10 μg/mL L-ascorbic acid, 1 μg/mL 
hydrocortisone, 1 μg/mL insulin, 200 U/mL penicillin and 200 U/mL streptomycin. 
All reagents were supplied by Sigma-Aldrich. Cells were cultured until 70 to- 80 % 
confluency then washed with warm PBS and treated with 1 mL of TrypLE™ Express 
dissociation media (Gibco) supplemented with 4 U/mL of porcine elastase (Sigma-
Aldrich), incubated at 37°C until 70 to 80% of the cells were showing a shrunken 
morphology, medium was discarded and 1 mL of TrypLE™ Express dissociation 
medium per flask was added. Flasks were incubated until the cells were completely 
detached from the plastic surface. Complete medium was added and cells transferred 
to a new flask. Cells at passage 5 to 10 were transferred to 24 well tissue culture 
plates (Corning) at 1× 10
5 
cells /well and cultured 1 day in complete medium. 
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Eighteen hours before the assay, medium was discarded and cells were rinsed 3 times 
with warm PBS and antibiotic free medium was added. 
 
4. 2. 1. 2 Bacteria Preparation 
S. uberis strains FSL Z1-048 and FSL Z1-124 were grown in BHI for 18 h at 37°C 
under shaking (200 rpm). Salmonella enterica serovar Typhimurium strain 12023 
and Escherichia coli laboratory strain TOP10 were grown in LH broth for 18 h at 
37°C under shaking (200 rpm). Bacterial suspensions were washed three times in 
PBS (e.g. pellets resuspended in PBS after centrifugation at 4000×g for 20 min at 
4°C) and resuspended in PBS. Concentrations of live bacteria were determined by 
viable count (See section 2. 2. 2 for details). Suspensions were diluted at target 
concentrations and stored at 4° C prior to use. 
 
4. 2. 1. 3 Adhesion and Invasion Assay 
The bacteria challenge preparation was added to the supernatant of the completely 
confluent monolayer of BME-UV1 cells. S. uberis strains FSL Z1-048 and FSL Z1-
124 were added at multiplicity of infection (MOI) of 10 and 100 (e. i. bacteria: 
epithelial cells ratio). Positive and negative controls for the invasion assay were 
included. Invasive Salmonella enterica serovar Typhimurium strain 12023 (Sherry et 
al., 2011) kindly provided by Professor David GE Smith (Moredun Research 
Institute) was included as positive control for the invasion assay. Escherichia coli 
laboratory strain TOP10 (Invitrogen, Paisley, UK) was included as negative control 
for the invasion assay. Epithelial cells were challenged with approximately 1×10
6 
cfu 
of positive or negative control per well. Cells and bacteria were co-incubated for 3 h 
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at 37° C and 5% CO2. Cell culture supernatants were then discarded and wells were 
vigorously washed 3 times with warm PBS in order to eliminate non-adherent 
bacteria. Cells were washed 3 times with warm PBS and lysed by adding 500 μL per 
well of 0.1% vol/vol Triton X-100 (Sigma-Aldrich) diluted in PBS. Lysates were 
serially diluted in cold PBS and 20 μL spots of the serial dilutions were plated in 
triplicates on blood agar plates (E&O Laboratories). Plates were incubated overnight 
at 37° C, colonies were counted and the concentration of bacteria (cfu/mL) 
associated with the cells (adhered to the surface and internalized) was calculated for 
the invasion assay. Washed cells were incubated 1 h at 37° C 5% CO2  with 1 mL per 
well of growth medium supplemented with 150 μg/mL gentamicin to kill the 
extracellular bacteria. Cells were washed 3 times with warm PBS and lysed by 
adding 500 μL per well of 0.1% vol/vol Triton X-100 (Sigma-Aldrich) diluted in 
PBS. Lysates were serially diluted in cold PBS and 20 μL spots of the serial dilutions 
were plated in triplicates on blood agar plates (E&O Laboratories). Plates were 
incubated overnight at 37° C, colonies were counted and the concentration of 
bacteria (cfu/mL) internalized in the cells was calculated. The number of bacteria that 
adhered on the surface was obtained by subtracting the bacteria internalized from the 









4. 2. 2 Biofilm Assay 
 
4. 2. 2. 1 S. uberis Strains  
Putatively host adapted and putatively non adapted strains of S. uberis were selected 
based on epidemiological data (Lang et al., 2009). Moreover two of the strains: 
putatively adapted FSL Z1-048 and putatively non adapted FSL Z1-124 were 
characterized by a very different outcome when experimentally infused in the 
lactating mammary gland (See Chapters 2 and 3), with strain FSL Z1-048 able to 
cause clinical mastitis in all the cows challenged and strain FSL Z1-124 not able to 
cause mastitis. Strains FSL Z1-048 and FSL Z1-124 were used for the challenge 
study as representatives of putatively host-adapted and non-adapted strains of S. 
uberis (Lang et al., 2009). Both strains, as well as 4 additional strains representative 
of each of the two categories were used to test their ability to form biofilm. Adapted 
strains were isolated from multiple cows in multiple herds whereas non adapted 












 Isolate Country Epidemiological context 
1 FSL Z1-048 The Netherlands Three countries, outbreak 
2 QMP B5-005 USA (NY) Three herds, multiple cows per herd 
3 FSL Z3-369 France Three countries, outbreak 
4 QMP B5-143 Italy Multiple cows in herd 
5 QMP B5-157 Italy Two herds, multiple cows in one herd 
6 FSL Z1-124 The Netherlands Unique ST 
7 FSL Z3-396 France Unique ST 
8 FSL Z1-266 New Zealand Unique ST 
9 QMP B5-001 USA (NY) Unique ST 
10 QMP B5-153 Italy Unique ST 
11 20539 N/A N/A 
(Adapted from Lang et al., 2009) 
Table 4. 1 S. uberis strains used for the biofilm formation assay. Isolates 1 to 5 were 
chosen as representative of putatively host adapted strains, isolates 6 to 10 as 
representative of putatively non adapted strains. Strain 20539 was included as 
positive control as known biofilm producer (Gilchrist, 2011). 
 
4. 2 .2. 2 Biofilm Formation Assay 
The ability to form biofilm was assessed by using the protocol described by Gilchrist 
(2011) with some modifications. S. uberis strains were cultured in brain heart 
infusion broth (BHI; Oxoid, Basingstoke, UK) for 16 h at 37 °C under shaking (150 
rpm). BHI culture was diluted 100 fold in one of three different media preparations 
which have been tested: (1) BME-UV1 complete medium, (2) BME-UV1 complete 
medium supplemented with 0.5% wt/vol casein, and (3) RPMI-1640 chemically 
defined medium (CDM) supplemented with 0.5% casein) RPMI-1640 CDM was 
composed of RPMI-1640 (Sigma-Aldrich) supplemented with 0.8% wt/vol Lactose, 
260 mg/L L-Glutamic acid, 150 mg/L Magnesium sulphate heptahydrate, 10 mg/L 
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Ferrous sulphate heptahydrate, 10 mg/L Manganese sulphate tetrahydrate 10 mg/L. 
All the reagents were supplied by Sigma-Aldrich. Two hundred μL per well of 
inoculated media were aliquoted into 96 well flat bottom polystyrene tissue culture 
plates (Corning). Plates were incubated statically at 37 °C 5% CO2 for 24 h. Medium 
was discarded and wells were washed 3 times with distilled water to remove cells not 
adhered to the plate. Plates were air dried for 45 min then biofilm (associated with 
the adherent cells) were stained by adding 100 μL/well of 1% crystal violet solution 
(Fisher scientific, Loughborough, UK). Stain was discarded and wells washed with 
distilled water until excess stain was completely removed. Plates were air dried for 
45 min then 200 μL/well  of ethanol were added and incubated for 15 min. Optical 
density at 562 nm was read with a ELx808 absorbance micro plate reader (Biotek 
instruments, Potton, UK) to quantify the biofilm formation. For each strain 8 
technical replicates (wells) were performed. For RPMI-1640 CDM supplemented 
with 0.5% casein, 3 biological replicates were performed whereas the biofilm 
formation in BME-UV1 cells growth medium and BME-UV1 cells growth medium 
supplemented with 0.5% casein was tested once based on results from the first round 
of assays (see Results). 
 
4. 2. 3 Statistical analysis 
Adhesion and invasion data expressed as concentration of bacteria that invaded cell 
and concentration of bacteria that adhered to the cells respectively were analysed by 
analysis of variance (ANOVA) using Genstat software (VSN International, Hemel 
Hempstead, UK). Adhesion and invasion concentrations were base-10 logarithmic 
transformed to ensure the data from each treatment group had an approximately 
 
109 
normal distribution and used as outcome variable in a two way ANOVA. Strain and 
MOI were used as treatment factor, interaction between strain and MOI was also 
evaluated. Normal distribution of the residuals was visually assessed by plotting 
them on charts. Post-hoc comparisons with Tukey HSD test were performed where 
appropriate with statistical significance declared when P < 0.05. 
Ability to produce biofilm expressed as absorbance was analysed by one-way 
analysis of variance (ANOVA) using Genstat software (VSN International, Hemel 
Hempstead, UK). Normal distribution of the residuals was visually assessed by 
plotting them on charts. Least square difference (LSD) post-hoc comparison were 
performed with statistical significance declared when P < 0.05. 
 
4. 2. 4 Genome Analysis for Sua Gene 
 
4. 2. 4. 1 Growth Conditions and DNA Extraction 
The bacterial isolates FSL Z1-048 and FSL Z1-124 were streaked onto 5% (v/v) 
sheep blood agar plates (E&O Laboratories) and grown aerobically at 37°C for 24 h 
in order to assess purity. A single colony was then selected and used to inoculate 5 
mL of BHI broth (Oxoid). After overnight incubation at 37˚C in an aerobic 
environment, genomic DNA was extracted from cells harvested from 1 mL of BHI 
broth culture using an Epicentre MasterPure Gram-positive DNA purification kit 
according to manufacturer`s instruction (Epicentre, Madison, WI). DNA 
concentration was quantified using a NanoDrop 1000 (Thermo Scientific) and the 
product (0.5μg DNA) visually examined on a Gel Red (Cambridge Bioscience, 
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Cambridge, UK) stained 1% agarose gel (running conditions: 100V/cm for 1 h) in 
order to assess the absence of DNA shearing. 
 
4. 2. 4 .2 Genome Sequencing and Assembly 
Whole genome sequencing of strains FSL Z1-048 and FSL Z1-124 was performed 
using an Illumina Solexa Genome Analyzer by the Genepool sequencing core facility 
(University of Edinburgh, UK). De novo assembly of Solexa reads was performed by 
Genepool using VELVET 0.6.  
 
4. 2. 4. 3 Genomic Analysis for Strain Identity Confirmation 
The presence of the encoding gene for Streptococcus uberis adhesion molecule (sua) 
within the whole genome sequences of S. uberis strains FSL-Z1 O48 and FSL-Z1 
124 was evaluated using BioEdit software (Hall, 1999; http://www.mb- 
io.ncsu.edu/bioedit /bioedit.html). A local nucleotide database file for strain FSL Z1-
048 and FSL Z1-124 was created within BioEdit, thereby enabling to assess the 
presence of known nucleotide sequences within the strains through the Basic Local 
Alignment Search Tool (BLASTN). The reference nucleotide sequence of sua  was 
extracted from NCBI (NCBI Accession no. DQ232760) and BLAST searched 
against FSL Z1-048 and FSL Z1-124 genomes using BioEdit software. The 2970 bp 
nucleotide sequence of sua was further analysed using sequence manipulation suit 
ORF finder (http://www.bioinformatics.org/sms2/orf_find.html Stothard, 2000 ) to 





4. 2. 4. 4 Sua Sequencing 
In order to further confirm the nucleotide sequence of the Sua gene of strains FSL 
Z1-048 and FSL Z1-124 it was amplified by a PCR and amplicons were sequenced. 
The 2970 bp nucleotide sequence was amplified using the forward primer LfbpDL5 
5`-GTCATTTGGTAGGAGTGGCTG-3`and the reverse primer LfbpDL6 5`-
TGGTTGATATAGCACTTGGTGAC-3 (Luther et al., 2008) which provide the full 
length amplification of the 2970 bp gene. PCR was conducted in a final volume of 
100 μL containing 50 μL of GoTaq green master mix (Promega, Madison, WI, 
USA), 50 μL of water, 300 nM of primers LfbpDL5 and LfbpDL6 and 100 ng of 
genomic DNA as template. The cycling profile consisted of 94°C for 2 min followed 
by 30 cycles of 30 s at 94°C, 30 s at 54°C, and 2 min at 68°C followed by 7 min at 
68°C. Fifteen μL of the PCR product was visualized on a 1% agarose gel. The PCR 
products were purified using Genclean turbo kit (MP Biomedicals, Solon, OH, USA) 
following manufacturer`s instructions. Two 15 μL aliquots of the purified PCR 
products were forwarded to Eurofins Genetic Services (London, UK) for 
bidirectional sequencing using primers LfbpDL5 and LfbpDL6.  Sequencing reads 
were aliged and analysed using the SeqMan program within the Lasergene 11 









4. 3 Results 
 
4. 3. 1 Adhesion and Invasion Assay  
Both S. uberis strain FSL Z1-048 and FSL Z1-124 were able to adhere to the bovine 
mammary epithelial cell line BME-UV1 after 3 h of co-incubation. However strain 
FSL Z1-048 was approximately 1000 fold  more able to adhere to the cells than 
strain FSL Z1-124 at MOI 10 and 100 (P<0.01) (Figure 4. 2). Adherence was 
increased at MOI 100 compared to MOI 10 approximately 15 fold for both strain 
FSL Z1-048 (P < 0.01) and strain FSL Z1-124 (P < 0.01) (Figure 4. 1). Both strains 
were able to invade epithelial cells after 3 h of incubation (Figure 4. 2). FSL Z1-124 
showed higher ability to invade cells than strain FSL Z1-048. FSL Z1-124 was 37 
fold and 1.7 fold more invasive than strain FSL Z1-048 at MOI 10 and MOI 100 
respectively. Bacterial concentration had an effect on  internalization of strain FSL 
Z1-048, which was 63 fold more invasive at MOI 100 compared to that observed at 
MOI 10 (P< 0.01), whereas for strain FSL Z1-124 internalization at MOI 100 was 
not significantly different to that observed at MOI 10 (Figure 4. 2).The positive 
control included in the invasion assay S. enterica serovar Typhimurium was able to 
adhere (Figure 4. 1) and to invade (Figure 4. 2) the mammary epithelial cells in all 
the assays. The negative control E. coli laboratory strain was not able to invade the 








Figure 4. 1 Adhesion of S. uberis to epithelial cells in vitro. Results are expressed as 
concentration of bacteria recovered attached to the mammary epithelial cells BME-
UV1 after 3 h of co-incubation. Cells were incubated with strain FSL Z1-048 or 
strain FSL Z1-124, at a multiplicity of infection (e.g. bacteria: cells) of 10 (white 
columns) and 100 (striped columns). The values represent the mean and the standard 
deviation of 3 replicates. The solid grey bar represents the number of S. enterica 
serovar Typhimurium strain 12023 bacteria used as positive control. Statistically 
significant differences between groups are marked with asterisks (Tukey HSD test 
after ANOVA, * P < 0.05). 
 
 
Figure 4. 2 Invasion of S. uberis to epithelial cells in vitro. Results are expressed as 
concentration of bacteria recovered internalized in the mammary epithelial cells 
BME-UV1 after 3 h of co-incubation. Cells were incubated with strain FSL Z1-048 
or strain FSL Z1-124, at a multiplicity of infection of 10 (white columns) and 100 
(striped columns). The values represent the mean and the standard deviation of 3 
replicates. The solid grey bar represents the number of S. enterica serovar 
Thypimurium strain 12023 bacteria used as positive control. Statistically significant 
and non-significant differences between groups are marked with asterisks and NS 































































4. 3. 2 Biofilm Assay  
Ability to form biofilm was tested in 5 putatively host adapted and five putatively 
non adapted strains of S. uberis. Ability to form biofilm when grown in RPMI-1640 
CDM supplemented with 0.5% casein varied amongst the strains tested (Figure 4. 3). 
The two strains with the highest ability to form biofilm were the putatively non 
adapted strains FSL Z1-124 and QMP B5-153. The ability to form biofilm of these 
two strains was similar to the positive control strain 20539. The host adapted strain 
QMP B5-005 and the non adapted FSL Z3-396 exhibited moderate biofilm 
formation, which was significantly lower than non adapted strains FSL Z1-124 and 
QMP B5-153 (P < 0.05), but significantly higher than all the other strains tested 
(FSL Z1-048, FSL Z3-369,QMP B5-143, QMP B5-157, FSL Z1-266, QMP B5-001) 
(P < 0.05). In preliminary experiments ability to form biofilm was also tested in 
BME-UV1 complete medium and BME-UV1 complete medium supplemented with 
casein, however none of the strains were able to form biofilm in these media with the 
exception of strain QMP B5-143 in BME-UV1 medium with casein (results not 
shown). Therefore, no additional replicates were performed with those media. The 
results show that test strains used in the mammary epithelial cell assays do not form 
biofilm in the culture media used in those assays, implying that adherence results 









Figure 4. 3 Biofilm formation of 10 strains of S. uberis either putatively host adapted 
or non adapted. Ability to form biofilm was tested in RPMI-1640 CDM medium 
supplemented with 0.5% wt/vol casein. Bars represent the amount of biofilm 
produced after 24 h of culture as optical density and standard deviations. For each 
strain 3 replicates were performed, for each replicate 8 technical replicate (e.g. wells) 
were performed. Letters (a, b ,c) mark strains with a similar ability to produce 














































































































4. 3. 3 Sua Gene  
The Sua gene was identified in the whole genome sequences of both strain FSL Z1-
048 and strain FSL Z1-124. Identity of the sua sequence of strain FSL Z1-048 with 
sua of S. uberis strain UT888 (NCBI, National Center for Biotechnology 
Information, Bethesda, MD, USA, GenBank, Accession no. DQ232760.1) was 99% 
(2955/2971), with one base pair gap in position 700 (5`→3`) of the submitted 
sequence.(Figure 4. 5). For strain FSL Z1-124 identity with strain UT888 was 99% 
(2939/2971) and no gaps were present. The presence of sua was confirmed by 
amplification by PCR in both strains. Sequencing of the PCR products confirmed the 
genome sequence of the two strains including the deletion of a single base from sua 
in FSL Z1-048. Analysis of open reading frames (ORF) in the full length 2971 bp 
Sua gene showed that strain FSL Z1-124 has an ORF on the direct strand extending 
from base 94 to base 2811 translating in a protein of 905 amino acids in length 
(Figure 5. 5 ), which is the full length of the SUAM protein described (Almeida et 
al., 2006) with 98% (884/905) identity with strain UT888 SUAM protein. The 
nucleotide base missing in sua of strain FSL Z1-048 resulted in an ORF extending 
from base 94 to base 744 which would be translated in a protein of 216 amino acids 









UT888           GTCATTTGGTAGGAGTGGCTGTTTTTGCTGAAAATGCTAAAGAAGAACGTGAACAGATGG 60 
FSLZ1-048       ************************************************************ 60 
FSLZ1-124       ************************************************************ 60 
                 
 
UT888           CATATAAATCATTGCTTAAAGTTTCTGAAATAGATGTCAAGAACAATAAAGTCGTCGTTG 120 
FSLZ1-048       ************************************************************ 120 
FSLZ1-124       ************************************************************ 120 
                 
 
UT888           AAGTTGGGAATATTTTTAACGATATATAATGTATGGAGAGAAAAAGGGAATATTATGGAA 180 
FSLZ1-048       ************************************************************ 180 
FSLZ1-124       *******************T*****G***********************T********** 180 
                 
 
UT888           CTCGAAAACACAAAATCTAATCAGATTAAAACAACACTTGCTTTAACGTCAACACTCGCA 240 
FSLZ1-048       T*********************************************************** 240 
FSLZ1-124       T*********************************************************** 240 
                  
 
UT888           CTTCTTGGAACTGGTGTTGGTATGGGACATACCGTTAATGCGGATGACATGACAACTGCT 300 
FSLZ1-048       ************************************************************ 300 
FSLZ1-124       ****************************************************A******* 300 
                 
 
UT888           GATCAATCACCTAAATTACAAGGTGAAGAAGCAACATTGGCGCCTACAAACATTGAAGAT 360 
FSLZ1-048       ************************************************************ 360 
FSLZ1-124       *****************************************A****************** 360 
                 
 
UT888           ACTAAAGCAGCCATTGATACTAAAACAGCTACATTAGCAGAACAAACCGATGCTCTTAAT 420 
FSLZ1-048       *******************T****************************G*********** 420 
FSLZ1-124       ****G******************************************************* 420 
                 
 
UT888           ACTGTAAATGAGACAATCACAAGCACAAATGAAGAATTAGCTACTTTAGAAGGAGGCTTA 480 
FSLZ1-048       ************************************************************ 480 
FSLZ1-124       ************************************************************ 480 
                 
 
UT888           GCTGATAAAGAAACAGCAGTTGCAGATGCTGAAAAAACATTGGAGTCTGTTTCAAATGCC 540 
FSLZ1-048       ************************************************************ 540 
FSLZ1-124       ************************************************************ 540 
                 
 
UT888           TCAGAAGAAGAATTTAATCAATTAGCAGAACAAAATAAAGCTGACTTAGCTAAAACTCAA 600 
FSLZ1-048       ************************************************************ 600 
FSLZ1-124       *****************************************C****************** 600 
                 
 
UT888           GAGGAGCTAAAACTTGCTGAAGCAACAAAAGAAGAAGTTGCAACACAGGTATTGACACAA 660 
FSLZ1-048       ************************************************************ 660 
FSLZ1-124       ************************************************************ 660 
                 
 
UT888           TCTGACGAGGTAACAGCTGCAGCTAATGAAGCTAAAAAAATGGCTGAAAAAGTTGCACAA 720 
FSLZ1-048       ***************************************-******************** 719 
FSLZ1-124       ************************************************************ 720 
                 
 
UT888           GCAGAGACAAAAGTTTCAGACTTGACGAAAATGGTCAATCAACCAGAAGCAATAACAGCT 780 
FSLZ1-048       ************************************************************ 779 
FSLZ1-124       ****************T******************A************************ 780 
                 
 
UT888           CAAGTTGAAATAGAACAAAACAATGTCAAAATCATTTCGGAAGATTTAGCAAAAGCCAAA 840 
FSLZ1-048       ************************************************************ 839 
FSLZ1-124       ************************************************************ 840 
                 
 
UT888           ACTGATTTAGTTGCTGTAACAGATAATACAAAAACACAATTAGCAAATGATTTAGCGACT 900 
FSLZ1-048       ************************************************************ 899 




                 
 
UT888           GCTCAATCTAGCTTAAGTGCCAAACAAAATGAATTAGCTAAAGTACAGTCACAAACAAGT 960 
FSLZ1-048       ************************************************************ 959 
FSLZ1-124       ************************************************************ 960 
                 
 
UT888           AATGTCGCAGTGAATGTTATGGGTGCTAATAAAATGGTTGCTCCAACTAATTACCCAATT 1020 
FSLZ1-048       ************************************************************ 1019 
FSLZ1-124       ************************************************************ 1020 
                 
 
UT888           AATGAAATCAAAAAATTAATGTCAAGTGGTTACATTGGGACACAATCTTATCTAAATACA 1080 
FSLZ1-048       ************************************************************ 1079 
FSLZ1-124       ************************************************************ 1080 
                 
 
UT888           TTCTATGCTTTAAAAGATCAACTGGTTTCTAAAGCAGAAGTTGGGGCATACTTAAATCAT 1140 
FSLZ1-048       ************************************************************ 1139 
FSLZ1-124       **************************C*********A*********************** 1140 
                 
 
UT888           TACGTTGATATCGCAAGTGACTTAAACCGTATCGTTAACCCAGATAACTTATCAGTTGAG 1200 
FSLZ1-048       ************************************************************ 1199 
FSLZ1-124       ************************************************************ 1200 
                 
 
UT888           GTTCAAAATGAATTGGCTGTATTTGCAGCAACATTGATTAATTCTGTTCGTCAGCAATTT 1260 
FSLZ1-048       *****************************************************A****** 1259 
FSLZ1-124       ************************************************************ 1260 
                 
 
UT888           GGTCTTTCTGCAGTCGAAGTGACGCAAGGTGCTCAAGAGTTTGCTCGCACTTTGACTCAA 1320 
FSLZ1-048       **********************************************************G* 1319 
FSLZ1-124       ***********************A************************************ 1320 
                 
 
UT888           AACTATAAAGCAACACATGGAAACACTGTTCCTTTCTTTAATTACAATCAACCTGGCAAG 1380 
FSLZ1-048       **********T************************************************* 1379 
FSLZ1-124       ************************************************************ 1380 
                 
 
UT888           AATGGTCATATAGGCATTGGTCCACACGATAGAACAATTATCGAACAAGCAGCTACAAGT 1440 
FSLZ1-048       ************************************************************ 1439 
FSLZ1-124       **********C************************************************* 1440 
                 
 
UT888           GTTGGCTTAAAAGCTAATGATGATAACATGTATGAAAACATCGGATTCTTTGATGATGTT 1500 
FSLZ1-048       **************************T********************************* 1499 
FSLZ1-124       ************************************************************ 1500 
                 
 
UT888           CATACTGTTAATGGTATCAAACGTAGTATTTATAACAGTATTAAGTACATGCTGTTTACA 1560 
FSLZ1-048       ************************************************************ 1559 
FSLZ1-124       **************************************C********************* 1560 
                 
 
UT888           GACCTCACCTATGGAAATACATTTGGACATACGGTTAACTTGTTGCGTTCTGATAAAACA 1620 
FSLZ1-048       ***T******************************************************** 1619 
FSLZ1-124       ***T******************************************************** 1620 
                 
 
UT888           AACCCAAGTGCTCCGGTCTATTTAGGAGTTTCAACAGAAACTGTTGGTGGTTTAAATACC 1680 
FSLZ1-048       ************************************************************ 1679 
FSLZ1-124       *****************T****************************************** 1680 
                 
 
 
UT888           CACTATGTTATCTTCCCGGCAAGCAATATTGTAAATGCCAGCCAGTTCAGCAAACAAGTG 1740 
FSLZ1-048       ********************************************A*************** 1739 
FSLZ1-124       **************************C********A********A*************** 1740 




UT888           GTTTCAGGTCCATTAACAACAGTTGATAACAGTGCTAAAATTAGCACTCTTCAAGCAAGT 1800 
FSLZ1-048       ************************************************************ 1799 
FSLZ1-124       ************************************************************ 1800 




UT888           ATTGCTTCTGTTGAGTCTAAAATTCAAACCTTACAAAAACGTATTGCAAATATTTCTTCA 1860 
FSLZ1-048       ***A******************************************************** 1859 
FSLZ1-124       ************************************************************ 1860 
                 
 
UT888           GAAGCACTAGTTATCTCTGCACAGAGAAAAGTAGATGGTTTAGCTGCAAAACTTCAAAAA 1920 
FSLZ1-048       ************G*********************************************** 1919 
FSLZ1-124       **************************************************G********* 1920 
                 
 
UT888           GCTGAATCTAACGTTGAAAAAGCAAAAGCTCAACTTCAACAGTTAAAAGATTCAAAAGAA 1980 
FSLZ1-048       *********************************************C************** 1979 
FSLZ1-124       *********************************************C************** 1980 
                 
 
UT888           GATTTACATAAACAACTTGCTTTTGCCCTTTCAACTCGTAAGGATTTAAAAGGTCAACTT 2040 
FSLZ1-048       ************************T*********************************** 2039 
FSLZ1-124       ************************************************************ 2040 
                 
 
UT888           GACGAATCGCTTGTTCACCTAAATCAGTCTAAAATTCTTTTTCATAGCTTAGAAGAAAAA 2100 
FSLZ1-048       *****************************************A****************** 2099 
FSLZ1-124       *****************************************A****************** 2100 
                 
 
UT888           CAAAGTCAAGTGGCAAGTCAAATTAACGTCTTGACATTGAAGAAGGCACAACTTGAAAAA 2160 
FSLZ1-048       ************************************************************ 2159 
FSLZ1-124       ********************************************A*************** 2160 
                  
 
UT888           GAACTAGCCTTTAACTCTCATCCAAATCGTGAAAAAGTTGCAAAAGAAAAAGTTGAAGAG 2220 
FSLZ1-048       ************************************************************ 2219 
FSLZ1-124       ************************************************************ 2220 
                 
 
UT888           GCTCAAAAAGCATTAACAGAAACCTTATCTCAAATTAAAACTAAAAAAGCTATCTTAAAT 2280 
FSLZ1-048       ************************************************************ 2279 
FSLZ1-124       ************************************************************ 2280 
                 
 
UT888           GATTTAACACAAGAAAAAGCAAAATTGACGTCAGCAATCACAACAACTGAACAACAAATT 2340 
FSLZ1-048       ************************************************************ 2339 
FSLZ1-124       ************************************************************ 2340 
                 
 
UT888           GTTTTGTTGAAGAATCATTTAGCAAATCAAGTGGCGAATGCTCCAAAAATCAGCAGTATT 2400 
FSLZ1-048       ************************************************************ 2399 
FSLZ1-124       *******************************************************A**** 2400 
                  
 
UT888           GTCCAAAGATCAGAAAACAATGGAGTAAGACCTGATGTTTCTGATACAAGAGAGAAGGCA 2460 
FSLZ1-048       *********************A************************************** 2459 
FSLZ1-124       **********T**********A********G***************************** 2460 
                 
 
UT888           GTAGATACTGCTCAAGAAGCGACAATTCTTGCTCAAGCAGAAACAATGGCTGAAGAAGTC 2520 
FSLZ1-048       ************************************************************ 2519 
FSLZ1-124       *********************************************G*****A******** 2520 
                  
 
UT888           ATTACAAATTCTGCAAAAGCCATTGTTGCAAATGCTCAAAATGTTGCACAAGAGATTATG 2580 
FSLZ1-048       ************************************************************ 2579 
FSLZ1-124       ************************A*********************************** 2580 




UT888           AAAGTAGCACCTGAAGTAACACCTGATCAAGGAGTTGTTGCAAAAGTTGCAGATAATATT 2640 
FSLZ1-048       ************************************************************ 2639 
FSLZ1-124       ************************************************************ 2640 
                 
 
UT888           AAGAAAAATAATGCCCCAGCAAGTAAATCATATGGTGCAAGTTCATCAACTGTAGGAAAT 2700 
FSLZ1-048       **************************************************G********* 2699 
FSLZ1-124       ************************************************************ 2700 
                 
 
UT888           GCTACTTCTTCACGAGATGAAAGTACAAAACGTGCTTTAAGAGCAGGAATTGTTATGCTG 2760 
FSLZ1-048       ************************************************************ 2759 
FSLZ1-124       ************************************************************ 2760 
                 
 
UT888           GCAGCAGCAGGACTTACTGGTTACAAACTCAGAAGAGATGGCAAAAAATAAGAAAATCAA 2820 
FSLZ1-048       ************************************************************ 2819 
FSLZ1-124       ************************************************************ 2820 
                 
 
UT888           AGGAAAAATTGATTGACAGAAAGTACCGTCTATGTTACTATAGTAGACGGTACTTTTTAC 2880 
FSLZ1-048       ************************************************************ 2879 
FSLZ1-124       ************************************************************ 2880 
                 
 
UT888           TTTTGGTCTCTCAAAAGTGTACAGAGACGTGCTGACAATTGTTGCAAAAGTACACACAGA 2940 
FSLZ1-048       ************************************************************ 2939 
FSLZ1-124       ************************************************************ 2940 
                 
 
UT888           TATAGGCTGTCACCAAGTGCTATATCAACCA 2971 
FSLZ1-048       ******************************* 2970 
FSLZ1-124       ******************************* 2971 
                 
 
Figure 4. 4 Alignment of DNA sequence (5`→3`) of sua of S. uberis strains  FSL 
Z1-048 and FSL Z1-124 obtained from whole genome sequencing and confirmed by 
amplification and sequencing of the specific fragment with sua of strain UT888 
(Almeida et al., 2006). Deletion of one base in sua of strain FSL Z1-048 is marked 














UT888           MSRTIKSSLKLGIFLTIYNVWREKGNIMELENTKSNQIKTTLALTSTLALLGTGVGMGHTVNADDMTTADQSPKLQGEEA 80 
FSL_Z1-124      ***************M*C*******I***F************************************K************* 80 
FSL_Z1-048      *****************************F************************************************** 80 
                 
 
UT888           TLAPTNIEDTKAAIDTKTATLAEQTDALNTVNETITSTNEELATLEGGLADKETAVADAEKTLESVSNASEEEFNQLAEQ 160 
FSL_Z1-124      **********R**************N****************************************************** 160 
FSL_Z1-048      **********K****I**************************************************************** 160 
                 
 
UT888           NKADLAKTQEELKLAEATKEEVATQVLTQSDEVTAAANEAKKMAEKVAQAETKVSDLTKMVNQPEAITAQVEIEQNNVKI 240 
FSL_Z1-124      ******************************************************L************************* 240 
FSL_Z1-048      ******************************************WLK----------------------------------- 205 
 
 
UT888           ISEDLAKAKTDLVAVTDNTKTQLANDLATAQSSLSAKQNELAKVQSQTSNVAVNVMGANKMVAPTNYPINEIKKLMSSGY 320 
FSL_Z1-124      ******************************************************************************** 320 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                                 
 
UT888           IGTQSYLNTFYALKDQLVSKAEVGAYLNHYVDIASDLNRIVNPDNLSVEVQNELAVFAATLINSVRQQFGLSAVEVTQGA 400 
FSL_Z1-124      *********************K********************************************************** 400 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                                 
 
UT888           QEFARTLTQNYKATHGNTVPFFNYNQPGKNGHIGIGPHDRTIIEQAATSVGLKANDDNMYENIGFFDDVHTVNGIKRSIY 480 
FSL_Z1-124      *********************************T********************************************** 480 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                                 
 
UT888           NSIKYMLFTDLTYGNTFGHTVNLLRSDKTNPSAPVYLGVSTETVGGLNTHYVIFPASNIVNASQFSKQVVSGPLTTVDNS 560 
FSL_Z1-124      **********F*************************************************K******************* 560 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                                 
 
UT888           AKISTLQASIASVESKIQTLQKRIANISSEALVISAQRKVDGLAAKLQKAESNVEKAKAQLQQLKDSKEDLHKQLAFALS 640 
FSL_Z1-124      ****************************************************************Q*************** 640 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                            
 
UT888           TRKDLKGQLDESLVHLNQSKILFHSLEEKQSQVASQINVLTLKKAQLEKELAFNSHPNREKVAKEKVEEAQKALTETLSQ 720 
FSL_Z1-124      **********************L********************************************************* 720 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                                 
 
UT888           IKTKKAILNDLTQEKAKLTSAITTTEQQIVLLKNHLANQVANAPKISSIVQRSENNGVRPDVSDTREKAVDTAQEATILA 800 
FSL_Z1-124      ***********************************************N****L***R*********************** 800 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                                 
 
UT888           QAETMAEEVITNSAKAIVANAQNVAQEIMKVAPEVTPDQGVVAKVADNIKKNNAPASKSYGASSSTVGNATSSRDESTKR 880 
FSL_Z1-124      ******************************************************************************** 880 
FSL_Z1-048      --------------------------------------------------------------------------------  
                                                                                                 
 
UT888           ALRAGIVMLAAAGLTGYKLRRDGKK 905 
FSL_Z1-124      ************************* 905 
FSL_Z1-048      -------------------------  
                                         
 
 
Figure 4. 4 Alignment of amino-acid translation of sua sequence of strains FSL Z1-124, and FSL 
Z1-048 with strain UT888 (Almeida et al., 2006). The five functional domains, identified in strain 
UT888 (I to V), are marked. The predicted protein of strain FSL Z1-048 resulted truncated 











Adhesion and invasion of epithelial cells of the mammary gland has been suggested 
as crucial step in development of intramammary infection of S. uberis (Matthews et 
al., 1994; Tamilselvam et al., 2006) and other mastitis pathogens such as S. aureus 
(Hebert et al., 2000) and E. coli (Dopfer et al., 2001; Dogan et al., 2007). In the 
present study we tested the ability of two strains of S. uberis that elicit a different 
clinical response to adhere and to internalize into bovine mammary epithelial cells in 
vitro. Strain FSL Z1-048 and FSL Z1-124 both possessed the ability to grow in fresh 
milk yet only strain FSL Z1-048 caused IMI and clinical signs in all challenged 
animals (Chapter 2). Adhesion to the epithelium of the mammary gland in the early 
stage of the infection could allow the bacteria to remain in the mammary gland 
without being eliminated during the milking and eventually cause mastitis. Both 
strains were able to adhere to the epithelial cells after 3 h of co-incubation however 
at MOI 10 strain FSL Z1-048 was approximately 1,000 fold more able to adhere than 
strain FSL Z1-124. These data suggest that adhesion may play a role in the higher 
virulence of strain FSL Z1-048 observed in vivo. 
 
Both strains were also able to invade mammary epithelial cells, in this case strain 
FSL Z1-124 was found intracellularly 37 fold more than strain FSL Z1-048 at MOI 
10. The ability of strain FSL Z1-124 to invade the epithelium did not alter with MOI, 
whereas ability to invade of strain FSL Z1-048 was greater with a MOI 100 
compared to 10, indicating that internalization for strain FSL Z1-048, is 
concentration dependent. After infusion of this strain in the lactating mammary gland 
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we observed an increase in concentration of bacteria recovered in milk of 
approximately 1,000 fold between 12 and 36 h PI (see Chapter 2, Figure 2. 4A). The 
increase in bacterial concentration could increase the ability of S. uberis to invade the 
mammary epithelium.  
 
Internalization in the mammary epithelial cells would protect the pathogen from the 
activity of the phagocytes present in the mammary gland such as PMN and 
macrophages. It could also provide protection against the vast majority of the 
antibiotics currently used in the therapy of the IMI (Zadoks, 2007). However, data 
obtained in vitro should be evaluated carefully since invasion of mammary gland 
cells by S. uberis has never been observed in vivo to date (Thomas et al., 1992; 
Pedersen et al., 2003). In the past adhesion and invasion of S. uberis has been studied 
extensively in vitro using the immortalized mammary epithelial cell MAC-T 
(Matthews et al., 1994; Tamilselvam et al., 2006). The immortalized cell line BME-
UV1 used in the present study was used to study the internalization process of CNS 
species involved in bovine mastitis (Hyvonen et al., 2009). Although a direct 
comparison of the two cell lines as in vitro mastitis model has never been carried out, 
it could be speculated that the cell line BME-UV1 retaining many morphological and 
physiological characteristics of the secretory mammary epithelium such as the ability 
to form a monolayer capable of maintaining apical polarization and cell junction 
integrity (Quesnell et al., 1996), could represent a reasonable model of bovine 




Despite its ability to invade the epithelial cells in vitro strain FSL Z1-124 was not 
able to cause mastitis in any of the mammary glands challenged (Chapter 2). After 
the infusion in the mammary gland strain FSL Z1-124 was recovered at a maximal 
concentration of approximately 10
5 
lower than that observed for strain FSL Z1-048, 
and only at sporadic time points up to 168 h after intramammary infusion (see 
Chapter 2, Figure 2. 4). These observations may suggest that invasion can happen in 
vivo but is not a crucial step in the development of intramammary infection. It is 
possible that strain FSL Z1-124, after entering into the mammary gland, invades 
epithelial cells rapidly where it does not multiply, whereas strain FSL Z1-048, being 
only attached to epithelial cells, can multiply using milk as source of nutrients. 
 
Mammary epithelial cells are able to recognize mastitis pathogens and initiate the 
host immune response through the synthesis and the release of chemo attractants 
such as IL-8 and pro inflammatory cytokines such as IL-1β and IL-6 (Rainard and 
Riollet, 2006). IL-8 is chemoattractant expressed by mammary epithelial cells in 
response to contact with major mastitis pathogens such as S. aureus, E. coli 
(Lahouassa et al., 2007) and S. uberis (Swanson et al., 2009; Wellnitz et al., 2012) 
and the expression of IL-8 is dependent on concentration of the pathogen (Günther et 
al., 2010; Wellnitz et al., 2012). Pro- inflammatory cytokines were absent in the milk 
of the mammary gland challenged with strain FSL Z1-124 except for very low levels 
of IL-8. Interestingly, IL-8 was only detected in quarters in which the bacteria were 
recovered, suggesting IL-8 production may have be a result of an interaction between 
the bacteria and the mammary epithelium in a similar manner to that seen in vitro, 
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although the concentration reached by the cytokine in vivo following challenge with 
strain FSL Z1-124 was not sufficient to evoke other detectable effects. 
 
In addition to the findings in this study, internalization of S. uberis has previously 
been observed in vitro following challenge of MAC-T cells, an immortalized bovine 
mammary epithelial cell line (Almeida et al., 2006; Tamilselvam et al., 2006). In 
MAC-T challenge studies internalization in vitro was shown to be partially mediated 
by Streptococcus uberis adhesion molecule (SUAM), with deletion of sua reducing 
the ability of S. uberis to adhere and internalize to the mammary epithelial 
cells(Kerro Dego et al., 2011). The gene encoding SUAM (sua) has been shown to 
be conserved in strains of S. uberis from different geographical locations (Luther et 
al., 2007). Analysis of genome sequence of the two challenge isolates showed the 
presence of sua encoding for the SUAM in both strain FSL Z1-048 and FSL Z1-124. 
Further analysis revealed that sua gene in strain FSL Z1-124 would code for a 
protein of 905 amino acids in length as described by Luther et al. (2008) whereas sua 
in strain FSL Z1-048 is predicted to code for  a truncated protein of 216 amino acids 
in length. Four out of 5 predicted epitopes thought to be involved in the process of 
adhesion and adhesion mediated by SUAM are located between 342 and 719 amino 
acid residue (Almeida et al., 2011). It is therefore unlikely that SUAM produced by 
strain FSL Z1-048 is completely functional as an adhesin. 
 
Recent studies suggest that SUAM is not the only adhesin involved in the adhesion 
and invasion process of the mammary epithelial cells. Deletion of sua reduced but 
did not eliminate completely the ability of S. uberis to adhere to and to invade MAC-
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T cells in vitro (Chen et al., 2011), moreover production of random mutants revealed 
that other adhesins could be involved in the adhesion and invasion process (Kerro 
Dego et al., 2011). Therefore, adherence of strain FSL Z1-048 to the mammary 
epithelium is likely to be mediated by other, as yet unidentified, SUAM independent 
mechanisms. 
 
In addition to the challenge strains FSL Z1-048 and FSL Z1-124, 4 putatively 
adapted and 4 putatively non adapted strains of S. uberis selected based on 
epidemiological and genetic characteristics were tested for the ability to form biofilm 
in vitro. The non adapted strain FSL Z1-124 showed a higher ability to form biofilm 
compared to strain FSL Z1-048. Our results however suggest that ability to form 
biofilm does not play a role in the pathogenesis of IMI caused by S. uberis. In 
addition no clear association between host adaptation and ability to form biofilm was 
observed among other strains tested. These observations need to be considered 
carefully because biofilm formation greatly depends on culture conditions (Gilchrist, 
2011), as exemplified by the lack of biofilm formation in BME-UV1 medium 
compared to RPMI CDM. Therefore, different culture conditions should be tested to 
confirm these results. 
 
In conclusion adhesion to the mammary epithelial cells may at least partially explain 
the differences observed in the pathogenicity of the strains FSL Z1-048 and FSL Z1-
124 suggesting that the adhesion to the mammary epithelial cells play a role in the 









5. 1 Introduction 
 
In our challenge experiments (Chapter 1 and 2) we observed differences in the ability 
of two strains of S. uberis to cause mastitis when infused in the lactating mammary 
gland. The putatively host adapted strain FSL Z1-048 caused clinical mastitis in all 
the lactating cows challenged whereas the putatively non adapted strain FSL Z1-124 
was not able to cause mastitis in any of the quarters challenged. S. uberis bacteria 
were recovered in milk from 4 cows challenged with strain FSL Z1-124  at sporadic 
time points (Chapter 3, Figure 3. 1 A and B). Concentration reached by strain FSL 
Z1-124 was also 10
5 
 fold lower than the maximal concentration reached  by strain 
FSL Z1-048. In contrast FSL Z1-048 was recovered in all the quarters challenged 
within 18 h PI (post infusion). Since both the strains were able to grow in milk 
samples obtained from the challenged quarters pre infusion to a similar degree  
(Chapter 2, Figure 2. 2), we hypothesize that strain FSL Z1-124 is less able to invade 
the mammary gland at early stages of the infection. This may be explained, at least 
partially, by a the higher ability of strain FSL Z1-048 to adhere to the mammary 
epithelial cells as shown in Chapter 4. In addition, differences might be explained by 
a different ability to resist to the host defense of the mammary gland, specifically to 
the cellular defenses represented by phagocytes such as macrophage and PMN. In the 
present experiment we tested the ability of bovine macrophages  and PMN to kill S. 
uberis strains FSL Z1-048 and FSL Z1-124. 
 
Although the proportion of the total mammary leukocyte population reported varies 
depending on the study, macrophages represent a major cell population in the healthy 
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lactating mammary gland (Schwarz et al., 2011). Macrophage are phagocytic cells 
that represent the first line of defense against pathogens in the mammary gland 
(Rainard and Riollet, 2006; Sordillo and Streicher, 2002). Their function is to 
phagocytose and kill pathogens by the production of nitrogen reactive species such 
as nitric oxide. Moreover, mammary gland macrophages are involved in the initiation 
of the immune response following the recognition of pathogens via pattern 
recognition receptors by the production of proinflammatory cytokines such as TNF-α 
and IL-1β (Rainard and Riollet, 2006). 
 
The role of macrophages in IMI caused by S. uberis is not entirely clear. After 
intramammary challenge with S. uberis strain 0140J, microscopic analysis 
demonstrated bacteria were within the cytoplasm of mammary macrophages, 
suggesting they may play a role in clearance of S. uberis from the mammary gland 
(Thomas et al., 1994). However subsequent studies conducted in vitro showed that 
ability to kill the pathogenic strain 0140J was different between macrophages 
isolated from the lactating mammary gland (e.g. from milk) and macrophages 
isolated from the dry mammary gland secretions or blood monocytes (Denis et al., 
2006). In fact,  macrophages from dry cow secretions and blood monocytes were 
able to kill S. uberis, whereas macrophages isolated from lactating mammary gland 
were able to ingest but not to kill the bacteria. These same milk macrophages were, 
however, able to kill S. aureus, suggesting that cells were not damaged during the 
isolation procedure and that the failure of milk macrophages to kill S. uberis in this 
study was due to a specific ability of S. uberis to resist to macrophage bactericidal 
activity (Denis et al., 2006).  
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Polymorphonuclear leukocytes (PMN) are the first cell population recruited in the 
mammary gland following a bacterial infection (Rainard and Riollet, 2006). 
Migration of the cells from the blood to the mammary gland is mediated by pro 
inflammatory cytokines such as TNF-α, IL-1β and IL-8 (Paape et al., 2003). The role 
of PMN is to ingest and kill the bacteria at the site of the infection. PMN are crucial 
in response to the  intramammary infection caused by major mastitis pathogens such 
as Escherichia coli and Staphylococcus aureus. It was observed that cows with a 
better recruitment of PMN after the intramammary challenge with E. coli showed 
less severe clinical signs (Shuster et al., 1996). Similar findings were observed in 
cows with chronic sub-clinical S. aureus mastitis where the induced depletion of 
circulating PMN resulted in a gangrenous mastitis (Schalm et al., 1976).  Both the 
studies suggest that PMN, even if not able to clear completely the infection, limit the 
number of bacteria thus reducing the symptoms during an IMI. 
 
The role of PMN in IMI caused by S. uberis is less clear. Differences in the ability of 
PMN to kill different strains of S. uberis have been observed in vitro. Similar to our 
study, a difference in the ability of S. uberis strains to cause clinical mastitis was 
observed by Hill (1988b) and Leigh (1990). In their studies strains  0140J and EF20 
were shown to differ in their ability to resist to PMN bactericidal activity, with 
O140J being more resistant to PMN killing than EF20 in vitro.  This may explain the 
difference observed in clinical outcome in the challenge studies conducted with these 
two strains Hill (1988b), with strain 0140J able to cause mastitis in the vast majority 
of the cows challenged and EF20 causing mastitis only in a small proportion of 
animals, and suggests that resistance to PMN killing is important determinant of 
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strain pathogenicity. Additional studies also suggest that different strains of S. uberis 
have different abilities to resist PMN. A separate challenge study conducted with 
strain 0140J (Bannerman et al., 2004) and a study conducted with strain UT888 
(Rambeaud et al., 2003) showed that despite the massive influx of PMN in the 
mammary gland after the infusion, PMN were not able to control the infection, 
consistent with the idea that some strains are resistant to PMN killing. In contrast, a 
challenge study conducted with strain U103 (Pedersen et al., 2003) showed that 
influx of PMN reduced the number of bacteria after an initial peak suggesting that 
PMN are able to control the intramammary infection by this S. uberis strain. 
 
We observed a similar result in our challenge experiment with an influx of PMN in 
the mammary gland following the infection with strain FSL Z1-048 being coincident 
with a decrease in concentration of bacteria after a peak, which led to the clearance 
of the infection by 14 days in 5 of 6 animals (Chapter 2, Figure 2. 4).  In our in vivo 
challenge experiments we also observed an increase of IL-17A in milk of 4 quarters 
challenged with strain FSL Z1-048. This increase coincided with a drop in milk 
bacterial concentration and cows cleared the infection by 14 days PI (Chapter 2,  
Figure 2. 10), suggesting a possible role of IL-17 in resolution of the IMI. IL-17, 
produced mainly by Th17 CD4 cells, is considered an amplifier of the acute 
inflammatory response by the innate immune system (Murphy, 2012). This function 
in considered important in controlling extracellular infection (Curtis and Way, 2009). 
Recent studies showed that IL-17 simulates the phagocytosis ability of human 
macrophages (Silverpil et al., 2006) and the bactericidal activity of PMN from mice 
and humans (Lu et al., 2008). Interferon-γ is a cytokine produced by Th1 
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lymphocytes (Ellis and Beaman, 2004), in the context of  bovine mastitis, it has been 
shown that IFN-γ is capable of stimulating neutrophil killing activity against the 
mastitis pathogens S. aureus and E. coli (Fox et al., 1990), but not the killing activity 
of  mammary gland macrophages (Quiroga et al., 1993) suggesting that IFN-γ can 
play a role in the response to the IMI. Although IFN-γ was not elevated in response 
to  challenge with strain FSL Z1-048 in our challenge experiment (Chapter 2, Figure 
2. 9) it has been observed in response to the strain 0140J (Bannerman et al., 2004) 
suggesting that it may be important in the response to other strains of S. uberis.  
 
The objective of the present experiment is to test the ability of bovine macrophages 
and PMN to kill the S. uberis challenge strains FSL Z1-048 and FSL Z1-124 and the 
ability of IL-17A to stimulate the bactericidal activity of bovine macrophage and 
PMN toward S. uberis. Moreover ability of IFN-γ to stimulate the bactericidal 
activity of PMN toward S. uberis is tested. 
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5. 2 Materials and Methods 
 
5. 2. 1 Strains 
FSL Z1-048 and FSL Z1-124 were chosen respectively as representative of 
putatively host adapted and putatively non adapted strains of S. uberis for the 
macrophage killing assay. See section (Chapter 2 and 4 for the details). 
 
5. 2. 2 Monocyte Derived Macrophage Killing Assay 
The ability of bovine monocyte derived macrophage to kill S. uberis strain FSL Z1-
048 and FSL Z1-124 was tested. Cells were obtained from 3 Holstein non-lactating 
heifers. Age was comprised between 9 and 12 months). The experiment was 
conducted at Moredun Research Institute (Penicuick, UK) with approval of the 
Institute’s Experiments and Ethical Review Committee in accordance with the 
Animals (Scientific Procedures) Act 1986. Approximately 100 mL of blood were 
collected from the jugular vein and mixed immediately with an equal volume of 
Alsever`s solution as anticoagulant (D-glucose 113.76 mM, sodium chloride 71.87 
mM, sodium citrate dihydrate 27.20 mM, citric acid 2.86 mM in water). The mix of 
blood and anticoagulant was layered on phicoll plus (GE healthcare, Amersham, UK) 
at a ratio of 2:1 and the PBMC layer was separated by centrifuging at 900 × g for 30 
min at 4°C. The PBMC layer was pipetted off and transferred to a new falcon tube 
and washed 3 times in complete medium (RPMI-1640 supplemented with 10% 
vol/vol heat inactivated fetal calf serum, 200 U/mL penicillin, 200 U/mL 
streptomycin, 1% vol/vol  glutamine (Sigma-Aldrich, Dorset, UK). Cells were finally 
resuspended in up to 2 mL buffer, then labelled with mouse anti-human CD14 
 
134 
microbeads (Miltenyi, Bisley, UK) and isolated by positive selection on LS  
magnetic column (Miltenyi-Biotech) following manufacturer`s instructions. Viable 
cells were counted by trypan blue dye exclusion and seeded in complete medium at 
1×10
6
 cells/well in flat bottom 96 wells polystyrene tissue culture plates (Corning, 
NY, USA). Cells were cultured for 6 days at 37°C, 5% CO2. Medium was changed 
every second day. 24 h before the assay, complete medium was replaced with 
complete medium without antimicrobials and where appropriate supplemented with 
10 ng/mL of recombinant bovine IL-17A (Kingfisher Biotech, Saint Paul, MN, 
USA). To conduct the assays, 100 μL of supernatant were removed and replaced 
with 100 μL of medium containing S. uberis bacteria strain FSL Z1-048 or FSL Z1-
124 pre-incubated for 20 min at 37°C with heat inactivated adult bovine serum 
(Gibco) as source of opsonins. Based on preliminary experiments bacteria were 
diluted to have a multiplicity of infection (MOI) of 5 (i.e. 5 bacteria per cell). 
Bacteria and cells were co-incubated for 2 h at 37°C, 5% CO2 before 50 μL of 0.1% 
vol/vol tryton X-100 (Sigma-Aldrich) diluted in PBS were added in order to lyse the 
cells. Cell lysates were 10-fold serially diluted in cold PBS and 20 μL spots were 
plated in triplicates on blood agar plates (E&O Laboratories, Bonnybridge, UK). Cfu 
were counted where possible for the dilution factor presenting 5 to 50 colonies per 
spot and concentration was calculated. For each treatment (strain, IL-17A 
stimulation) 3 technical replicates (i.e. wells) were performed. The entire experiment 
was repeated in a 2-week period, collecting each time blood from the three animals. 
In preliminary experiments purity of macrophage culture after the magnetic bead 
separation was assessed by flow cytometry. Briefly, 10 μL of anti CD14 antibody 
(clone VPM65, mouse IgG1 isotype, Moredun Research Institute) were added to 1 
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mL of cell suspension in complete medium containing 1×10
6
 cells and incubated for 
30 min at 4°C. Cells were washed 3 times by centrifugation at 1500 × g for 5 min at 
4°C. 100 μL of goat anti mouse IgG Alexa 488 conjugated secondary antibody 
diluted 1:2000 were added and incubated for 30 min at 4°C. Cells were acquired with 
a 2 laser Cyan flow cytometer (Beckman Coulter, High Wycombe, UK). Data were 
collected for a minimum of 10,000 cells for each cell preparation sample, and cells 
were gated based on forward and side scatter to exclude cellular debris from the 
analysis. Data were analysed using FlowJo software (Tree Star). The percentage of 
CD14 positive cells was calculated. Cytocentrifuge preparations of selected cell 
samples after 7 days of culture were prepared using a Shandon Cytospin 4 
cytocentrifuge (Thermo Electron Corporation, Milford, MA, USA) and stained using 
a REASTAIN Quick-Diff Kit (Reagena Toivala, Finland) for microscopic 
examination. 
 
5. 2. 3 PMN Killing Assay 
To test the ability of bovine PMN to kill S. uberis strains FSL Z1-048 and FSL Z1-
124, PMN were isolated from blood of 4 mid lactating Holstein cows (parity 2 to 5). 
The experiment was conducted at Department of Population Medicine and 
Diagnostic Sciences, College of Veterinary Medicine, Cornell University (Ithaca, 
NY, USA) using animals held by the Cornell Teaching and Research Facility (Ithaca, 
NY, USA). Approximately 20 mL of blood were collected from the jugular vein in 
vacutainer vials containing heparin as anti-coagulant. Blood was processed within 1 
h of collection diluting it with an equal volume of PBS, the mixture was then layered 
on Ficoll-Paque plus (GE Healthcare, Pittsburgh, PA, USA ) and centrifuged at for 
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30 min at 900×g 4°C. The granulocyte layer was transferred to a fresh 50 mL falcon 
tube. Residual erythrocytes were lysed by adding 5 mL of lysis solution (0.8% wt/vol 
NH4Cl, 0.1 mM EDTA in water) pre warmed at 37°C. Cell suspension was gently 
mixed until the erythrocytes were completely lysed. 20 mL of PBS were added, then 
cells were washed twice by spinning at 300 × g for 10 min at 4°C and finally 
resuspended in RPMI-1640 (Gibco) supplemented with 10% heat inactivated FCS 
and 4 mM glutamine. Viable cells were microscopically counted based on trypan 
exclusion staining. Cells were seeded in 96-well polystyrene cell culture plate 
(Corning) at 5×10
5 
cells per well in a total volume of 200 μL. Cells were stimulated 
with bovine recombinant cytokines IFN-γ (AbD Serotec, Kidlington, UK) or IL-17A 
(Kingfisher) at  10, 100, 1000 ng/mL for 2 h at 37°C, 5% CO2. After pre-incubation 
for 20 min at 37°C with heat inactivated adult bovine serum (Gibco) as source of 
opsonins, S. uberis strains FSL Z1-048 and FSL Z1-124 were added to wells at MOI 
of 1 with PMN. Bacteria and PMN were co-incubated for 90 min at 37°C, 5% CO2. 
Fifty μL of 0.1% vol/vol tryton X-100 (Sigma-Aldrich) diluted in PBS were added in 
order to lyse the cells. Cell lysates were 10 fold serially diluted in cold PBS and 20 
μL spots were plated in triplicates on blood agar plates. Cfu were counted where 
possible for the dilution factor presenting 5 to 50 colonies per spot and concentration 
was calculated. In preliminary experiments the purity of cell population after 
isolation of PMN was tested with flow cytometry analysis. Cells were stained with 
antibodies against anti CD11b (Monoclonal FITC conjugated, Mouse IgG2b, 
VMRD) and anti CD14 (Monoclonal APC conjugated Mouse IgG1, VMRD) 
antigens using a protocol described by Schwarz et al. (2011). PMN from 4 animals 
were tested separately, for each treatment (strain, cytokine) 3 technical replicates 
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were performed.  An average of the 3 technical replicates was used as input for the 
statistical analysis. All procedures were approved by the Cornell Institutional Animal 
Care and Use Committee 
 
5. 2. 4 Statistical Analysis 
Percentage survival was calculated as the percentage of the viable bacteria compared 
to viable bacteria in wells containing the medium only and no host cells. Percentage 
survival was used as input for a two-way analysis of variance (ANOVA) using 
Genstat software (VSN International, Hemel Hempstead, UK). Strain and cytokine 
stimulation were used as treatment factor, interaction between strain and cytokine 
was also evaluated. A blocking structure with cells from individual animals was 
used. Charts were visually checked to assess the normal distribution of the residuals. 
Post-hoc comparisons with Tukey HSD test and LSD test were performed where 
appropriate with statistical significance declared when P < 0.05.  
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5. 3 Results 
 
5. 3. 1 Macrophage Killing Assay 
The ability of macrophages derived from blood monocytes to kill S. uberis strains 
FSL Z1-048 and FSL Z1-124 was tested. Flow cytometry on preliminary 
experiments showed that approximately 90% of the cells after the purification from 
blood were CD14
+ 
(Figure 5. 1). After 7 days of culture approximately 95% of the 
cells at microscopic examination were showing the morphology of differentiated 
macrophage.  
 
Monocyte derived macrophages were able to kill strain FSL Z1-124. The proportion 
of viable bacteria present after 2 h of co-incubation with host cells was 57.5 ± 21.8% 
of the bacteria incubated in the medium only (Figure 5. 2) indicating that blood 
derived macrophage were able to kill this S. uberis strain. In contrast, macrophages 
failed to kill strain FSL Z1-048. Bacteria recovered after 2 h were 123.8 ± 33.2% of 
the bacteria incubated in the medium only, suggesting a replication in presence of 
macrophages (Figure 5. 2). 
 
Stimulation of the macrophages for 24 h with 10 ng/mL of bovine recombinant IL-
17A significantly increased their ability to kill the strain FSL Z1-048 (P < 0.05, 
Figure 5. 2) whereas stimulation with IL-17A did not significantly enhance the 





Figure 5. 1 Example of flow cytometric analysis of cells isolated from blood using 
CD14 beads. Cells were gated based on side and forward scatter (left figure) to 
exclude cell debris. Monocytes were identified as CD14
+
 (FITC) cells (Q2 quadrant). 
 
Figure 5. 2 Killing of S. uberis strains FSL Z1-048 and FSL Z1-124 by bovine 
monocyte derived macrophages. Data represent the percentage ± standard deviation 
of bacteria survived after 2 h of co-incubation with macrophages compared with 
bacteria in medium alone. Cells were stimulated for 24 h with 10 ng/mL of rbIL-17A 
(striped bars) or left untreated (empty bars). Cells were isolated from blood of 3 
animals and the experiment was repeated twice.  



















































5. 3. 2 PMN Killing Assay 
Flow cytometry analysis showed that approximately 75% of the cells after the PMN 




 thus likely to be PMN (Figure 5. 3). In fact, 
CD14 antigen is expressed by monocyte but not on PMN (Schwarz et al., 2011). This 
proportion was confirmed by microscopic observation of morphology of cells present 
in the cell preparations  
 
PMN cells isolated from bovine blood were able to kill both S. uberis strain FSL Z1-
048 and FSL Z1-124 (Figure 5. 4A and B). Bactericidal ability of PMN alone was 
significantly different between the two strains (P < 0.05), with higher bactericidal 
activity observed with strain FSL Z1-048. Percentage survival for strain FSL Z1-048 
was 32.9 ± 10.2 (Figure 5. 4A) whereas for strain FSL Z1-124 it was 55.8 ± 18.8 
(Figure 5. 4B). 
 
Stimulation with recombinant cytokines IL-17A or IFN-γ increased the killing ability 
of PMN, however only at certain concentrations (Figure 5. 4A and B). 10 ng/mL of 
IL-17A increased the killing ability toward strain FSL Z1-048 and toward strain FSL 
Z1-124 compared to PMN cultures without IL-17A, with the mean percentage 
survival of bacteria being 20.4 ± 4.3 and 43.8 ± 18.9 % for strains FSL Z1-048 and 
FSL Z1-124, respectively. IL-17A at 100 ng/mL increased the killing ability of PMN 
for strain FSL Z1-048 only, with mean percentage survival being 28.4 ± 8.1 (Figure 





10 ng/mL of IFN-γ increased the killing ability of PMN towards both strain FSL Z1-
048 and FSL Z1-124, with mean percentage survival being 24.3 ± 10.2 and 45.8 ± 
17.8 for strains FSL Z1-048 and FSL Z1-124, respectively. IFN-γ at 100 ng/mL 
increased the killing ability of PMN for strain FSL Z1-124 only (mean percentage 
survival 39.2 ± 15.2, Figure 5. 4B), whereas IFN-γ at 1,000 ng/mL increased the 
killing ability of PMN for strain FSL Z1-048 only (mean percentage survival 22.1 ± 




Figure 5. 3 Example of flow cytometric analysis of PMN isolated from blood. Cells 
were gated based on side and forward scatter (left figure) to exclude cell debris. 












Figure 5. 4 Killing ability of PMN isolated from bovine blood. Cells isolated from 
blood were co-incubated with S. uberis strain FSL Z1-048 (A) or strain FSL Z1-124 
(B). Host cells were also stimulated with recombinant cytokines IL-17A (striped 
bars) or IFN-γ (grey bars) at different concentrations. Means and standard deviations 
of percentage survival (i.e. bacteria that survived after co-incubation compared with 
bacteria cultured in medium only) of 4 animals for strain FSL Z1-048 and 3 animals 
for strain FSL Z1-124. Means significantly different (LSD test, P < 0.05) from cell 
alone were marked by asterisks. “Cells alone” refers to the combination of bacteria 


































































































































































5. 4 Discussion 
 
In this study we tested the ability of bovine macrophages and PMN to kill two 
different strains of S. uberis in vitro. These strains were chosen as representative of 
putatively adapted and putatively non adapted strains of S. uberis and elicit a 
different host response when infused in the lactating mammary gland (Chapter 2). In 
our challenge study we observed an increase in the bacterial count in the milk of 
cows challenged with strain FSL Z1-048 within 12 and 18 h (Table 2. 3; Fig 2. 4 A 
and B) whereas strain FSL Z1-124 was isolated only at sporadic time points in a 
limited number of cows (Fig 2. 4 A and B). This suggests that the differences 
between the two strains occur at an early stage after the infusion of the bacteria in the 
teat cistern.  
 
Bovine macrophages were able to kill the putatively non adapted strain FSL Z1-124 
in vitro whereas they were not able to kill the adapted strain FSL Z1-048. This 
suggests that differences in the pathogenicity observed in vivo in our challenge study 
(See Chapter 2 and 3) could be, at least partially, explained by the different ability of 
the macrophages to kill S. uberis at the early stages of the infection. In vivo, resident 
macrophages may be able to kill strain FSL Z1-124 and clear the bacteria before 
infection becomes established. Conversely, strain FSL Z1-048 would not be cleared 
by macrophages and thus bacteria would be able to replicate within the mammary 
gland. Macrophages are one of the most represented cell populations in the healthy 
lactating mammary gland, and are thought to be the first defence in case of infection 
(Raianrd and Riollet, 2006; Sordillo and Streicher 2002). Due to the technical 
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problems encountered in the isolation of the milk macrophages resulting in an 
insufficient number of cells available for the assay in this experiment, we used 
macrophages derived from blood monocytes. In other studies macrophages isolated 
from dry mammary gland secretions (Grant et al., 1997), milk (Denis et al., 2006) or 
blood monocytes (Denis et al., 2006) were used. The killing ability of monocyte 
derived macrophages in the present study for strain FSL Z1-048 is comparable to that 
reported for the pathogenic strain 0140J following incubation with milk macrophages 
(Denis et al., 2006). This suggests that ability to resist to macrophage killing may 
play a role in the pathogenicity of this strain. Although a comparison between the 
present study and the study conducted by Denis and co-workers needs to be carefully 
evaluated due to the diverse origin and isolation technique of the macrophages used.  
 
Bovine PMN were able to kill both strain FSL Z1-048 and FSL Z1-124. Differences 
between strains were observed. Surprisingly, the pathogenic strain FSL Z1-048 was 
killed more easily than the non-pathogenic strain FSL Z1-124. This results is in 
contrast with another study where ability to resist to PMN killing was related with 
the pathogenicity of the strain when infused it the lactating mammary gland (Hill, 
1988b; Leigh et al., 1990). PMN are present in relatively low number in the healthy 
mammary gland and they are recruited in large number from the blood following an 
inflammatory stimulus (Paape et al., 2003). Our data suggests that ability of S. uberis 
strains FSL Z1-048 and FSL Z1-124 to invade at an early stage the mammary gland 
and cause mastitis is not related with the different ability of the two strains to resist 
to the PMN killing. PMN may, however, play a role in the resolution of the mastitis 
caused by S. uberis strain FSL Z1-048. In fact, in our study we observed a reduction 
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in the number of bacteria in milk in quarters challenged with strain FSL Z1-048 
between 36 and 96 h PI of approximately 10,000 fold (Chapter 2, Figure 2. 4A). The 
first reduction in bacterial count was coincident with the massive influx of PMN 
(Figure 2. 6), and ability of PMN to kill S.uberis strain FSL Z1-048 in vitro supports 
this hypothesis. The role of PMN in the resolution of S. uberis appears to be highly 
variable between studies. PMN were not able to reduce the bacterial number 
following the IMI with S. uberis strain 0140J (Bannerman et al., 2004) despite the 
massive infiltration into the mammary gland, whereas for strain UT888 a decrease in 
the bacterial count was observed only 120 h following the increase of SCC 
(Rambeaud et al., 2003). In another challenge study with strain U103, a reduction of  
bacteria number was coincident with the influx of PMN (Pedersen et al., 2003). 
Comparison of these studies is difficult due to different challenge model used, 
however they suggest, together with our observations that ability to resist to PMN 
killing may vary among S. uberis strains and for certain strains such as our challenge 
strain FSL Z1-048 may play an important role in clearance of the IMI.. 
 
The first reduction in the bacterial count in cows challenged with strain FSL Z1-048 
was also coincident in four animals with the production of IL-17A in the mammary 
gland (Chapter 2, Figure 2. 10), suggesting that IL-17A may play a role in resolution 
of infection. For this reason, the effects of IL-17A on macrophage and PMN function 
were assessed. 
 
Stimulation of bovine PMN with rbIL-17A increased the killing ability against both 
strain FSL Z1-048 and FSL Z1-124, at least for low concentrations of IL-17A. 
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Studies conducted on PMN from humans and mice showed that similar 
concentrations of IL-17A increase the in vitro killing ability of human neutrophils 
against Streptococcus pneumomiae (Lu et al., 2008), which was attributed due to the 
enhancement of phagocytic activity. In our challenge experiment the maximal 
average concentration of IL-17A in milk was approximately 20 fold lower than the 
lowest concentration of IL-17A used in the in vitro experiment. The concentration in 
milk however may not be representative of the concentration in the mammary gland 
tissue or in the alveoli due to the dilution effect. These observations together suggest 
that IL-17 plays a role in the response to IMI caused by S. uberis by increasing the 
killing ability of PMN in the mammary gland. 
 
We observed an increased in vitro bactericidal activity of bovine macrophage against 
S. uberis strain FSL Z1-048 following stimulation with IL-17A. Although 
macrophages are the least represented cell population in the milk after an 
inflammatory response (Koess and Hamann, 2008; Schwarz et al., 2011a; Schwarz et 
al., 2011b), these data suggest that IL-17 can stimulate mammary gland macrophages 
which may contribute to the clearance of S. uberis infection. A previous study 
showed that stimulation of mouse bronchoalveolar macrophages or human 
monocyte-derived macrophages stimulated with IL-17 increased their phagocytosis 
ability (Silverpil et al., 2006). These data further support the hypothesis that IL-17 
plays an important role in clearance of extracellular bacteria. A recent study shown 
that IL-17A plays a role in the clearance of intracellular infection of macrophage 
with the Mycobacterium bovis bacillus Calmette–Guérin (BCG) The authors 
investigated the mechanisms of action of IL-17A on murine macrophages finding 
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that IL-17A promotes the clearance of BCG internalized by macrophages by 
stimulating the expression of inducible nitric oxide synthase (iNOS) and production 
of nitric oxide (NO) (Ling et al., 2013). Similarly to what we observed in the present 
study for the augmented killing activity of PMN induced by IL-17A the response to 
the stimulation with this cytokine was found to be dose dependant.  Without 
stimulation of IL17A macrophages are not capable to kill strain FSL-048 this 
suggests that the presence of IL-17A is necessary also in vivo for bacterial killing of 
this strain by macrophages. This suggests that the clearance of this strain observed in 
Chapter 2 was correlated with the appearance of this cytokine in the mammary gland. 
It can be speculated that activated macrophages can contribute with PMN to the 
clearance of IMI caused by strain FSL Z1-048. 
 
We also observed an increased bactericidal ability of PMN following stimulation 
with recombinant IFN-γ. IFN-γ is a potent inducer of PMN function such as 
phagocytosis, production of reactive oxygen species and production of nitric oxide 
(Ellis and Beaman, 2004). It has also been found to increase the ability of neutrophils 
from the bovine mammary gland to phagocytise and kill S. aureus (Sordillo and 
Babiuk, 1991). However in our challenge study we detect IFN-γ in the mammary 
gland of only one cow challenged with strain FSL Z1-048 suggesting that the 
majority of the cows challenged did not respond to the infection with production of 
IFN-γ. Thus, the relevance of this mechanism in the resolution of IMI caused by FSL 




In summary, we demonstrate that ability of S. uberis to resist to macrophage killing 
may play an important role in the early pathogenesis of IMI determining the outcome 
of infection.  We also demonstrate that bovine PMN are able to kill a pathogenic 
strain of S. uberis,. This can contribute to the clearance of the infection caused by 







6. 1 General Discussion 
 
The aims of the present study were to test the hypothesis that putatively host adapted 
strains of S. uberis and non adapted strains yield a different host response when 
infused in the bovine mammary gland. Moreover we tested the hypothesis that an 
immune memory exists in the mammary gland by a secondary challenge, and that 
immune memory if present, is strain specific and systemic. Based on the challenge 
results and literature we investigated in vitro some possible mechanisms that could 
explain the differences observed between the two strains in vivo.  
 
We demonstrated in Chapter 2 that the putatively adapted strain FSL Z1-048 elicits a 
clinical and immune response different than the non-adapted strain FSL Z1-124. 
Surprisingly the intramammary infection with the putatively adapted strain FSL Z1-
048 elicited a clinical mastitis that self cured rather than a persistent sub-clinical 
mastitis, as observed in the field studies that led to its isolation and characterisation 
(Zadoks et al., 2003). Different criteria for defining host adaptation in S. uberis 
mastitis have been formulated in the past, in addition to the theory proposed by 
Zadoks (2007). The host adaptation could be considered as the ability to cause IMI in 
all, or the vast majority, of the cows challenged, as described in early studies that 
identified strains of S. uberis with different abilities to cause IMI (Hill, 1988a). 
Considering this criteria strain FSL Z1-048 could be defined as host adapted as it 
was able to cause IMI in all the animals challenged. The infectious dose may be 
critical for determining clinical outcome following IMI, however, a low challenge 
dose (200 cfu) of FSL Z1-048 was used in these studies which was comparable to the 
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dose used in models with strain 0140J (Hill, 1988b; Bannermann et al., 2004) which 
infected all animals challenged and also strain EF20 which failed to infect the vast 
majority of the quarters challenged (Hill, 1988b). In a separate S. uberis challenge 
experiment approximately 10000 cfu of strain UT888 failed to infect some of the 
quarters (Rambeaud et al., 2003), indicating that even at higher doses some strains of 
S. uberis have limited capacity to infect the bovine mammary gland. The cows 
challenged with strain FSL Z1-048 excreted S. uberis with milk until the end of the 
study (14 days) with a concentration that reached a peak of 10
8 
cfu/mL, and this level 
of shedding could provide the opportunity for the bacteria to spread amongst the 
cows as described during the outbreaks caused by this strain. Cow to cow 
transmissions could then occur at milking via the milking equipment, as described 
during an outbreak caused by strain FSL Z1-048 (Zadoks et al., 2003), or indirectly 
by contamination of the herd environment.  
 
The differences between the two strains seem to occur at early stages after the entry 
of the bacteria in the mammary gland. Several mechanisms described by the 
literature which could explain the differences observed were investigated in vitro. 
These include ability to grow in milk, epithelial adhesion and invasion, resistance to 
killing by phagocytes and ability to form biofilm. 
 
Ability to grow in milk has been suggested as a virulence factor in mastitis caused by 
S. uberis (Leigh, 1999) and E. coli (Kornalijnslijper et al., 2003), because a rapid 
growth would enable bacteria to replicate within the mammary gland at a rate 
exceeding that by which they are cleared via milking and by the activity of the 
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phagocytes such as macrophage and PMN. Both the strains used in the present study, 
although with a different rate, grew well in the milk from the cows used in the 
challenge experiment. This is in contrast to what has been observed for E. coli where 
faster growth rates in milk were correlated with clinical mastitis (Kornalijnslijper et 
al., 2003). In the studies performed in this thesis, growth of S. uberis did not differ 
between the individual animals suggesting that growth in milk of S. uberis is a 
characteristic of the strains rather than the composition of milk of individual animals. 
In the challenged experiment cows were milked 9 h after the challenge and milk 
samples were negative for all the cows challenged with either strain FSL Z1-048 and 
FSL Z1-124, suggesting that concentration of the bacteria in milk in vivo depends on 
other factors in addition to the mere ability to grow in milk. Other factors are more 
likely to explain the differences observed in the outcome of the intramammary 
challenge such as the ability to adhere and invade the mammary epithelial cells and 
the resistance to the killing of the phagocytes. 
 
Adhesion and invasion is considered an important step in the process of colonization 
of the mammary gland by S. uberis (Tamilselvam et al., 2006).The ability of the two 
challenge strains to adhere and to invade the mammary epithelial cells was 
investigated in vitro. The putatively host adapted strain FSL Z1-048 was 
approximately 1,000 fold more able to adhere to the mammary epithelial cells after 3 
h of co-incubation compared to the non-adapted strain FSL Z1-124. This suggests 
that the ability to adhere to the epithelial cells could, at least in part, explain the 
differences observed in vivo between the two strains. Adherence to the epithelium 
would in fact allow the bacteria to resist clearance from the mammary gland as a 
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result of milk flow during milking. In our study we tested the ability to adhere at 3 h, 
however, this is a relatively short time period and it would be important to further 
investigate the adhesion at later time points. This would allow a comparison between 
the results obtained in vitro and the in vivo situation. In fact, cows are normally 
milked with a 12 h interval. It could be hypothesised that during the milking process 
bacteria that are not attached to the host cells are excreted with milking and only 
those attached to the host cells and the bacteria in the residual milk are left in the 
mammary gland after milking.  
 
Both strains were able invade the epithelial cells in vitro, but the non adapted strain 
FSL Z1-124 was more invasive than strain FSL Z1-048. Strain FSL Z1-124 was 
isolated in a limited number of animals challenged. From these observations it could 
be hypothesized that once infused in the mammary gland, strain FSL Z1-124 invades 
the epithelial cells (as demonstrated in vitro in the present study, Chapter 4) and is 
able to survive in the mammary epithelial cells (Tamilselvam et al., 2006) but does 
not multiply significantly intracellularly. Moreover, remaining extracellular FSL Z1-
124 bacteria  would either be removed by milk flow or killed efficiently by resident 
macrophage of the mammary gland, as suggested by in vitro macrophage killing data 
(Chapter 5) resulting in clearance of the majority of the infection at early stages. In 
contrast, strain FSL Z1-048 adheres to the epithelial cells and grows in the alveoli at 
a rate that exceeds the elimination rate with milking and the elimination by the 




Analysis of the genome, further validated by amplification and sequencing of the 
target gene, showed that sua of strain FSL Z1-048 has a one base deletion which 
would translate in a truncated form of Streptococcus uberis adhesion molecule 
(SUAM). SUAM has been found to mediate the adhesion and invasion of mammary 
epithelial cells by S. uberis in vitro (Almeida et al., 2006). Sua , the gene encoding 
for this protein, has been detected in many strains of S. uberis by PCR amplification 
(Luther et al., 2008), however the presence of mutations which could affect the 
function of the protein as described for strain FSL Z1-048 has never been evaluated. 
The presence of strains which do not synthesize SUAM might reduce the efficacy of 
a vaccine against that elicits antibodies against that molecule.  
 
The potential absence of functional SUAM in strain FSL Z1-048 suggests that 
adhesion and invasion of the epithelial cells observed in vitro for this strain is likely 
to be mediated by other mechanisms. The presence of other mechanisms of adhesion 
and invasion are also suggested by a study showing that deletion of the gene 
encoding SUAM does not abrogate completely the ability to adhere and invade the 
mammary epithelial cells in vitro (Kerro Dego et al., 2011). 
 
Recent studies highlighted the importance of Sortase A anchored proteins in S. 
uberis. Sortase A (SrtA) is an enzyme encoded by SrtA gene involved in the 
anchoring of proteins on the cell wall after synthesis. A limited number of Srt A 
anchored proteins have been identified by genomic and proteomic analysis. The 
secretion of SrtA substrates seems to be greatly dependent on experimental growth 
conditions (Egan et al., 2010). A recent paper showed that S. uberis mutants lacking 
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SrtA are less pathogenic than the isogenic wild type strain (Leigh et al., 2010). The 
function of SrtA anchored proteins in S. uberis is not known. Authors, comparing the 
sequence of these proteins with other streptococci species, suggest that two of the 
SrtA anchored proteins identified in strain 0140J are homologues of proteins known 
to be involved in adhesion and invasion process in other streptococci species. For 
instance sub1095 is homologue of Collagen like protein SclB of Streptococcus 
pyogenes, which is involved in the adhesion to fibroblasts. Another collagen like 
protein found in S. pyogenes, Sub1145, is involved in the process of adhesion and 
invasion of epithelial cells. Sub1145 is found to be homologous to a protein found in 
group B Streptococci involved in the invasion of human epithelial cells. It could be 
hypothesized that lack of SrtA impairs the anchoring of proteins involved in the 
adhesion to host cells. Although out of the scope of this study presence of SrtA was 
confirmed in the genome of the two S. uberis challenge strains. It is therefore 
unlikely that the low pathogenicity of strain FSL Z1-124 is due to the lack of this 
enzyme. 
 
Much of the research conducted in the past on adhesion and invasion of S. uberis has 
focused on SUAM. However our findings that FSL Z1-048 is able to adhere to the 
mammary epithelial cells even if not encoding for a functional form of SUAM, and 
recent literature data on SrtA anchored proteins suggest that other adhesins might 
play a role in adhesion and invasion of mammary epithelial cells by S. uberis.  
As in previous studies, the in vitro adhesion and invasion data in this thesis were 
obtained using immortalized cell lines. In this study BME-UV1 cells were used. This 
cell line retains physiological functions of the mammary epithelium such as tight 
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junctions (Quesnall et al., 2006). However, since adhesion of S. uberis to primary 
epithelial mammary cells is considerably lower than that observed using MAC-T cell 
line (Ditcham et al 1996; Lammers et al., 2001) and little or no adhesion is observed 
in vivo with S. uberis (Thomas et al., 1994), the use of immortalized cell lines such 
as BME-UV1 and MAC-T cells for studying adhesion and invasion may not be 
optimal. It would therefore be important to further investigate the adhesion and 
invasion ability of S. uberis using a system as close as possible to the in vivo 
situation. For instance, this could be performed in vitro using primary epithelial cell 
cultures (Lammers et al., 2001) which retain more of the in vivo characteristics. 
Interaction with the cells and localization in the mammary gland of S. uberis bacteria 
could also be investigated in vivo using various techniques such as 
immunohistochemistry, immunofluorescence or fluorescent in situ hybridization 
(FISH). FISH has been used for detection of S. uberis bacteria in sheep mammary 
gland tissue (Addis et al., 2013), and although the technique needs further 
improvement to augment the specificity, it could be used in cattle samples. Tissue 
samples could be obtained from the mammary gland of animals with a natural case 
or an experimentally induced S. uberis mastitis at post mortem or from living animals 
by mammary gland biopsy as described for E. coli (Dogan et al., 2006), and co-
localisation of bacteria with epithelial or other cells determined. At the end of the 
secondary challenge experiment (Chapter 3), tissue samples of the mammary gland 
were collected for further analysis. Although out of the scope of this study, 
preliminary results of gram stained tissue samples showed clusters of bacteria 
associated with alveolar mammary epithelial cells in those quarters that were 




Although not able to induce mastitis in our challenge experiments, strain FSL Z1-124 
was isolated from a clinical case of mastitis affecting a heifer at parturition (Zadoks, 
personal communication) suggesting that is not a completely a-virulent strain. It 
could be hypothesised that this strain and other non adapted strains can cause the 
intramammary infection only when the host defences are impaired as for other 
environmental pathogens. This can happen frequently during the peripartum period 
and early lactation. The negative energy balance in the early lactation can cause 
hyperketonemia which impairs the udder defence against  pathogens (reviewed by  
Suriyasathaporn et al., 2000). Ketones can reduce the bactericidal activity of bovine 
macrophage in vitro by reducing the production of oxidative species and by reducing 
their phagocytosis activity (Cerone et al., 2007). Considering our in vitro 
observations which demonstrated efficient killing of FSL Z1-124 by monocyte-
derived macrophages (Chapter 4), it could be speculated that during the peripartum 
period macrophages resident in the mammary which normally kill non adapted S. 
uberis strains such as FSL Z1-124 are unable to kill the bacteria allowing them to 
replicate. Mastitis at parturition can be also caused by pathogens that infect the 
mammary gland during the dry period and persist until the calving without signs of 
mastitis, as suggested for E. coli (Quesnell et al., 2012). Authors suggest that the 
inflammatory response in the mammary gland is suppressed during the late gestation 
due to an IL-10 mediated Th2 type response, which allows bacteria to survive 
intracellularly in the epithelial cells. At parturition, a shift toward a Th1 type 
response causes the appearance of clinical signs. Given the ability of S. uberis to 
infect dry cows (Zadoks, 2007) and to invade the epithelial cells as suggested by both 
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the literature (Almeida and Oliver, 2006) and by the studies in this thesis (Chapter 4), 
it is possible that this mechanism could play a role in IMI caused by S. uberis. This 
could be investigated in challenge studies of dry cows or periparturient cows. 
 
S. uberis is a highly heterogeneous bacterial species (Leigh, 1999, Zadoks 2007). It 
would therefore be important to extend the observations made in vitro for the two 
strains FSL Z1-048 and FSL Z1-124 to other strains. Several putatively host adapted 
and non-adapted strains have been collected and are available for further 
experiments. In addition to the criteria that have been used to define host adaptation 
characteristics in this study, other criteria can be used to select strains. For instance 
strains can be selected based on the host species (i.e. ovine and bovine stains, 
Gilchrist et al., 2013). It would be possible to repeat the in vitro assays conducted in 
the present study to determine if the differences observed between the two S. uberis 
strains are common amongst other host adapted and non adapted strains. This would 
be important in order to avoid approaches in mastitis management and/or vaccine 
development based on data obtained from a limited number of strains which could 
target antigens or mechanisms present in only a limited number of S. uberis strains.   
 
The primary challenge with strain FSL Z1-048 showed that clearance of the infection 
could be due to the influx of PMN which cause the initial reduction of the bacterial 
concentration and to the influx in the mammary gland of T-cells at later stages. A 
recent study showed that bovine CD8
+ 
T cells are able to directly kill S. uberis in 
vitro (Denis et al., 2011), providing a possible explanation for our observations. The 
efficacy of PMN in controlling S. uberis is debated since some strains induced a 
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massive influx of PMN which is not able to clear the infection (Rambeaud et al., 
2003; Bannerman et al., 2004), whereas in another study the influx of PMN was 
concomitant with a drop in the bacterial concentration (Pedersen et al., 2003). The 
differences observed could be due to the different strains used in these models. 
Following our observation made in vivo that the influx of PMN coincides with the 
initial drop in bacterial concentration (described in Chapter 2), we tested the ability 
of bovine PMN to kill the challenge strains in vitro. Bovine PMN were able to kill 
approximately 70% of FSL Z1-048 bacteria following co-incubation for 90 min, 
indicating that the influx of PMN could have been at least partly responsible for the 
clearance of bacteria from the mammary gland.  
 
To further study the observations made in this thesis, mathematical modelling could 
be used. This study provides several parameters that could be used to generate a 
mathematical model which describes the intramammary challenge. Mathematical 
models have been used to study various aspects of intramammary infection in cattle. 
For example, a predator prey model was developed to study the role of neutrophils in 
response to Staphylococcus aureus (Detilleaux et al, 2004), using a simple model 
considering bacterial growth and PMN killing rate. Another group (White et al., 
2009) developed a model with the aim of describing the outcome of intramammary 
infection (e.g. transient or persistent) with E. coli, taking in account pro-
inflammatory and anti-inflammatory cytokine responses. The present study provides 
several parameters obtained in vivo and in vitro that could be used to construct a 
mathematical model to further study the role of single components of the host 
response. These data include: growth rate in vitro, growth in vivo, PMN and 
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macrophage killing, adhesion to and invasion of mammary epithelial cells in vitro, 
concentration of cytokines in vivo. For instance, a simple model could be constructed 
using the data obtained in vitro on PMN killing and the effect of IL-17A on 
bactericidal activity of these cells to elucidate the role of PMN, IL-17 and T-cells in 
the clearance of S. uberis infection, determining for example if the presence of IL-17 
is necessary to clear the infection as observed in our challenge study in 4/6 cows.  
 
Recent data highlights the importance of the early immune events during the 
intramammary infection (Schukkent et al., 2011, Wellnitz and Bruckmeier 2012).  
One area that could be investigated to explain the differences between host adapted 
and non adapted  S. uberis strains is the immune response of the mammary epithelial 
cells following the interaction with S. uberis. A recent transcriptomic study showed 
that epithelial cells along with infiltrated immune cells play an important role in the 
response to S. uberis IMI (deGreeff et al., 2013). Moreover, mammary epithelial 
cells respond differently in vitro to different strains of S. uberis. The two strains 
chosen present also a different clinical response in the live animal (Wellnitz et al, 
2013). The authors suggest that a stronger immune response of the epithelial cells in 
response to one of the two strains tested leads to the production of pro-inflammatory 
cytokines such as IL-8 and IL-1β which start the inflammatory response that 
ultimately clears that strain in vivo. Similar results were obtained in a microarray 
study showing that primary epithelial cells isolated from animals with high 
susceptibility to mastitis had a lower immune response to either E. coli and S. aureus 
than cows with low susceptibility to mastitis (Brand et al., 2011). In our challenge 
study the concentration of pro-inflammatory cytokines in milk from cows challenged 
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with non-pathogenic strain FSL Z1-124 was undetectable except for IL-8 at limited 
time points. However, the ELISA tests used in these studies is not able to detect very 
small changes in cytokines measured due to a lack of sensitivity. Therefore, the 
possibility that strain FSL Z1-124 is recognized earlier by the innate immune system 
cannot be ruled out and further studies would be needed to determine if any immune 
response is generated. The inflammatory response of mammary epithelial cells to the 
strains used in the present study could be further studied in vivo or in vitro. Tissue 
samples from the mammary gland could be collected from experimentally challenged 
animals and used for microarray analysis (Swanson et al., 2009, de Greaff et al., 
2013) and IHC could be used to identify leukocyte migration into the mammary 
gland. The use of in vitro mammary gland primary cell cultures or immortalized cell 
lines would allow a more accurate dissection of the response due to the use of a 
single cell type. Tissue slices have been used for lung infection models (Liberati et 
al., 2013). It may be possible to develop a similar technique for the mammary gland. 
The main advantage of using tissue slices compared to the tissue sample is that it is 
possible to exclude the inflammatory cells migrating in the tissue in response to the 
stimuli.   Expression of genes of interest in these in vitro systems could be measured 
with quantitative RT-PCR or microarray analysis, whereas production of the protein 
product could be quantified by ELISA.   
 
Production of cytokines and other inflammatory mediators could also be investigated 
with proteome analysis. A recent study measured the production of several 
inflammatory mediators in the mammary gland in response to S. uberis mastitis 
(Bislev et al., 2012a). In this study the peptides were extracted from the tissue, 
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however it is also possible to perform proteomic analysis on cell cultures and milk. A 
database is also available providing data for proteomic analysis of  bovine mammary 
gland  peptides (Bislev et al., 2012a). Proteome targeted analysis is capable of 
quantification of peptides present in very low concentration.  
 
Along with management measures such as mastitis control plans, vaccination is 
considered an important tool in the reduction of IMI in dairy cattle (Denis et al., 
2009, Bharathan and Mullarky, 2011). However, the development of an effective 
vaccine against mastitis pathogens, and particularly against S. uberis, has proven 
difficult (Leigh 1999, Denis et al., 2011). It is still a matter of debate if the mammary 
gland is able to mount an efficient immune response against the most common 
mastitis pathogens after an immunization. Studies conducted on natural cases of 
mastitis showed no protection in cows following an IMI to a subsequent case of IMI 
(Schukken et al., 2009, Schukken et al., 2013). This however could have be due to 
different strains involved in the subsequent infections. Experiments conducted using 
immunogens such as tuberculin (Nonnecke et al., 1986) and ovalbumin (Rainard et 
al., 2013) showed that the mammary gland presents an immunological memory as 
defined by an inflammatory response in the animals immunized a response following 
the re-challenge with the same immunogen used. Milk lymphocytes are however less 
responsive than blood lymphocytes (Nonnecke  and Kehrli, 1985; Nonnecke et al., 
1986) and this could explain the lack of protection to the IMI.  
 
In our study we showed that previous IMI with S. uberis does not induce complete 
protection against a subsequent S. uberis infection. However a degree of protection, 
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with a reduction of bacterial concentration and a reduction of inflammatory cytokine 
responses, was observed in quarters primary challenged with strain FSL Z1-048 and 
secondary challenged with the same (homologous) strain. Similar findings with 
partial protection were reported by vaccines studies conducted using killed (Finch et 
al., 1994) or live (Finch et al., 1997) S. uberis. 
 
A limitation of the present study was represented by the high SCC in quarters 
primary challenged with strain FSL Z1-048 at the time of the secondary challenge. 
High SCC is protective against IMI (Schukken et al., 1999) although unacceptable as 
mean of control in dairy farming as it reduces the quality of  milk. The presence of 
high SCC at challenge did not allow to determine if the protective response observed 
was due to the PMN infiltration itself as a result of the primary challenge, or to an 
immunological adaptive memory response. The flow cytometry data, however, 
suggested that a memory immune response, characterised by a more rapid expansion 
of T cell populations (CD4, CD8 and γδ) within the milk, was present after the 
secondary challenge. A protective response characterised by lymphocyte influx into 
the mammary gland has been observed before following  S. uberis vaccination 
experiments (Finch et al., 1994; Finch et al., 1997). This suggests that the increased 
influx of mammary lymphocyte populations following secondary challenge may play 
a role in protection. 
 
Lymphocyte responses are considered crucial in the development of vaccine against 
mastitis pathogens (Denis, 2009; Barathan and Mullarky, 2011). Although antibody 
responses can be induced in the mammary gland they are not thought  to be 
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protective: In fact the presence of antibodies against S. uberis do not increase the 
killing activity of neutrophils. (Leigh and Field, 1994). It is therefore important to 
further study the cell mediated immune response to S. uberis IMI. The secondary 
challenge experiment described in Chapter 3 could be repeated using strain FSL Z1-
048 strain as primary and secondary challenge strain. Given the low pathogenicity of 
strain FSL Z1-124 other secondary heterologous strains might be selected to be 
tested as secondary challenge stains to test the strain specificity of the immune 
response.  
 
To allow the SCC to return to the physiological level (i.e. < 200,000 cells/mL) and 
avoid difficulties in interpreting the mechanism(s) of protection following secondary 
challenge, a longer rest period could be given to the challenged animals prior to the 
secondary challenge. It would be important to increase the frequency of sampling for 
flow cytometry analysis to allow a more precise study of the timing of the influx of 
lymphocytes in the mammary gland. To further study the role of cell mediated 
immune response, T-cells could be isolated from the blood and from the milk of the 
challenge quarters. The isolation could be achieved using antibody coated magnetic 
beads as described by Denis et al., (2011). Once isolated cells can be cultured and 
used for a range of experiments, such as re stimulation with S. uberis antigens to 
determine if S. uberis specific T cells are present if so, characterise the responding 
cell types.   
 
IL-17A is the prototypic member of a family of cytokines which act as effectors of 
the Th17 response (Curtis and Way, 2009). Its function is to potentiate the innate 
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immune mechanisms, such as the recruitment functional enhancement of phagocytes 
and production of antimicrobial compounds (Pappu et al., 2011). The Th17 response 
is considered particular important in response to extracellular pathogens such as 
bacteria (Curtis and Way, 2009) and there is growing evidence that IL-17 is 
important in the context of the immune response to IMI (Bharathan  and Mullarky, 
2011; Rainard et al., 2013). IL -17A was detected in milk of 4 cows following the 
primary challenge with strain FSL Z1-048. This, to our knowledge, is the first 
description of IL-17A at protein level in response to an intramammary infection in 
cattle. The challenge data also suggest that IL-17A is involved in the clearance of the 
intramammary infection. In fact, the increase in concentration of IL-17A in milk 
coincided with the decrease of the bacterial concentration. 
The effect of IL-17A toward phagocytes present in the mammary gland during the 
intramammary infection with S. uberis was further  investigated in vitro showing an 
increased killing ability of bovine PMN stimulated with recombinant IL-17A toward 
strain FSL Z1-048. Moreover the stimulation of bovine macrophages with 
recombinant IL-17A augmented the killing activity of these cells against strain FSL 
Z1-048. These data together suggest that IL-17A plays a role in the clearance of the 
IMI of S. uberis by stimulating the killing activity of phagocytes. Since the vast 
majority of the cells present in the milk after the challenge were PMN this 
potentiating activity of IL-17 on phagocyte function would be potentially important 
in vivo.   
 
Recent studies conducted in vitro (Bougarn et al., 2011) and in vivo (Rainard et al., 
2013) have shown that IL-17 up-regulates the production of peptides by mammary 
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epithelial cells with anti-bacterial functions such as calgranulin A, calgranulin B, 
Lingual antimicrobial peptide (LAP) and Tracheal antimicrobial peptide (TAP), as 
well as production of inducible. Nitric oxide synthases (iNOS) (Bougran et al., 
2011). These compounds may contribute to the response observed against the 
intramammary infection with S. uberis.  
 
IL-17 is mainly produced by Th17 CD4
+  
lymphocytes (Curtis and Way, 2009), and 
in our challenge study we observed the increase of IL-17A in milk coincident with 
the influx of CD4
+ 
cells in the mammary gland. This suggests that CD4
+
 T cells were 
the source of IL-17, although these observation needs to be carefully considered due 
to the limited number of sampling points for the flow cytometry analysis. A recent 
study (Rainard et al., 2013) showed that during mastitis caused by intramammary 
challenge with Ovalbumin, IL-17 is produced in the mammary gland, further 
supporting a role for IL-17 in bovine mastitis. The source of IL-17 in response to the 
intramammary infection with S. uberis could be further investigated using the 
challenge model that we developed. T cells could be isolated from the milk following 
the challenge with strain FSL Z1-048 and intracellular labelling for IL-17 by flow 
cytometry could be used to determine if T-cells are the indeed source of this cytokine 
at protein level.  
 
Results of the present study further support the hypothesis that Th17 response plays a 
central role in the context of the mammary gland immunity, as illustrated in Figure 6. 
1. In support of this hypothesis it has been found that protective immune memory 
induced by vaccine against a number of extracellular pathogens such as 
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Streptococcus pneumoniae (Lu et al., 2008; Moffit et al., 2011), Klebsiella 
pneumoniae (Chen et al., 2011) and Bordetella pertussis (Warfel and Merkel., 2013) 
is mediated by CD4 Th17 cells. The development of a vaccine toward S. uberis and 
other mastitis pathogens that stimulates a Th17 response is therefore an attractive 





































6. 2 Conclusions  
In conclusion the present studies demonstrate that host adapted and non adapted 
strains of S. uberis elicit different clinical and immune responses after experimental 
challenge of lactating dairy cows. These differences may be due to different 
interactions of the two strains with mammary gland macrophages and the mammary 
epithelial cells but do not appear to be associated with their ability to grow in milk. 
These observations need further investigation to determine the mechanisms involved 
and to extend these conclusions apply to other strains. PMN, lymphocyte responses, 
and in particular the IL-17 response appear to be involved in the  reduction of  the  
bacterial load observed in vivo leading to the clearance of the IMI caused by the 
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